EX-99.1:Report of Independent Registered Public Accounting Firms | ||||||||
EX-99.2:Consolidated Financial Statements for the year ended December 31, 2010, and notes thereto |
TOTAL S.A. |
||||
Date: March 14, 2011 | By: | /s/ JEROME SCHMITT | ||
Name: | Jérôme SCHMITT | |||
Title: | Treasurer |
KPMG Audit A division of KPMG S.A. |
ERNST & YOUNG Audit |
|||
1, cours Valmy | Faubourg de lArche | |||
92923 Paris La Défense Cedex | 11, allée de lArche | |||
92037 Paris La Défense | ||||
Cedex |
KPMG Audit A division of KPMG S.A. |
ERNST & YOUNG Audit | |||||
/s/ JAY NIRSIMLOO
|
/s/ PASCAL MACIOCE | /s/ LAURENT VITSE | ||||
Jay Nirsimloo
|
Pascal Macioce | Laurent Vitse | ||||
Partner
|
Partner | Partner |
For the year ended December 31, | ||||||||||||||||
(M)(a) | 2010 | 2009 | 2008 | |||||||||||||
Sales |
(Notes 4 & 5) | 159,269 | 131,327 | 179,976 | ||||||||||||
Excise taxes |
(18,793 | ) | (19,174 | ) | (19,645 | ) | ||||||||||
Revenues from sales |
140,476 | 112,153 | 160,331 | |||||||||||||
Purchases net of inventory variation |
(Note 6) | (93,171 | ) | (71,058 | ) | (111,024 | ) | |||||||||
Other operating expenses |
(Note 6) | (19,135 | ) | (18,591 | ) | (19,101 | ) | |||||||||
Exploration costs |
(Note 6) | (864 | ) | (698 | ) | (764 | ) | |||||||||
Depreciation, depletion and amortization of tangible assets
and mineral interests |
(8,421 | ) | (6,682 | ) | (5,755 | ) | ||||||||||
Other income |
(Note 7) | 1,396 | 314 | 369 | ||||||||||||
Other expense |
(Note 7) | (900 | ) | (600 | ) | (554 | ) | |||||||||
Financial interest on debt |
(465 | ) | (530 | ) | (1,000 | ) | ||||||||||
Financial income from marketable securities & cash equivalents |
131 | 132 | 473 | |||||||||||||
Cost of net debt |
(Note 29) | (334 | ) | (398 | ) | (527 | ) | |||||||||
Other financial income |
(Note 8) | 442 | 643 | 728 | ||||||||||||
Other financial expense |
(Note 8) | (407 | ) | (345 | ) | (325 | ) | |||||||||
Equity in income (loss) of affiliates |
(Note 12) | 1,953 | 1,642 | 1,721 | ||||||||||||
Income taxes |
(Note 9) | (10,228 | ) | (7,751 | ) | (14,146 | ) | |||||||||
Consolidated net income |
10,807 | 8,629 | 10,953 | |||||||||||||
Group share |
10,571 | 8,447 | 10,590 | |||||||||||||
Minority interests |
236 | 182 | 363 | |||||||||||||
Earnings per share () |
4.73 | 3.79 | 4.74 | |||||||||||||
Fully-diluted earnings per share () |
4.71 | 3.78 | 4.71 | |||||||||||||
(a) | Except for per share amounts. |
Page 1
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Consolidated net income |
10,807 | 8,629 | 10,953 | |||||||||
Other comprehensive income |
||||||||||||
Currency translation adjustment |
2,231 | (244 | ) | (722 | ) | |||||||
Available for sale financial assets |
(100 | ) | 38 | (254 | ) | |||||||
Cash flow hedge |
(80 | ) | 128 | | ||||||||
Share of other comprehensive income of associates, net amount |
302 | 234 | 173 | |||||||||
Other |
(7 | ) | (5 | ) | 1 | |||||||
Tax effect |
28 | (38 | ) | 30 | ||||||||
Total other comprehensive income (net amount) (note 17) |
2,374 | 113 | (772 | ) | ||||||||
Comprehensive income |
13,181 | 8,742 | 10,181 | |||||||||
- Group share |
12,936 | 8,500 | 9,852 | |||||||||
- Minority interests |
245 | 242 | 329 |
Page 2
As of December 31, | ||||||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||||||
ASSETS |
||||||||||||||||
Non-current assets |
||||||||||||||||
Intangible assets, net |
(Notes 5 & 10) | 8,917 | 7,514 | 5,341 | ||||||||||||
Property, plant and equipment, net |
(Notes 5 & 11) | 54,964 | 51,590 | 46,142 | ||||||||||||
Equity affiliates: investments and loans |
(Note 12) | 11,516 | 13,624 | 14,668 | ||||||||||||
Other investments |
(Note 13) | 4,590 | 1,162 | 1,165 | ||||||||||||
Hedging instruments of non-current financial debt |
(Note 20) | 1,870 | 1,025 | 892 | ||||||||||||
Other non-current assets |
(Note 14) | 3,655 | 3,081 | 3,044 | ||||||||||||
Total non-current assets |
85,512 | 77,996 | 71,252 | |||||||||||||
Current assets |
||||||||||||||||
Inventories, net |
(Note 15) | 15,600 | 13,867 | 9,621 | ||||||||||||
Accounts receivable, net |
(Note 16) | 18,159 | 15,719 | 15,287 | ||||||||||||
Other current assets |
(Note 16) | 7,483 | 8,198 | 9,642 | ||||||||||||
Current financial assets |
(Note 20) | 1,205 | 311 | 187 | ||||||||||||
Cash and cash equivalents |
(Note 27) | 14,489 | 11,662 | 12,321 | ||||||||||||
Total current assets |
56,936 | 49,757 | 47,058 | |||||||||||||
Assets classified as held for sale |
(Note 34) | 1,270 | | | ||||||||||||
Total assets |
143,718 | 127,753 | 118,310 | |||||||||||||
LIABILITIES & SHAREHOLDERS EQUITY |
||||||||||||||||
Shareholders equity |
||||||||||||||||
Common shares |
5,874 | 5,871 | 5,930 | |||||||||||||
Paid-in surplus and retained earnings |
60,538 | 55,372 | 52,947 | |||||||||||||
Currency translation adjustment |
(2,495 | ) | (5,069 | ) | (4,876 | ) | ||||||||||
Treasury shares |
(3,503 | ) | (3,622 | ) | (5,009 | ) | ||||||||||
Total shareholders equity Group share |
(Note 17) | 60,414 | 52,552 | 48,992 | ||||||||||||
Minority interests |
857 | 987 | 958 | |||||||||||||
Total shareholders equity |
61,271 | 53,539 | 49,950 | |||||||||||||
Non-current liabilities |
||||||||||||||||
Deferred income taxes |
(Note 9) | 9,947 | 8,948 | 7,973 | ||||||||||||
Employee benefits |
(Note 18) | 2,171 | 2,040 | 2,011 | ||||||||||||
Provisions and other non-current liabilities |
(Note 19) | 9,098 | 9,381 | 7,858 | ||||||||||||
Total non-current liabilities |
21,216 | 20,369 | 17,842 | |||||||||||||
Non-current financial debt |
(Note 20) | 20,783 | 19,437 | 16,191 | ||||||||||||
Current liabilities |
||||||||||||||||
Accounts payable |
18,450 | 15,383 | 14,815 | |||||||||||||
Other creditors and accrued liabilities |
(Note 21) | 11,989 | 11,908 | 11,632 | ||||||||||||
Current borrowings |
(Note 20) | 9,653 | 6,994 | 7,722 | ||||||||||||
Other current financial liabilities |
(Note 20) | 159 | 123 | 158 | ||||||||||||
Total current liabilities |
40,251 | 34,408 | 34,327 | |||||||||||||
Liabilities directly associated with the assets
classified as held for sale |
(Note 34) | 197 | | | ||||||||||||
Total liabilities and shareholders equity |
143,718 | 127,753 | 118,310 | |||||||||||||
Page 3
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
CASH FLOW FROM OPERATING ACTIVITIES |
||||||||||||
Consolidated net income |
10,807 | 8,629 | 10,953 | |||||||||
Depreciation, depletion and amortization |
9,117 | 7,107 | 6,197 | |||||||||
Non-current liabilities, valuation allowances, and deferred taxes |
527 | 441 | (150 | ) | ||||||||
Impact of coverage of pension benefit plans |
(60 | ) | | (505 | ) | |||||||
(Gains) losses on disposals of assets |
(1,046 | ) | (200 | ) | (257 | ) | ||||||
Undistributed affiliates equity earnings |
(470 | ) | (378 | ) | (311 | ) | ||||||
(Increase) decrease in working capital |
(496 | ) | (3,316 | ) | 2,571 | |||||||
Other changes, net |
114 | 77 | 171 | |||||||||
Cash flow from operating activities |
18,493 | 12,360 | 18,669 | |||||||||
CASH FLOW USED IN INVESTING ACTIVITIES |
||||||||||||
Intangible assets and property, plant and equipment additions |
(13,812 | ) | (11,849 | ) | (11,861 | ) | ||||||
Acquisitions of subsidiaries, net of cash acquired |
(862 | ) | (160 | ) | (559 | ) | ||||||
Investments in equity affiliates and other securities |
(654 | ) | (400 | ) | (416 | ) | ||||||
Increase in non-current loans |
(945 | ) | (940 | ) | (804 | ) | ||||||
Total expenditures |
(16,273 | ) | (13,349 | ) | (13,640 | ) | ||||||
Proceeds from disposals of intangible assets and property, plant and equipment |
1,534 | 138 | 130 | |||||||||
Proceeds from disposals of subsidiaries, net of cash sold |
310 | | 88 | |||||||||
Proceeds from disposals of non-current investments |
1,608 | 2,525 | 1,233 | |||||||||
Repayment of non-current loans |
864 | 418 | 1,134 | |||||||||
Total divestments |
4,316 | 3,081 | 2,585 | |||||||||
Cash flow used in investing activities |
(11,957 | ) | (10,268 | ) | (11,055 | ) | ||||||
CASH FLOW USED IN FINANCING ACTIVITIES |
||||||||||||
Issuance (repayment) of shares: |
||||||||||||
- Parent company shareholders |
41 | 41 | 262 | |||||||||
- Treasury shares |
49 | 22 | (1,189 | ) | ||||||||
- Minority shareholders |
| | (4 | ) | ||||||||
Dividends paid: |
||||||||||||
- Parent company shareholders |
(5,098 | ) | (5,086 | ) | (4,945 | ) | ||||||
- Minority shareholders |
(152 | ) | (189 | ) | (213 | ) | ||||||
Other transactions with minority shareholders |
(429 | ) | | | ||||||||
Net issuance (repayment) of non-current debt |
3,789 | 5,522 | 3,009 | |||||||||
Increase (decrease) in current borrowings |
(731 | ) | (3,124 | ) | 1,437 | |||||||
Increase (decrease) in current financial assets and liabilities |
(817 | ) | (54 | ) | 850 | |||||||
Cash flow used in financing activities |
(3,348 | ) | (2,868 | ) | (793 | ) | ||||||
Net increase (decrease) in cash and cash equivalents |
3,188 | (776 | ) | 6,821 | ||||||||
Effect of exchange rates |
(361 | ) | 117 | (488 | ) | |||||||
Cash and cash equivalents at the beginning of the period |
11,662 | 12,321 | 5,988 | |||||||||
Cash and cash equivalents at the end of the period |
14,489 | 11,662 | 12,321 | |||||||||
Page 4
Paid-in | ||||||||||||||||||||||||||||||||||||
surplus and | Currency | Shareholders | Total | |||||||||||||||||||||||||||||||||
Common shares issued | retained | translation | Treasury shares | equity Group | Minority | shareholders | ||||||||||||||||||||||||||||||
(M) | Number | Amount | earnings | adjustment | Number | Amount | share | interests | equity | |||||||||||||||||||||||||||
As of January 1, 2008 |
2,395,532,097 | 5,989 | 48,797 | (4,396 | ) | (151,421,232 | ) | (5,532 | ) | 44,858 | 842 | 45,700 | ||||||||||||||||||||||||
Net income 2008 |
| | 10,590 | | | | 10,590 | 363 | 10,953 | |||||||||||||||||||||||||||
Other comprehensive income
(Note 17) |
| | (258 | ) | (480 | ) | | | (738 | ) | (34 | ) | (772 | ) | ||||||||||||||||||||||
Comprehensive income |
| | 10,332 | (480 | ) | | | 9,852 | 329 | 10,181 | ||||||||||||||||||||||||||
Dividend |
| | (4,945 | ) | | | | (4,945 | ) | (213 | ) | (5,158 | ) | |||||||||||||||||||||||
Issuance of common shares
(Note 17) |
6,275,977 | 16 | 246 | | | | 262 | | 262 | |||||||||||||||||||||||||||
Purchase of treasury shares |
| | | | (27,600,000 | ) | (1,339 | ) | (1,339 | ) | | (1,339 | ) | |||||||||||||||||||||||
Sale of treasury shares(a) |
| | (71 | ) | | 5,939,137 | 221 | 150 | | 150 | ||||||||||||||||||||||||||
Share-based payments (Note 25) |
| | 154 | | 154 | | 154 | |||||||||||||||||||||||||||||
Other operations with minority
interests |
| | | | | | | |||||||||||||||||||||||||||||
Share cancellation (Note 17) |
(30,000,000 | ) | (75 | ) | (1,566 | ) | | 30,000,000 | 1,641 | | | | ||||||||||||||||||||||||
Transactions with shareholders |
(23,724,023 | ) | (59 | ) | (6,182 | ) | | 8,339,137 | 523 | (5,718 | ) | (213 | ) | (5,931 | ) | |||||||||||||||||||||
As of December 31, 2008 |
2,371,808,074 | 5,930 | 52,947 | (4,876 | ) | (143,082,095 | ) | (5,009 | ) | 48,992 | 958 | 49,950 | ||||||||||||||||||||||||
Net income 2009 |
| | 8,447 | | | | 8,447 | 182 | 8,629 | |||||||||||||||||||||||||||
Other comprehensive income
(Note 17) |
| | 246 | (193 | ) | | | 53 | 60 | 113 | ||||||||||||||||||||||||||
Comprehensive income |
| | 8,693 | (193 | ) | | | 8,500 | 242 | 8,742 | ||||||||||||||||||||||||||
Dividend |
| | (5,086 | ) | | | | (5,086 | ) | (189 | ) | (5,275 | ) | |||||||||||||||||||||||
Issuance of common shares
(Note 17) |
1,414,810 | 3 | 38 | | | | 41 | | 41 | |||||||||||||||||||||||||||
Purchase of treasury shares |
| | | | | | | | | |||||||||||||||||||||||||||
Sale of treasury shares(a) |
| | (143 | ) | | 2,874,905 | 165 | 22 | | 22 | ||||||||||||||||||||||||||
Share-based payments (Note 25) |
| | 106 | | | | 106 | | 106 | |||||||||||||||||||||||||||
Other operations with minority
interests |
| | (23 | ) | | | | (23 | ) | (24 | ) | (47 | ) | |||||||||||||||||||||||
Share cancellation (Note 17) |
(24,800,000 | ) | (62 | ) | (1,160 | ) | | 24,800,000 | 1,222 | | | | ||||||||||||||||||||||||
Transactions with shareholders |
(23,385,190 | ) | (59 | ) | (6,268 | ) | | 27,674,905 | 1,387 | (4,940 | ) | (213 | ) | (5,153 | ) | |||||||||||||||||||||
As of December 31, 2009 |
2,348,422,884 | 5,871 | 55,372 | (5,069 | ) | (115,407,190 | ) | (3,622 | ) | 52,552 | 987 | 53,539 | ||||||||||||||||||||||||
Net income 2010 |
| | 10,571 | | | | 10,571 | 236 | 10,807 | |||||||||||||||||||||||||||
Other comprehensive income
(Note 17) |
| | (216 | ) | 2,581 | | | 2,365 | 9 | 2,374 | ||||||||||||||||||||||||||
Comprehensive income |
| | 10,355 | 2,581 | | | 12,936 | 245 | 13,181 | |||||||||||||||||||||||||||
Dividend |
| | (5,098 | ) | | | | (5,098 | ) | (152 | ) | (5,250 | ) | |||||||||||||||||||||||
Issuance of common shares
(Note 17) |
1,218,047 | 3 | 38 | | | | 41 | | 41 | |||||||||||||||||||||||||||
Purchase of treasury shares |
| | | | | | | | | |||||||||||||||||||||||||||
Sale of treasury shares(a) |
| | (70 | ) | | 2,919,511 | 119 | 49 | | 49 | ||||||||||||||||||||||||||
Share-based payments (Note 25) |
| | 140 | | | | 140 | | 140 | |||||||||||||||||||||||||||
Other operations with minority
interests |
| | (199 | ) | (7 | ) | | | (206 | ) | (223 | ) | (429 | ) | ||||||||||||||||||||||
Share cancellation (Note 17) |
| | | | | | | | | |||||||||||||||||||||||||||
Transactions with shareholders |
1,218,047 | 3 | (5,189 | ) | (7 | ) | 2,919,511 | 119 | (5,074 | ) | (375 | ) | (5,449 | ) | ||||||||||||||||||||||
As of December 31, 2010 |
2,349,640,931 | 5,874 | 60,538 | (2,495 | ) | (112,487,679 | ) | (3,503 | ) | 60,414 | 857 | 61,271 | ||||||||||||||||||||||||
(a) | Treasury shares related to the stock option purchase plans and restricted stock grants. |
Page 5
| give a true and fair view of the Groups financial position, financial performance and cash flows; | ||
| reflect the substance of transactions; | ||
| are neutral; | ||
| are prepared on a prudent basis; and | ||
| are complete in all material aspects. |
Page 6
| The consideration transferred, the amount of minority interest and, in business combinations achieved in stages, the fair value at the acquisition date of the investment previously held in the acquired company | ||
| Over the fair value at the acquisition date of acquired identifiable assets and assumed liabilities. |
(i) | Monetary transactions |
(ii) | Translation of financial statements denominated in foreign currencies |
Page 7
Page 8
| Costs of exploratory wells which result in proved reserves are capitalized and then depreciated using the unit-of-production method based on proved developed reserves; | |
| Costs of dry exploratory wells and wells that have not found proved reserves are charged to expense; | |
| Costs of exploratory wells are temporarily capitalized until a determination is made as to whether the well has found proved reserves if both of the following conditions are met: |
| The well has found a sufficient quantity of reserves to justify its completion as a producing well, if appropriate, assuming that the required capital expenditures are made; | ||
| The Group is making sufficient progress assessing the reserves and the economic and operating viability of the project. This progress is evaluated on the basis of indicators such as whether additional exploratory works are under way or firmly planned (wells, seismic or significant studies), whether costs are being incurred for development studies and whether the Group is waiting for governmental or other third-party authorization of a proposed project, or availability of capacity on an existing transport or processing facility. |
Page 9
| Surface infrastructures; | ||
| Machinery and mobile equipment which are significantly costly; | ||
| Utilities and off-sites. |
| the technical feasibility of the project and the availability of the adequate resources for the completion of the intangible asset; | |
| the ability of the asset to generate probable future economic benefits; | |
| the ability to measure reliably the expenditures attributable to the asset; and | |
| the feasibility and intention of the Group to complete the intangible asset and use or sell it. |
| if the project benefits from a specific funding, the capitalization of borrowing costs is based on the borrowing rate; | ||
| if the project is financed by all the Groups debt, the capitalization of borrowing costs is based on the weighted average borrowing cost for the period. |
Page 10
|
Furniture, office equipment, machinery and tools | 3-12 years | ||
|
Transportation equipments | 5-20 years | ||
|
Storage tanks and related equipment | 10-15 years | ||
|
Specialized complex installations and pipelines | 10-30 years | ||
|
Buildings | 10-50 years |
Page 11
| Cash management |
| Long-term financing |
i. | Fair value hedge of the interest rate risk on the external debt and of the currency risk of the loans to subsidiaries. Changes in fair value of derivatives are recognized in the statement of income as are changes in fair value of underlying financial debts and loans to subsidiaries. | ||
The fair value of those hedging instruments of long-term financing is included in the assets under Hedging instruments on non-current financial debt or in the liabilities under Non-current financial debt for the non-current portion. The current portion (less than one year) is accounted for in Current financial assets or Other current financial liabilities. | |||
In case of the anticipated termination of derivative instruments accounted for as fair value hedges, the amount paid or received is recognized in the statement of income and: |
| If this termination is due to an early cancellation of the hedged items, the adjustment previously recorded as revaluation of those hedged items is also recognized in the statement of income; | ||
| If the hedged items remain in the balance sheet, the adjustment previously recorded as a revaluation of those hedged items is spread over the remaining life of those items. |
ii. | Cash flow hedge of the currency risk of the external debt. Changes in fair value are recorded in equity for the effective portion of the hedging and in the statement of income for the ineffective portion of the hedging. Amounts recorded in equity are transferred to the income statement when the hedged transaction affects profit or loss. | ||
The fair value of those hedging instruments of long-term financing is included in the assets under Hedging instruments on non-current financial debt or in the liabilities under Non-current financial debt for the non-current portion. The current portion (less than one year) is accounted for in Current financial assets or Other current financial liabilities. | |||
If the hedging instrument expires, is sold or terminated by anticipation, gains or losses previously recognized in equity remain in equity. Amounts are recycled in the income statement only when the hedged transaction affects profit or loss. |
| Foreign subsidiaries equity hedge |
| Financial instruments related to commodity contracts |
Page 12
| Financial debts, swaps |
| Financial instruments related to commodity contracts |
| Other financial instruments |
| Fair value hierarchy |
| level 1: quotations for assets and liabilities (identical to the ones that are being valued) obtained at the valuation date on an active market to which the entity has access; | ||
| level 2: the entry data are observable data but do not correspond to quotations for identical assets or liabilities; | ||
| level 3: the entry data are not observable data. For example: these data come from extrapolation. This level applies when there is no market or observable data and the company has to use its own hypotheses to estimate the data that other market players would have used to determine the fair value of the asset. |
Page 13
Page 14
| emission rights granted free of charge are accounted for at zero carrying amount; | ||
| liabilities resulting from potential differences between available quotas and quotas to be delivered at the end of the compliance period are accounted for as liabilities and measured at fair market value; | ||
| spot market transactions are recognized in income at cost; and | ||
| forward transactions are recognized at their fair market value on the face of the balance sheet. Changes in the fair value of such forward transactions are recognized in income. |
| property, plant and equipment, and intangible assets are measured using historical cost model instead of revaluation model; | |
| actuarial gains and losses on pension and other post-employment benefit obligations are recognized according to the corridor method (see Note 1 paragraph R to the Consolidated Financial Statements); | |
| jointly-controlled entities are consolidated under the equity method, as provided for in the alternative method of IAS 31 Interests in joint ventures, as from January 1st, 2010. |
Page 15
(iii) | Until June 30, 2010, TOTALs equity share of adjustment items reconciling Business net income to Net income attributable to equity holders of Sanofi-Aventis (see Note 3, paragraph on the sales of Sanofi-Aventis shares and loss of significant influence over Sanofi-Aventis) |
(i) | Operating income (measure used to evaluate operating performance) |
(ii) | Net operating income (measure used to evaluate the return on capital employed) |
Page 16
(iii) | Adjusted income |
(iv) | Fully-diluted adjusted earnings per share |
(v) | Capital employed |
(vi) | ROACE (Return on Average Capital Employed) |
(vii) | Net debt |
| Upstream |
| Total E&P Canada Ltd., a TOTAL subsidiary, signed in July 2010 an agreement with UTS Energy Corporation (UTS) to acquire UTS Corporation with its main asset, a 20% interest in the Fort Hills mining project in the Athabasca region of the Canadian province of Alberta. | ||
Total E&P Canada completed on September 30, 2010 the acquisition of all UTS shares for a cash amount of 3.08 Canadian dollars per share. Taking into account the cash held by UTS and acquired by TOTAL (232 million), the cost of the acquisition for TOTAL amounts to 862 million. This amount mainly represents the value of mineral interests that have been recognized as intangible assets on the face of the Consolidated Balance Sheet for 646 million and the value of tangible assets that have been recognized on the face of the Consolidated Balance Sheet for 217 million. | |||
| TOTAL completed in September 2010 an agreement for the sale to BP and Hess of its interests in the Valhall (15.72%) and Hod (25%) fields, in the Norwegian North Sea, for an amount of 800 million. | ||
| TOTAL signed in September 2010 an agreement with Santos and Petronas to acquire a 20% interest in the GLNG project in Australia. Upon completion of this transaction finalised in October 2010, the project brings together Santos (45%, operator), Petronas (35%) and TOTAL (20%). | ||
The acquisition cost amounts to 566 million and it mainly represents the value of mineral interests that have been recognized as intangible assets on the face of the Consolidated Balance Sheet for 617 million. | |||
In addition, TOTAL announced in December 2010 the signature of an agreement to acquire an additional 7.5% interest in this project (see Note 34 to the Consolidated Financial Statements). | |||
| TOTAL sold in December 2010 its 5% interest in Block 31, located in the Angolan ultra deep offshore, to the company China Sonangol International Holding Limited. |
| Downstream |
| TOTAL and ERG announced in January 2010 that they have signed an agreement to create a joint venture, named TotalErg, by contribution of the major part of their activities in the refining and marketing business in Italy. TotalErg has been operational since October 1st, 2010. The shareholder pact calls for joint governance as well as operating independence for the new entity. TOTALs interest in TotalErg is 49% and is accounted for by the equity method (see Note 12 to the Consolidated Financial Statements). |
| Chemicals |
| TOTAL closed on April 1, 2010 the sale of its consumer specialty chemicals business, Mapa Spontex, to U.S.-based Jarden Corporation for an enterprise value of 335 million. |
| Corporate |
| On March 24, 2010, TOTAL S.A. filed a public tender offer followed by a squeeze out with the French Autorité des Marchés Financiers (AMF) in order to buy the 1,468,725 Elf Aquitaine shares that it did not already hold, representing 0.52% of Elf Aquitaines share capital and 0.27% of its voting rights, at a price of |
Page 17
305 per share (including the remaining 2009 dividend). On April 13, 2010, the French Autorité des marchés financiers (AMF) issued its clearance decision for this offer. | |||
The public tender offer was open from April 16 to April 29, 2010 inclusive. The Elf Aquitaine shares targeted by the offer which were not tendered to the offer have been transferred to TOTAL S.A. under the squeeze out upon payment to the shareholders equal to the offer price on the first trading day after the offer closing date, i.e. on April 30, 2010. | |||
On April 30, 2010, TOTAL S.A. announced that, following the squeeze out, it held 100% of Elf Aquitaine shares, with the transaction amounting to 450 million. | |||
In application of revised standard IAS 27 Consolidated and Separate Financial Statements, effective for annual periods beginning on or after January 1, 2010, transactions with minority interests are accounted for as equity transactions, i.e. in consolidated shareholders equity. | |||
As a consequence, following the squeeze out of the Elf Aquitaine shares by TOTAL S.A., the difference between the consideration paid and the book value of minority interests acquired was recognized directly as a decrease in equity. | |||
| During 2010, TOTAL progressively sold 1.88% of Sanofi-Aventis share capital, thus reducing its interest to 5.51%. | ||
As from July 1, 2010, given its reduced representation on the Board of Directors and the decrease in the percentage of voting rights, TOTAL ceases to have a significant influence over Sanofi-Aventis and no longer consolidates this investment under the equity method. The investment in Sanofi-Aventis is accounted for as a financial asset available for sale in the line Other investments of the balance sheet at its fair value, i.e. at the stock price. | |||
Net income as of December 31, 2010 includes a 135 million gain relating to this change in the accounting treatment. |
| Upstream |
| In December 2009, TOTAL signed an agreement with Chesapeake Energy Corporation whereby Total acquired a 25% share in Chesapeakes Barnett shale gas portfolio located in the United States (State of Texas). The acquisition cost of these assets amounted to 1,562 million and it represented the value of mineral interests that have been recognized as intangible assets on the face of the Consolidated Balance Sheet for 1,449 million and the value of tangible assets that have been recognized on the face of the Consolidated Balance Sheet for 113 million. As no cash payment has occurred in 2009, a corresponding debt has been recognized in the sections Provisions and other non-current liabilities and Other creditors and accrued liabilities for 818 million and 744 million respectively. |
| Corporate |
| During 2009, TOTAL progressively sold 3.99% of Sanofi-Aventis share capital, thus reducing its interest to 7.39%. Sanofi-Aventis is accounted for by the equity method in TOTALs Consolidated Financial Statements for the year ended December 31, 2009. |
| Upstream |
| Pursuant to the tender offer described in the prospectus on May 13, 2008 and renewed by the notices on June 19, July 4 and July 16, 2008, TOTAL acquired 100% of Synenco Energy Incs Class A ordinary shares. Synencos main asset is a 60% interest in the Northern Lights project in the Athabasca region of the Canadian province of Alberta. | ||
The acquisition cost, net of cash acquired (161 million) for all shares amounted to 352 million. This cost essentially represented the value of the companys mineral interests that have been recognized as intangible assets on the face of the Consolidated Balance Sheet for 221 million. | |||
Synenco Energy Inc. is fully consolidated in TOTALs Consolidated Financial Statements. Its contribution to the consolidated net income for fiscal year 2008 was not material. | |||
| In August 2008, TOTAL acquired the Dutch company Goal Petroleum BV. The acquisition cost amounted to 349 million. This cost essentially represented the value of the companys mineral interests that have been recognized as intangible assets on the face of the Consolidated Balance Sheet for 292 million. | ||
Goal Petroleum BV is fully consolidated in TOTALs Consolidated Financial Statements. Its contribution to the consolidated net income for fiscal year 2008 was not material. |
Page 18
| Pursuant to the agreements signed between the partners in November 2008, the Groups participation in the Kashagan field decreased from 18.52% to 16.81%. |
| Corporate |
| During 2008, TOTAL progressively sold 1.68% of Sanofi-Aventis share capital, thus reducing its interest to 11.38%. Sanofi-Aventis is accounted for by the equity method in TOTALs Consolidated Financial Statements for the year ended December 31, 2008. |
| the Upstream segment includes the activities of the Exploration & Production division and the Gas & Power division; | ||
| the Downstream segment includes activities of the Refining & Marketing division and the Trading & Shipping division; and | ||
| the Chemicals segment includes Base Chemicals and Specialties. |
Page 19
For the year ended December 31, 2010 | ||||||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||||||||||||||
Non-Group sales |
18,527 | 123,245 | 17,490 | 7 | | 159,269 | ||||||||||||||||||
Intersegment sales |
22,540 | 4,693 | 981 | 186 | (28,400 | ) | | |||||||||||||||||
Excise taxes |
| (18,793 | ) | | | | (18,793 | ) | ||||||||||||||||
Revenues from sales |
41,067 | 109,145 | 18,471 | 193 | (28,400 | ) | 140,476 | |||||||||||||||||
Operating expenses |
(18,271 | ) | (105,660 | ) | (16,974 | ) | (665 | ) | 28,400 | (113,170 | ) | |||||||||||||
Depreciation, depletion and amortization of
tangible assets and mineral interests |
(5,346 | ) | (2,503 | ) | (533 | ) | (39 | ) | | (8,421 | ) | |||||||||||||
Operating income |
17,450 | 982 | 964 | (511 | ) | | 18,885 | |||||||||||||||||
Equity in income (loss) of affiliates
and other items |
1,533 | 141 | 215 | 595 | | 2,484 | ||||||||||||||||||
Tax on net operating income |
(10,131 | ) | (201 | ) | (267 | ) | 263 | | (10,336 | ) | ||||||||||||||
Net operating income |
8,852 | 922 | 912 | 347 | | 11,033 | ||||||||||||||||||
Net cost of net debt |
(226 | ) | ||||||||||||||||||||||
Minority interests |
(236 | ) | ||||||||||||||||||||||
Net income |
10,571 | |||||||||||||||||||||||
For the year ended December 31, 2010 | ||||||||||||||||||||||||
(adjustments(a)) | ||||||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||||||||||||||
Non-Group sales |
||||||||||||||||||||||||
Intersegment sales |
||||||||||||||||||||||||
Excise taxes |
||||||||||||||||||||||||
Revenues from sales |
||||||||||||||||||||||||
Operating expenses |
| 923 | 92 | | 1,015 | |||||||||||||||||||
Depreciation, depletion and amortization of
tangible assets and mineral interests |
(203 | ) | (1,192 | ) | (21 | ) | | (1,416 | ) | |||||||||||||||
Operating income (b) |
(203 | ) | (269 | ) | 71 | | (401 | ) | ||||||||||||||||
Equity in income (loss) of affiliates
and other items (c) |
183 | (126 | ) | (16 | ) | 227 | 268 | |||||||||||||||||
Tax on net operating income |
275 | 149 | | (6 | ) | 418 | ||||||||||||||||||
Net operating income (b) |
255 | (246 | ) | 55 | 221 | 285 | ||||||||||||||||||
Net cost of net debt |
| |||||||||||||||||||||||
Minority interests |
(2 | ) | ||||||||||||||||||||||
Net income |
283 | |||||||||||||||||||||||
(a) | Adjustments include special items, inventory valuation effect and, until June 30, 2010, equity share of adjustments related to Sanofi-Aventis. |
Upstream | Downstream | Chemicals | Corporate | |||||||||||||
(b) Of which inventory valuation effect |
||||||||||||||||
on operating income |
| 863 | 130 | | ||||||||||||
on net operating income |
| 640 | 113 | | ||||||||||||
(c) Of which equity share of adjustments
related to Sanofi-Aventis |
| | | (81 | ) |
Page 20
For the year ended December 31, 2010 (adjusted) | ||||||||||||||||||||||||
(M)(a) | Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||||||||||||||
Non-Group sales |
18,527 | 123,245 | 17,490 | 7 | | 159,269 | ||||||||||||||||||
Intersegment sales |
22,540 | 4,693 | 981 | 186 | (28,400 | ) | | |||||||||||||||||
Excise taxes |
| (18,793 | ) | | | | (18,793 | ) | ||||||||||||||||
Revenues from sales |
41,067 | 109,145 | 18,471 | 193 | (28,400 | ) | 140,476 | |||||||||||||||||
Operating expenses |
(18,271 | ) | (106,583 | ) | (17,066 | ) | (665 | ) | 28,400 | (114,185 | ) | |||||||||||||
Depreciation, depletion and amortization of
tangible assets and mineral interests |
(5,143 | ) | (1,311 | ) | (512 | ) | (39 | ) | | (7,005 | ) | |||||||||||||
Adjusted operating income |
17,653 | 1,251 | 893 | (511 | ) | | 19,286 | |||||||||||||||||
Equity in income (loss) of affiliates
and other items |
1,350 | 267 | 231 | 368 | | 2,216 | ||||||||||||||||||
Tax on net operating income |
(10,406 | ) | (350 | ) | (267 | ) | 269 | | (10,754 | ) | ||||||||||||||
Adjusted net operating income |
8,597 | 1,168 | 857 | 126 | | 10,748 | ||||||||||||||||||
Net cost of net debt |
(226 | ) | ||||||||||||||||||||||
Minority interests |
(234 | ) | ||||||||||||||||||||||
Adjusted net income |
10,288 | |||||||||||||||||||||||
Adjusted fully-diluted earnings per share () |
4.58 | |||||||||||||||||||||||
(a) | Except for earnings per share |
For the year ended December 31, 2010 | ||||||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||||||||||||||
Total expenditures |
13,208 | 2,343 | 641 | 81 | 16,273 | |||||||||||||||||||
Total divestments |
2,067 | 499 | 347 | 1,403 | 4,316 | |||||||||||||||||||
Cash flow from operating activities |
15,573 | 1,441 | 934 | 545 | 18,493 | |||||||||||||||||||
Balance sheet as of December 31, 2010 |
||||||||||||||||||||||||
Property, plant and equipment, intangible assets, net |
50,565 | 8,675 | 4,388 | 253 | 63,881 | |||||||||||||||||||
Investments in equity affiliates |
5,002 | 2,782 | 1,349 | | 9,133 | |||||||||||||||||||
Loans to equity affiliates and other non-current assets |
4,184 | 1,366 | 979 | 4,099 | 10,628 | |||||||||||||||||||
Working capital |
(363 | ) | 9,154 | 2,223 | (211 | ) | 10,803 | |||||||||||||||||
Provisions and other non-current liabilities |
(16,076 | ) | (2,328 | ) | (1,631 | ) | (1,181 | ) | (21,216 | ) | ||||||||||||||
Assets and liabilities classified as held for sale |
660 | | 413 | | 1,073 | |||||||||||||||||||
Capital Employed (balance sheet) |
43,972 | 19,649 | 7,721 | 2,960 | 74,302 | |||||||||||||||||||
Less inventory valuation effect |
| (4,088 | ) | (409 | ) | 1,061 | (3,436 | ) | ||||||||||||||||
Capital Employed (Business segment information) |
43,972 | 15,561 | 7,312 | 4,021 | 70,866 | |||||||||||||||||||
ROACE as a percentage |
21 | % | 8 | % | 12 | % | 16 | % | ||||||||||||||||
Page 21
For the year ended December 31, 2009 | ||||||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||||||||||||||
Non-Group sales |
16,072 | 100,518 | 14,726 | 11 | | 131,327 | ||||||||||||||||||
Intersegment sales |
15,958 | 3,786 | 735 | 156 | (20,635 | ) | | |||||||||||||||||
Excise taxes |
| (19,174 | ) | | | | (19,174 | ) | ||||||||||||||||
Revenues from sales |
32,030 | 85,130 | 15,461 | 167 | (20,635 | ) | 112,153 | |||||||||||||||||
Operating expenses |
(14,752 | ) | (81,281 | ) | (14,293 | ) | (656 | ) | 20,635 | (90,347 | ) | |||||||||||||
Depreciation, depletion and amortization of
tangible assets and mineral interests |
(4,420 | ) | (1,612 | ) | (615 | ) | (35 | ) | | (6,682 | ) | |||||||||||||
Operating income |
12,858 | 2,237 | 553 | (524 | ) | | 15,124 | |||||||||||||||||
Equity in income (loss) of affiliates
and other items |
846 | 169 | (58 | ) | 697 | | 1,654 | |||||||||||||||||
Tax on net operating income |
(7,486 | ) | (633 | ) | (92 | ) | 326 | | (7,885 | ) | ||||||||||||||
Net operating income |
6,218 | 1,773 | 403 | 499 | | 8,893 | ||||||||||||||||||
Net cost of net debt |
(264 | ) | ||||||||||||||||||||||
Minority interests |
(182 | ) | ||||||||||||||||||||||
Net income |
8,447 | |||||||||||||||||||||||
For the year ended December 31, 2009 | ||||||||||||||||||||||||
(adjustments(a)) | ||||||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||||||||||||||
Non-Group sales |
||||||||||||||||||||||||
Intersegment sales |
||||||||||||||||||||||||
Excise taxes |
||||||||||||||||||||||||
Revenues from sales |
||||||||||||||||||||||||
Operating expenses |
(17 | ) | 1,558 | 344 | | 1,885 | ||||||||||||||||||
Depreciation, depletion and amortization of
tangible assets and mineral interests |
(4 | ) | (347 | ) | (40 | ) | | (391 | ) | |||||||||||||||
Operating income (b) |
(21 | ) | 1,211 | 304 | | 1,494 | ||||||||||||||||||
Equity in income (loss) of affiliates
and other items (c) |
(160 | ) | 22 | (123 | ) | (117 | ) | (378 | ) | |||||||||||||||
Tax on net operating income |
17 | (413 | ) | (50 | ) | (3 | ) | (449 | ) | |||||||||||||||
Net operating income (b) |
(164 | ) | 820 | 131 | (120 | ) | 667 | |||||||||||||||||
Net cost of net debt |
| |||||||||||||||||||||||
Minority interests |
(4 | ) | ||||||||||||||||||||||
Net income |
663 | |||||||||||||||||||||||
(a) | Adjustments include special items, inventory valuation effect and equity share of adjustments related to Sanofi-Aventis. |
Upstream | Downstream | Chemicals | Corporate | |||||||||||||
(b) Of which inventory valuation effect |
||||||||||||||||
on operating income |
| 1,816 | 389 | | ||||||||||||
on net operating income |
| 1,285 | 254 | | ||||||||||||
(c) Of which equity share of adjustments related to Sanofi-Aventis |
| | | (300 | ) |
Page 22
For the year ended December 31, 2009 (adjusted) | ||||||||||||||||||||||||
(M) (a) | Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||||||||||||||
Non-Group sales |
16,072 | 100,518 | 14,726 | 11 | | 131,327 | ||||||||||||||||||
Intersegment sales |
15,958 | 3,786 | 735 | 156 | (20,635 | ) | | |||||||||||||||||
Excise taxes |
| (19,174 | ) | | | | (19,174 | ) | ||||||||||||||||
Revenues from sales |
32,030 | 85,130 | 15,461 | 167 | (20,635 | ) | 112,153 | |||||||||||||||||
Operating expenses |
(14,735 | ) | (82,839 | ) | (14,637 | ) | (656 | ) | 20,635 | (92,232 | ) | |||||||||||||
Depreciation, depletion and amortization of
tangible assets and mineral interests |
(4,416 | ) | (1,265 | ) | (575 | ) | (35 | ) | | (6,291 | ) | |||||||||||||
Adjusted operating income |
12,879 | 1,026 | 249 | (524 | ) | | 13,630 | |||||||||||||||||
Equity in income (loss) of affiliates
and other items |
1,006 | 147 | 65 | 814 | | 2,032 | ||||||||||||||||||
Tax on net operating income |
(7,503 | ) | (220 | ) | (42 | ) | 329 | | (7,436 | ) | ||||||||||||||
Adjusted net operating income |
6,382 | 953 | 272 | 619 | | 8,226 | ||||||||||||||||||
Net cost of net debt |
(264 | ) | ||||||||||||||||||||||
Minority interests |
(178 | ) | ||||||||||||||||||||||
Adjusted net income |
7,784 | |||||||||||||||||||||||
Adjusted fully-diluted earnings per share () |
3.48 | |||||||||||||||||||||||
(a) | Except for earnings per share |
For the year ended December 31, 2009 | ||||||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||||||||||||||
Total expenditures |
9,855 | 2,771 | 631 | 92 | 13,349 | |||||||||||||||||||
Total divestments |
398 | 133 | 47 | 2,503 | 3,081 | |||||||||||||||||||
Cash flow from operating activities |
10,200 | 1,164 | 1,082 | (86 | ) | 12,360 | ||||||||||||||||||
Balance sheet as of December 31, 2009 |
||||||||||||||||||||||||
Property, plant and equipment, intangible assets,
net |
43,997 | 9,588 | 5,248 | 271 | 59,104 | |||||||||||||||||||
Investments in equity affiliates |
4,260 | 2,110 | 652 | 4,235 | 11,257 | |||||||||||||||||||
Loans to equity affiliates and other non-current
assets |
3,844 | 1,369 | 850 | 547 | 6,610 | |||||||||||||||||||
Working capital |
660 | 7,624 | 2,151 | 58 | 10,493 | |||||||||||||||||||
Provisions and other non-current liabilities |
(15,364 | ) | (2,190 | ) | (1,721 | ) | (1,094 | ) | (20,369 | ) | ||||||||||||||
Assets and liabilities classified as held for sale |
| | | | | |||||||||||||||||||
Capital Employed (balance sheet) |
37,397 | 18,501 | 7,180 | 4,017 | 67,095 | |||||||||||||||||||
Less inventory valuation effect |
| (3,202 | ) | (282 | ) | 840 | (2,644 | ) | ||||||||||||||||
Capital Employed
(Business segment information) |
37,397 | 15,299 | 6,898 | 4,857 | 64,451 | |||||||||||||||||||
ROACE as a percentage |
18 | % | 7 | % | 4 | % | 13 | % | ||||||||||||||||
Page 23
For the year ended December 31, 2008 | ||||||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||||||||||||||
Non-Group sales |
24,256 | 135,524 | 20,150 | 46 | | 179,976 | ||||||||||||||||||
Intersegment sales |
25,132 | 5,574 | 1,252 | 120 | (32,078 | ) | | |||||||||||||||||
Excise taxes |
| (19,645 | ) | | | | (19,645 | ) | ||||||||||||||||
Revenues from sales |
49,388 | 121,453 | 21,402 | 166 | (32,078 | ) | 160,331 | |||||||||||||||||
Operating expenses |
(21,915 | ) | (119,425 | ) | (20,942 | ) | (685 | ) | 32,078 | (130,889 | ) | |||||||||||||
Depreciation, depletion and
amortization of
tangible assets and mineral interests |
(4,005 | ) | (1,202 | ) | (518 | ) | (30 | ) | | (5,755 | ) | |||||||||||||
Operating income |
23,468 | 826 | (58 | ) | (549 | ) | | 23,687 | ||||||||||||||||
Equity in income (loss) of affiliates
and other items |
1,541 | (158 | ) | (34 | ) | 590 | | 1,939 | ||||||||||||||||
Tax on net operating income |
(14,563 | ) | (143 | ) | 76 | 315 | | (14,315 | ) | |||||||||||||||
Net operating income |
10,446 | 525 | (16 | ) | 356 | | 11,311 | |||||||||||||||||
Net cost of net debt |
(358 | ) | ||||||||||||||||||||||
Minority interests |
(363 | ) | ||||||||||||||||||||||
Net income |
10,590 | |||||||||||||||||||||||
For the year ended December 31, 2008 | ||||||||||||||||||||||||
(adjustments(a)) | ||||||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||||||||||||||
Non-Group sales |
||||||||||||||||||||||||
Intersegment sales |
||||||||||||||||||||||||
Excise taxes |
||||||||||||||||||||||||
Revenues from sales |
||||||||||||||||||||||||
Operating expenses |
| (2,776 | ) | (925 | ) | | (3,701 | ) | ||||||||||||||||
Depreciation, depletion and amortization of
tangible assets and mineral interest |
(171 | ) | | (6 | ) | | (177 | ) | ||||||||||||||||
Operating income (b) |
(171 | ) | (2,776 | ) | (931 | ) | | (3,878 | ) | |||||||||||||||
Equity in income (loss) of affiliates
and other items (c) |
(164 | ) | (195 | ) | (82 | ) | (345 | ) | (786 | ) | ||||||||||||||
Tax on net operating income |
57 | 927 | 329 | (2 | ) | 1,311 | ||||||||||||||||||
Net operating income (b) |
(278 | ) | (2,044 | ) | (684 | ) | (347 | ) | (3,353 | ) | ||||||||||||||
Net cost of net debt |
| |||||||||||||||||||||||
Minority interests |
23 | |||||||||||||||||||||||
Net income |
(3,330 | ) | ||||||||||||||||||||||
(a) | Adjustments include special items, inventory valuation effect and equity share of adjustments related to Sanofi-Aventis. |
Upstream | Downstream | Chemicals | Corporate | |||||||||||||
(b) Of which inventory valuation effect |
||||||||||||||||
on operating income |
| (2,776 | ) | (727 | ) | | ||||||||||
on net operating income |
| (1,971 | ) | (504 | ) | | ||||||||||
(c) Of which equity share of adjustments
related to Sanofi-Aventis |
| | | (393 | ) |
Page 24
For the year ended December 31, 2008 (adjusted) | ||||||||||||||||||||||||
(M) (a) | Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||||||||||||||
Non-Group sales |
24,256 | 135,524 | 20,150 | 46 | | 179,976 | ||||||||||||||||||
Intersegment sales |
25,132 | 5,574 | 1,252 | 120 | (32,078 | ) | | |||||||||||||||||
Excise taxes |
| (19,645 | ) | | | | (19,645 | ) | ||||||||||||||||
Revenues from sales |
49,388 | 121,453 | 21,402 | 166 | (32,078 | ) | 160,331 | |||||||||||||||||
Operating expenses |
(21,915 | ) | (116,649 | ) | (20,017 | ) | (685 | ) | 32,078 | (127,188 | ) | |||||||||||||
Depreciation, depletion and amortization of
tangible assets and mineral interests |
(3,834 | ) | (1,202 | ) | (512 | ) | (30 | ) | | (5,578 | ) | |||||||||||||
Adjusted operating income |
23,639 | 3,602 | 873 | (549 | ) | | 27,565 | |||||||||||||||||
Equity in income (loss) of affiliates
and other items |
1,705 | 37 | 48 | 935 | | 2,725 | ||||||||||||||||||
Tax on net operating income |
(14,620 | ) | (1,070 | ) | (253 | ) | 317 | | (15,626 | ) | ||||||||||||||
Adjusted net operating income |
10,724 | 2,569 | 668 | 703 | | 14,664 | ||||||||||||||||||
Net cost of net debt |
(358 | ) | ||||||||||||||||||||||
Minority interests |
(386 | ) | ||||||||||||||||||||||
Adjusted net income |
13,920 | |||||||||||||||||||||||
Adjusted fully-diluted earnings per share () |
6.20 | |||||||||||||||||||||||
(a) | Except for earnings per share |
For the year ended December 31, 2008 | ||||||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||||||||||||||
Total expenditures |
10,017 | 2,418 | 1,074 | 131 | 13,640 | |||||||||||||||||||
Total divestments |
1,130 | 216 | 53 | 1,186 | 2,585 | |||||||||||||||||||
Cash flow from operating activities |
13,765 | 3,111 | 920 | 873 | 18,669 | |||||||||||||||||||
Balance sheet as of December 31, 2008 |
||||||||||||||||||||||||
Property, plant and equipment, intangible assets,
net |
37,090 | 8,823 | 5,323 | 247 | 51,483 | |||||||||||||||||||
Investments in equity affiliates |
3,892 | 1,958 | 677 | 6,134 | 12,661 | |||||||||||||||||||
Loans to equity affiliates and other non-current
assets |
3,739 | 1,170 | 762 | 545 | 6,216 | |||||||||||||||||||
Working capital |
570 | 5,317 | 2,348 | (132 | ) | 8,103 | ||||||||||||||||||
Provisions and other non-current liabilities |
(12,610 | ) | (2,191 | ) | (1,903 | ) | (1,138 | ) | (17,842 | ) | ||||||||||||||
Assets and liabilities classified as held for sale |
| | | | | |||||||||||||||||||
Capital Employed (balance sheet) |
32,681 | 15,077 | 7,207 | 5,656 | 60,621 | |||||||||||||||||||
Less inventory valuation effect |
| (1,454 | ) | (46 | ) | 387 | (1,113 | ) | ||||||||||||||||
Capital Employed
(Business segment information) |
32,681 | 13,623 | 7,161 | 6,043 | 59,508 | |||||||||||||||||||
ROACE as a percentage |
36 | % | 20 | % | 9 | % | 26 | % | ||||||||||||||||
Page 25
Consolidated | ||||||||||||
For the year ended December 31, 2010 | statement of | |||||||||||
(M) | Adjusted | Adjustments(a) | income | |||||||||
Sales |
159,269 | | 159,269 | |||||||||
Excise taxes |
(18,793 | ) | | (18,793 | ) | |||||||
Revenues from sales |
140,476 | | 140,476 | |||||||||
Purchases, net of inventory variation |
(94,286 | ) | 1,115 | (93,171 | ) | |||||||
Other operating expenses |
(19,035 | ) | (100 | ) | (19,135 | ) | ||||||
Exploration costs |
(864 | ) | | (864 | ) | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests |
(7,005 | ) | (1,416 | ) | (8,421 | ) | ||||||
Other income |
524 | 872 | 1,396 | |||||||||
Other expense |
(346 | ) | (554 | ) | (900 | ) | ||||||
Financial interest on debt |
(465 | ) | | (465 | ) | |||||||
Financial income from marketable securities & cash equivalents |
131 | | 131 | |||||||||
Cost of net debt |
(334 | ) | | (334 | ) | |||||||
Other financial income |
442 | | 442 | |||||||||
Other financial expense |
(407 | ) | | (407 | ) | |||||||
Equity in income (loss) of affiliates |
2,003 | (50 | ) | 1,953 | ||||||||
Income taxes |
(10,646 | ) | 418 | (10,228 | ) | |||||||
Consolidated net income |
10,522 | 285 | 10,807 | |||||||||
Group share |
10,288 | 283 | 10,571 | |||||||||
Minority interests |
234 | 2 | 236 | |||||||||
(a) | Adjustments include special items, inventory valuation effect and, until June 30, 2010, equity share of adjustments related to Sanofi-Aventis. |
Consolidated | ||||||||||||
For the year ended December 31, 2009 | statement of | |||||||||||
(M) | Adjusted | Adjustments(a) | income | |||||||||
Sales |
131,327 | | 131,327 | |||||||||
Excise taxes |
(19,174 | ) | | (19,174 | ) | |||||||
Revenues from sales |
112,153 | | 112,153 | |||||||||
Purchases, net of inventory variation |
(73,263 | ) | 2,205 | (71,058 | ) | |||||||
Other operating expenses |
(18,271 | ) | (320 | ) | (18,591 | ) | ||||||
Exploration costs |
(698 | ) | | (698 | ) | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests |
(6,291 | ) | (391 | ) | (6,682 | ) | ||||||
Other income |
131 | 183 | 314 | |||||||||
Other expense |
(315 | ) | (285 | ) | (600 | ) | ||||||
Financial interest on debt |
(530 | ) | | (530 | ) | |||||||
Financial income from marketable securities & cash equivalents |
132 | | 132 | |||||||||
Cost of net debt |
(398 | ) | | (398 | ) | |||||||
Other financial income |
643 | | 643 | |||||||||
Other financial expense |
(345 | ) | | (345 | ) | |||||||
Equity in income (loss) of affiliates |
1,918 | (276 | ) | 1,642 | ||||||||
Income taxes |
(7,302 | ) | (449 | ) | (7,751 | ) | ||||||
Consolidated net income |
7,962 | 667 | 8,629 | |||||||||
Group share |
7,784 | 663 | 8,447 | |||||||||
Minority interests |
178 | 4 | 182 | |||||||||
(a) | Adjustments include special items, inventory valuation effect and equity share of adjustments related to Sanofi-Aventis. |
Page 26
Consolidated | ||||||||||||
For the year ended December 31, 2008 | statement of | |||||||||||
(M) | Adjusted | Adjustments(a) | income | |||||||||
Sales |
179,976 | | 179,976 | |||||||||
Excise taxes |
(19,645 | ) | | (19,645 | ) | |||||||
Revenues from sales |
160,331 | | 160,331 | |||||||||
Purchases, net of inventory variation |
(107,521 | ) | (3,503 | ) | (111,024 | ) | ||||||
Other operating expenses |
(18,903 | ) | (198 | ) | (19,101 | ) | ||||||
Exploration costs |
(764 | ) | | (764 | ) | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests |
(5,578 | ) | (177 | ) | (5,755 | ) | ||||||
Other income |
153 | 216 | 369 | |||||||||
Other expense |
(147 | ) | (407 | ) | (554 | ) | ||||||
Financial interest on debt |
(1,000 | ) | | (1,000 | ) | |||||||
Financial income from marketable securities & cash equivalents |
473 | | 473 | |||||||||
Cost of net debt |
(527 | ) | | (527 | ) | |||||||
Other financial income |
728 | | 728 | |||||||||
Other financial expense |
(325 | ) | | (325 | ) | |||||||
Equity in income (loss) of affiliates |
2,316 | (595 | ) | 1,721 | ||||||||
Income taxes |
(15,457 | ) | 1,311 | (14,146 | ) | |||||||
Consolidated net income |
14,306 | (3,353 | ) | 10,953 | ||||||||
Group share |
13,920 | (3,330 | ) | 10,590 | ||||||||
Minority interests |
386 | (23 | ) | 363 | ||||||||
(a) | Adjustments include special items, inventory valuation effect and equity share of adjustments related to Sanofi-Aventis. |
Adjustments to operating income | ||||||||||||||||||||
For the year ended December 31, 2010 | ||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Total | |||||||||||||||
Inventory valuation effect |
| 863 | 130 | | 993 | |||||||||||||||
Restructuring charges |
| | | | | |||||||||||||||
Asset impairment charges |
(203 | ) | (1,192 | ) | (21 | ) | | (1,416 | ) | |||||||||||
Other items |
| 60 | (38 | ) | | 22 | ||||||||||||||
Total |
(203 | ) | (269 | ) | 71 | | (401 | ) | ||||||||||||
Adjustments to net income, Group share | ||||||||||||||||||||
For the year ended December 31, 2010 | ||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Total | |||||||||||||||
Inventory valuation effect |
| 635 | 113 | | 748 | |||||||||||||||
TOTALs equity share of adjustments related to Sanofi-Aventis |
| | | (81 | ) | (81 | ) | |||||||||||||
Restructuring charges |
| (12 | ) | (41 | ) | | (53 | ) | ||||||||||||
Asset impairment charges |
(297 | ) | (913 | ) | (14 | ) | | (1,224 | ) | |||||||||||
Gains (losses) on disposals of assets |
589 | 122 | 33 | 302 | 1,046 | |||||||||||||||
Other items |
(37 | ) | (83 | ) | (33 | ) | | (153 | ) | |||||||||||
Total |
255 | (251 | ) | 58 | 221 | 283 | ||||||||||||||
Page 27
Adjustments to operating income | ||||||||||||||||||||
For the year ended December 31, 2009 | ||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Total | |||||||||||||||
Inventory valuation effect |
| 1,816 | 389 | | 2,205 | |||||||||||||||
Restructuring charges |
| | | | | |||||||||||||||
Asset impairment charges |
(4 | ) | (347 | ) | (40 | ) | | (391 | ) | |||||||||||
Other items |
(17 | ) | (258 | ) | (45 | ) | | (320 | ) | |||||||||||
Total |
(21 | ) | 1,211 | 304 | | 1,494 | ||||||||||||||
Adjustments to net income, Group share | ||||||||||||||||||||
For the year ended December 31, 2009 | ||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Total | |||||||||||||||
Inventory valuation effect |
| 1,279 | 254 | | 1,533 | |||||||||||||||
TOTALs equity share of adjustments related to Sanofi-Aventis |
| | | (300 | ) | (300 | ) | |||||||||||||
Restructuring charges |
| (27 | ) | (102 | ) | | (129 | ) | ||||||||||||
Asset impairment charges |
(52 | ) | (253 | ) | (28 | ) | | (333 | ) | |||||||||||
Gains (losses) on disposals of assets |
| | | 179 | 179 | |||||||||||||||
Other items |
(112 | ) | (182 | ) | 7 | | (287 | ) | ||||||||||||
Total |
(164 | ) | 817 | 131 | (121 | ) | 663 | |||||||||||||
Adjustments to operating income | ||||||||||||||||||||
For the year ended December 31, 2008 | ||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Total | |||||||||||||||
Inventory valuation effect |
| (2,776 | ) | (727 | ) | | (3,503 | ) | ||||||||||||
Restructuring charges |
| | | | | |||||||||||||||
Asset impairment charges |
(171 | ) | | (6 | ) | | (177 | ) | ||||||||||||
Other items |
| | (198 | ) | | (198 | ) | |||||||||||||
Total |
(171 | ) | (2,776 | ) | (931 | ) | | (3,878 | ) | |||||||||||
Adjustments to net income, Group share | ||||||||||||||||||||
For the year ended December 31, 2008 | ||||||||||||||||||||
(M) | Upstream | Downstream | Chemicals | Corporate | Total | |||||||||||||||
Inventory valuation effect |
| (1,949 | ) | (503 | ) | | (2,452 | ) | ||||||||||||
TOTALs equity share of adjustments related to Sanofi-Aventis |
| | | (393 | ) | (393 | ) | |||||||||||||
Restructuring charges |
| (47 | ) | (22 | ) | | (69 | ) | ||||||||||||
Asset impairment charges |
(172 | ) | (26 | ) | (7 | ) | | (205 | ) | |||||||||||
Gains (losses) on disposals of assets |
130 | | | 84 | 214 | |||||||||||||||
Other items |
(236 | ) | | (151 | ) | (38 | ) | (425 | ) | |||||||||||
Total |
(278 | ) | (2,022 | ) | (683 | ) | (347 | ) | (3,330 | ) | ||||||||||
| the recoverable amount of CGUs has been based on their value in use, as defined in Note 1 paragraph L to the Consolidated Financial Statements Impairment of long-lived assets; | ||
| future cash flows have been determined with the assumptions in the long-term plan of the Group. These assumptions (including future prices of products, supply and demand for products, future production volumes) |
Page 28
represent the best estimate by management of the Group of all economic conditions during the remaining life of assets; |
| future cash flows, based on the long-term plan, are prepared over a period consistent with the life of the assets within the CGU. They are prepared post-tax and include specific risks attached to CGU assets. They are discounted using a 8% post-tax discount rate, this rate being a weighted-average capital cost estimated from historical market data. This rate has been applied consistently for the years ending in 2008, 2009 and 2010; | ||
| value in use calculated by discounting the above post-tax cash flows using a 8% post-tax discount rate is not materially different from value in use calculated by discounting pre-tax cash flows using a pre-tax discount rate determined by an iterative computation from the post-tax value in use. These pre-tax discount rates are in a range from 9% to 12% in 2010. |
Page 29
Rest of | North | Rest of the | ||||||||||||||||||||||
(M) | France | Europe | America | Africa | world | Total | ||||||||||||||||||
For the year ended December 31, 2010 |
||||||||||||||||||||||||
Non-Group sales |
36,820 | 72,636 | 12,432 | 12,561 | 24,820 | 159,269 | ||||||||||||||||||
Property, plant and equipment, intangible assets, net |
5,666 | 14,568 | 9,584 | 20,166 | 13,897 | 63,881 | ||||||||||||||||||
Capital expenditures |
1,062 | 2,629 | 3,626 | 4,855 | 4,101 | 16,273 | ||||||||||||||||||
For the year ended December 31, 2009 |
||||||||||||||||||||||||
Non-Group sales |
32,437 | 60,140 | 9,515 | 9,808 | 19,427 | 131,327 | ||||||||||||||||||
Property, plant and equipment, intangible assets, net |
6,973 | 15,218 | 8,112 | 17,312 | 11,489 | 59,104 | ||||||||||||||||||
Capital expenditures |
1,189 | 2,502 | 1,739 | 4,651 | 3,268 | 13,349 | ||||||||||||||||||
For the year ended December 31, 2008 |
||||||||||||||||||||||||
Non-Group sales |
43,616 | 82,761 | 14,002 | 12,482 | 27,115 | 179,976 | ||||||||||||||||||
Property, plant and equipment, intangible assets, net |
7,260 | 13,485 | 5,182 | 15,460 | 10,096 | 51,483 | ||||||||||||||||||
Capital expenditures |
1,997 | 2,962 | 1,255 | 4,500 | 2,926 | 13,640 | ||||||||||||||||||
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Purchases, net of inventory variation(a) |
(93,171 | ) | (71,058 | ) | (111,024 | ) | ||||||
Exploration costs |
(864 | ) | (698 | ) | (764 | ) | ||||||
Other operating expenses(b) |
(19,135 | ) | (18,591 | ) | (19,101 | ) | ||||||
of which non-current operating liabilities (allowances) reversals |
387 | 515 | 459 | |||||||||
of which current operating liabilities (allowances) reversals |
(101 | ) | (43 | ) | (29 | ) | ||||||
Operating expenses |
(113,170 | ) | (90,347 | ) | (130,889 | ) | ||||||
(a) | Includes taxes paid on oil and gas production in the Upstream segment, namely royalties. | |
(b) | Principally composed of production and administrative costs (see in particular the payroll costs as detailed in Note 26 to the Consolidated Financial Statements Payroll and staff). |
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Gains (losses) on disposal of assets |
1,117 | 200 | 257 | |||||||||
Foreign exchange gains |
| | 112 | |||||||||
Other |
279 | 114 | | |||||||||
Other income |
1,396 | 314 | 369 | |||||||||
Foreign exchange losses |
| (32 | ) | | ||||||||
Amortization of other intangible assets (excl. mineral interests) |
(267 | ) | (142 | ) | (162 | ) | ||||||
Other |
(633 | ) | (426 | ) | (392 | ) | ||||||
Other expense |
(900 | ) | (600 | ) | (554 | ) | ||||||
Page 30
| 107 million of restructuring charges in the Upstream, Downstream and Chemicals segments; and | |
| 48 million of changes in provisions related to various antitrust investigations as described in Note 32 to the Consolidated Financial Statements Other risks and contingent liabilities. |
As of December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Dividend income on non-consolidated subsidiaries |
255 | 210 | 238 | |||||||||
Capitalized financial expenses |
113 | 117 | 271 | |||||||||
Other |
74 | 316 | 219 | |||||||||
Other financial income |
442 | 643 | 728 | |||||||||
Accretion of asset retirement obligations |
(338 | ) | (283 | ) | (229 | ) | ||||||
Other |
(69 | ) | (62 | ) | (96 | ) | ||||||
Other financial expense |
(407 | ) | (345 | ) | (325 | ) |
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Current income taxes |
(9,934 | ) | (7,213 | ) | (14,117 | ) | ||||||
Deferred income taxes |
(294 | ) | (538 | ) | (29 | ) | ||||||
Total income taxes |
(10,228 | ) | (7,751 | ) | (14,146 | ) | ||||||
Page 31
As of December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Net operating losses and tax carry forwards |
1,145 | 1,114 | 1,031 | |||||||||
Employee benefits |
535 | 517 | 519 | |||||||||
Other temporary non-deductible provisions |
2,757 | 2,184 | 2,075 | |||||||||
Gross deferred tax assets |
4,437 | 3,815 | 3,625 | |||||||||
Valuation allowance |
(576 | ) | (484 | ) | (475 | ) | ||||||
Net deferred tax assets |
3,861 | 3,331 | 3,150 | |||||||||
Excess tax over book depreciation |
(10,966 | ) | (9,791 | ) | (8,836 | ) | ||||||
Other temporary tax deductions |
(1,339 | ) | (1,179 | ) | (1,171 | ) | ||||||
Gross deferred tax liability |
(12,305 | ) | (10,970 | ) | (10,007 | ) | ||||||
Net deferred tax liability |
(8,444 | ) | (7,639 | ) | (6,857 | ) | ||||||
As of December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Deferred tax assets, non-current (note 14) |
1,378 | 1,164 | 1,010 | |||||||||
Deferred tax assets, current (note 16) |
151 | 214 | 206 | |||||||||
Deferred tax liabilities, non-current |
(9,947 | ) | (8,948 | ) | (7,973 | ) | ||||||
Deferred tax liabilities, current |
(26 | ) | (69 | ) | (100 | ) | ||||||
Net amount |
(8,444 | ) | (7,639 | ) | (6,857 | ) | ||||||
As of December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Opening balance |
(7,639 | ) | (6,857 | ) | (7,251 | ) | ||||||
Deferred tax on income |
(294 | ) | (538 | ) | (29 | ) | ||||||
Deferred tax on shareholders equity(a) |
28 | (38 | ) | 30 | ||||||||
Changes in scope of consolidation |
(59 | ) | (1 | ) | (1 | ) | ||||||
Currency translation adjustment |
(480 | ) | (205 | ) | 394 | |||||||
Closing balance |
(8,444 | ) | (7,639 | ) | (6,857 | ) | ||||||
(a) | This amount includes mainly current income taxes and deferred taxes for changes in fair value of listed securities classified as financial assets available for sale as well as deferred taxes related to the cash flow hedge (see Note 17 to the Consolidated Financial Statements). |
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Consolidated net income |
10,807 | 8,629 | 10,953 | |||||||||
Provision for income taxes |
10,228 | 7,751 | 14,146 | |||||||||
Pre-tax income |
21,035 | 16,380 | 25,099 | |||||||||
French statutory tax rate |
34.43 | % | 34.43 | % | 34.43 | % | ||||||
Theoretical tax charge |
(7,242 | ) | (5,640 | ) | (8,642 | ) | ||||||
Difference between French and foreign income tax rates |
(4,921 | ) | (3,214 | ) | (6,326 | ) | ||||||
Tax effect of equity in income (loss) of affiliates |
672 | 565 | 593 | |||||||||
Permanent differences |
1,375 | 597 | 315 | |||||||||
Adjustments on prior years income taxes |
(45 | ) | (47 | ) | 12 | |||||||
Adjustments on deferred tax related to changes in tax rates |
2 | (1 | ) | (31 | ) | |||||||
Changes in valuation allowance of deferred tax assets |
(65 | ) | (6 | ) | (63 | ) | ||||||
Other |
(4 | ) | (5 | ) | (4 | ) | ||||||
Net provision for income taxes |
(10,228 | ) | (7,751 | ) | (14,146 | ) | ||||||
Page 32
As of December 31, | 2010 | 2009 | 2008 | |||||||||||||||||||||
(M) | Basis | Tax | Basis | Tax | Basis | Tax | ||||||||||||||||||
2009 |
| | | | 233 | 115 | ||||||||||||||||||
2010 |
| | 258 | 126 | 167 | 79 | ||||||||||||||||||
2011 |
225 | 110 | 170 | 83 | 93 | 42 | ||||||||||||||||||
2012 |
177 | 80 | 121 | 52 | 61 | 19 | ||||||||||||||||||
2013 (a) |
146 | 59 | 133 | 43 | 1,765 | 587 | ||||||||||||||||||
2014 (b) |
1,807 | 602 | 1,804 | 599 | | | ||||||||||||||||||
2015 and after |
190 | 62 | | | | | ||||||||||||||||||
Unlimited |
774 | 232 | 661 | 211 | 560 | 189 | ||||||||||||||||||
Total |
3,319 | 1,145 | 3,147 | 1,114 | 2,879 | 1,031 | ||||||||||||||||||
(a) | Net operating losses and tax credit carryforwards in 2013 and after for 2008 | |
(b) | Net operating losses and tax credit carryforwards in 2014 and after for 2009 |
Page 33
As of December 31, 2010 | ||||||||||||
(M) | Cost | Amortization and impairment | Net | |||||||||
Goodwill |
1,498 | (596 | ) | 902 | ||||||||
Proved and unproved mineral interests |
10,099 | (2,712 | ) | 7,387 | ||||||||
Other intangible assets |
2,803 | (2,175 | ) | 628 | ||||||||
Total intangible assets |
14,400 | (5,483 | ) | 8,917 | ||||||||
As of December 31, 2009 | ||||||||||||
(M) | Cost | Amortization and impairment | Net | |||||||||
Goodwill |
1,776 | (614 | ) | 1,162 | ||||||||
Proved and unproved mineral interests |
8,204 | (2,421 | ) | 5,783 | ||||||||
Other intangible assets |
2,712 | (2,143 | ) | 569 | ||||||||
Total intangible assets |
12,692 | (5,178 | ) | 7,514 | ||||||||
As of December 31, 2008 | ||||||||||||
(M) | Cost | Amortization and impairment | Net | |||||||||
Goodwill |
1,690 | (616 | ) | 1,074 | ||||||||
Proved and unproved mineral interests |
6,010 | (2,268 | ) | 3,742 | ||||||||
Other intangible assets |
2,519 | (1,994 | ) | 525 | ||||||||
Total intangible assets |
10,219 | (4,878 | ) | 5,341 | ||||||||
Currency | ||||||||||||||||||||||||||||
Net amount as | Amortization and | translation | Net amount as of | |||||||||||||||||||||||||
(M) | of January 1, | Acquisitions | Disposals | impairment | adjustment | Other | December 31, | |||||||||||||||||||||
2010 |
7,514 | 2,466 | (62 | ) | (553 | ) | 491 | (939 | ) | 8,917 | ||||||||||||||||||
2009 |
5,341 | 629 | (64 | ) | (345 | ) | 2 | 1,951 | 7,514 | |||||||||||||||||||
2008 |
4,650 | 404 | (3 | ) | (259 | ) | (93 | ) | 642 | 5,341 | ||||||||||||||||||
Net goodwill as | Net goodwill as of | |||||||||||||||||||
(M) | of January 1, 2010 | Increases | Impairments | Other | December 31, 2010 | |||||||||||||||
Upstream |
78 | | | | 78 | |||||||||||||||
Downstream |
202 | 22 | (88 | ) | (54 | ) | 82 | |||||||||||||
Chemicals |
857 | | | (140 | ) | 717 | ||||||||||||||
Corporate |
25 | | | | 25 | |||||||||||||||
Total |
1,162 | 22 | (88 | ) | (194 | ) | 902 | |||||||||||||
Page 34
As of December 31, 2010 | ||||||||||||
(M) | Cost | Depreciation and impairment | Net | |||||||||
Upstream properties |
||||||||||||
Proved properties |
77,183 | (50,582 | ) | 26,601 | ||||||||
Unproved properties |
347 | (1 | ) | 346 | ||||||||
Work in progress |
14,712 | (37 | ) | 14,675 | ||||||||
Subtotal |
92,242 | (50,620 | ) | 41,622 | ||||||||
Other property, plant and equipment |
||||||||||||
Land |
1,304 | (393 | ) | 911 | ||||||||
Machinery, plant and equipment
(including transportation
equipment) |
23,831 | (17,010 | ) | 6,821 | ||||||||
Buildings |
6,029 | (3,758 | ) | 2,271 | ||||||||
Work in progress |
2,350 | (488 | ) | 1,862 | ||||||||
Other |
6,164 | (4,687 | ) | 1,477 | ||||||||
Subtotal |
39,678 | (26,336 | ) | 13,342 | ||||||||
Total property, plant and equipment |
131,920 | (76,956 | ) | 54,964 | ||||||||
As of December 31, 2009 | ||||||||||||
(M) | Cost | Depreciation and impairment | Net | |||||||||
Upstream properties |
||||||||||||
Proved properties |
71,082 | (44,718 | ) | 26,364 | ||||||||
Unproved properties |
182 | (1 | ) | 181 | ||||||||
Work in progress |
10,351 | (51 | ) | 10,300 | ||||||||
Subtotal |
81,615 | (44,770 | ) | 36,845 | ||||||||
Other property, plant and equipment |
||||||||||||
Land |
1,458 | (435 | ) | 1,023 | ||||||||
Machinery, plant and equipment
(including transportation
equipment) |
22,927 | (15,900 | ) | 7,027 | ||||||||
Buildings |
6,142 | (3,707 | ) | 2,435 | ||||||||
Work in progress |
2,774 | (155 | ) | 2,619 | ||||||||
Other |
6,506 | (4,865 | ) | 1,641 | ||||||||
Subtotal |
39,807 | (25,062 | ) | 14,745 | ||||||||
Total property, plant and equipment |
121,422 | (69,832 | ) | 51,590 | ||||||||
As of December 31, 2008 | ||||||||||||
(M) | Cost | Depreciation and impairment | Net | |||||||||
Upstream properties |
||||||||||||
Proved properties |
61,727 | (39,315 | ) | 22,412 | ||||||||
Unproved properties |
106 | (1 | ) | 105 | ||||||||
Work in progress |
9,586 | | 9,586 | |||||||||
Subtotal |
71,419 | (39,316 | ) | 32,103 | ||||||||
Other property, plant and equipment |
||||||||||||
Land |
1,446 | (429 | ) | 1,017 | ||||||||
Machinery, plant and equipment (including transportation equipment) |
21,734 | (14,857 | ) | 6,877 | ||||||||
Buildings |
5,739 | (3,441 | ) | 2,298 | ||||||||
Work in progress |
2,226 | (10 | ) | 2,216 | ||||||||
Other |
6,258 | (4,627 | ) | 1,631 | ||||||||
Subtotal |
37,403 | (23,364 | ) | 14,039 | ||||||||
Total property, plant and equipment |
108,822 | (62,680 | ) | 46,142 | ||||||||
Currency | ||||||||||||||||||||||||||||
Net amount as | Depreciation and | translation | Net amount as of | |||||||||||||||||||||||||
(M) | of January 1, | Acquisitions | Disposals | impairment | adjustment | Other | December 31, | |||||||||||||||||||||
2010 |
51,590 | 11,346 | (1,269 | ) | (8,564 | ) | 2,974 | (1,113 | ) | 54,964 | ||||||||||||||||||
2009 |
46,142 | 11,212 | (65 | ) | (6,765 | ) | 397 | 669 | 51,590 | |||||||||||||||||||
2008 |
41,467 | 11,442 | (102 | ) | (5,941 | ) | (1,151 | ) | 427 | 46,142 | ||||||||||||||||||
Page 35
As of December 31, 2010 | ||||||||||||
(M) | Cost | Depreciation and impairment | Net | |||||||||
Machinery, plant and equipment |
480 | (332 | ) | 148 | ||||||||
Buildings |
54 | (24 | ) | 30 | ||||||||
Other |
| | | |||||||||
Total |
534 | (356 | ) | 178 | ||||||||
As of December 31, 2009 | ||||||||||||
(M) | Cost | Depreciation and impairment | Net | |||||||||
Machinery, plant and equipment |
548 | (343 | ) | 205 | ||||||||
Buildings |
60 | (30 | ) | 30 | ||||||||
Other |
| | | |||||||||
Total |
608 | (373 | ) | 235 | ||||||||
As of December 31, 2008 | ||||||||||||
(M) | Cost | Depreciation and impairment | Net | |||||||||
Machinery, plant and equipment |
558 | (316 | ) | 242 | ||||||||
Buildings |
35 | (28 | ) | 7 | ||||||||
Other |
| | | |||||||||
Total |
593 | (344 | ) | 249 | ||||||||
Page 36
As of December 31, | ||||||||||||||||||||||||
Equity value | 2010 | 2009 | 2008 | 2010 | 2009 | 2008 | ||||||||||||||||||
(M) | % owned | equity value | ||||||||||||||||||||||
NLNG |
15.00 | % | 15.00 | % | 15.00 | % | 1,108 | 1,136 | 1,135 | |||||||||||||||
PetroCedeño EM |
30.32 | % | 30.32 | % | 30.32 | % | 1,136 | 874 | 760 | |||||||||||||||
CEPSA (Upstream share) |
48.83 | % | 48.83 | % | 48.83 | % | 340 | 385 | 403 | |||||||||||||||
Angola LNG Ltd. |
13.60 | % | 13.60 | % | 13.60 | % | 710 | 490 | 326 | |||||||||||||||
Qatargas |
10.00 | % | 10.00 | % | 10.00 | % | 85 | 83 | 251 | |||||||||||||||
Société du Terminal Méthanier de Fos Cavaou |
28.03 | % | 28.79 | % | 30.30 | % | 125 | 124 | 114 | |||||||||||||||
Dolphin Energy Ltd (Del) Abu Dhabi |
24.50 | % | 24.50 | % | 24.50 | % | 172 | 118 | 85 | |||||||||||||||
Qatar Liquefied Gas Company Limited II (Train B) |
16.70 | % | 16.70 | % | 16.70 | % | 184 | 143 | 82 | |||||||||||||||
Shtokman Development AG (a) |
25.00 | % | 25.00 | % | 25.00 | % | 214 | 162 | 35 | |||||||||||||||
AMYRIS (b) |
22.03 | % | | | 101 | | | |||||||||||||||||
Other |
| | | 749 | 745 | 700 | ||||||||||||||||||
Total associates |
4,924 | 4,260 | 3,891 | |||||||||||||||||||||
Other |
| | | 78 | | | ||||||||||||||||||
Total jointly-controlled entities |
78 | | | |||||||||||||||||||||
Total Upstream |
5,002 | 4,260 | 3,891 | |||||||||||||||||||||
CEPSA (Downstream share) |
48.83 | % | 48.83 | % | 48.83 | % | 2,151 | 1,927 | 1,810 | |||||||||||||||
Saudi Aramco Total Refining & Petrochemicals (Downstream share) (a) |
37.50 | % | 37.50 | % | 37.50 | % | 47 | 60 | 75 | |||||||||||||||
Wepec |
22.41 | % | 22.41 | % | 22.41 | % | | | | |||||||||||||||
Other |
| | | 159 | 123 | 73 | ||||||||||||||||||
Total associates |
2,357 | 2,110 | 1,958 | |||||||||||||||||||||
SARA (d) |
50.00 | % | | | 134 | | | |||||||||||||||||
TotalErg (b) |
49.00 | % | | | 289 | | | |||||||||||||||||
Other |
| | | 2 | | | ||||||||||||||||||
Total jointly-controlled entities |
425 | | | |||||||||||||||||||||
Total Downstream |
2,782 | 2,110 | 1,958 | |||||||||||||||||||||
CEPSA (Chemicals share) |
48.83 | % | 48.83 | % | 48.83 | % | 411 | 396 | 424 | |||||||||||||||
Qatar Petrochemical Company Ltd. |
20.00 | % | 20.00 | % | 20.00 | % | 221 | 205 | 192 | |||||||||||||||
Saudi Aramco Total Refining & Petrochemicals (Chemicals share) (a) |
37.50 | % | 37.50 | % | 37.50 | % | 4 | 5 | 6 | |||||||||||||||
Other |
| | | 68 | 46 | 55 | ||||||||||||||||||
Total associates |
704 | 652 | 677 | |||||||||||||||||||||
Samsung Total Petrochemicals (d) |
50.00 | % | | | 645 | | | |||||||||||||||||
Total jointly-controlled entities |
645 | | | |||||||||||||||||||||
Total Chemicals |
1,349 | 652 | 677 | |||||||||||||||||||||
Sanofi-Aventis (c) |
| 7.39 | % | 11.38 | % | | 4,235 | 6,137 | ||||||||||||||||
Total associates |
| 4,235 | 6,137 | |||||||||||||||||||||
Total jointly-controlled entities |
| | | |||||||||||||||||||||
Total Corporate |
| 4,235 | 6,137 | |||||||||||||||||||||
Total investments |
9,133 | 11,257 | 12,663 | |||||||||||||||||||||
Loans |
2,383 | 2,367 | 2,005 | |||||||||||||||||||||
Total investments and loans |
11,516 | 13,624 | 14,668 | |||||||||||||||||||||
(a) | Investment accounted for by the equity method as from 2008. | |
(b) | Investment accounted for by the equity method as from 2010. | |
(c) | End of the accounting for by the equity method of Sanofi-Aventis as of July 1st, 2010 (see Note 3 to the Consolidated Financial Statements). | |
(d) | Change in the consolidation method as of January 1st, 2010. |
Page 37
As of December 31, | For the year ended December 31, | |||||||||||||||||||||||
Equity in income (loss) | 2010 | 2009 | 2008 | 2010 | 2009 | 2008 | ||||||||||||||||||
(M) | % owned | Equity in income (loss) | ||||||||||||||||||||||
NLNG |
15.00 | % | 15.00 | % | 15.00 | % | 207 | 227 | 554 | |||||||||||||||
PetroCedeño EM |
30.32 | % | 30.32 | % | 30.32 | % | 195 | 166 | 193 | |||||||||||||||
CEPSA (Upstream share) |
48.83 | % | 48.83 | % | 48.83 | % | 57 | 23 | 50 | |||||||||||||||
Angola LNG Ltd. |
13.60 | % | 13.60 | % | 13.60 | % | 8 | 9 | 10 | |||||||||||||||
Qatargas |
10.00 | % | 10.00 | % | 10.00 | % | 136 | 114 | 126 | |||||||||||||||
Société du Terminal Méthanier de Fos Cavaou |
28.03 | % | 28.79 | % | 30.30 | % | | | (5 | ) | ||||||||||||||
Dolphin Energy Ltd (Del) Abu Dhabi |
24.50 | % | 24.50 | % | 24.50 | % | 121 | 94 | 83 | |||||||||||||||
Qatar Liquefied Gas Company Limited II (Train B) |
16.70 | % | 16.70 | % | 16.70 | % | 288 | 8 | (11 | ) | ||||||||||||||
Shtokman Development AG (a) |
25.00 | % | 25.00 | % | 25.00 | % | (5 | ) | 4 | | ||||||||||||||
AMYRIS (b) |
22.03 | % | | | (3 | ) | ||||||||||||||||||
Other |
| | | 177 | 214 | 178 | ||||||||||||||||||
Total associates |
1,181 | 859 | 1,178 | |||||||||||||||||||||
Other |
| | | 6 | | | ||||||||||||||||||
Total jointly-controlled entities |
6 | | | |||||||||||||||||||||
Total Upstream |
1,187 | 859 | 1,178 | |||||||||||||||||||||
CEPSA (Downstream share) |
48.83 | % | 48.83 | % | 48.83 | % | 172 | 149 | 76 | |||||||||||||||
Saudi Aramco Total Refining & Petrochemicals (Downstream share) (a) |
37.50 | % | 37.50 | % | 37.50 | % | (19 | ) | (12 | ) | | |||||||||||||
Wepec |
22.41 | % | 22.41 | % | 22.41 | % | 29 | | (110 | ) | ||||||||||||||
Other |
| | | 47 | 81 | (13 | ) | |||||||||||||||||
Total associates |
229 | 218 | (47 | ) | ||||||||||||||||||||
SARA (d) |
50.00 | % | | | 31 | | | |||||||||||||||||
TotalErg (b) |
49.00 | % | | | (11 | ) | | | ||||||||||||||||
Other |
| | | 2 | | | ||||||||||||||||||
Total jointly-controlled entities |
22 | | | |||||||||||||||||||||
Total Downstream |
251 | 218 | (47 | ) | ||||||||||||||||||||
CEPSA (Chemicals share) |
48.83 | % | 48.83 | % | 48.83 | % | 78 | 10 | 10 | |||||||||||||||
Qatar Petrochemical Company Ltd. |
20.00 | % | 20.00 | % | 20.00 | % | 84 | 74 | 66 | |||||||||||||||
Saudi Aramco Total Refining & Petrochemicals (Chemicals share) (a) |
37.50 | % | 37.50 | % | 37.50 | % | (1 | ) | (1 | ) | | |||||||||||||
Other |
| | | 41 | (4 | ) | (1 | ) | ||||||||||||||||
Total associates |
202 | 79 | 75 | |||||||||||||||||||||
Samsung Total Petrochemicals (d) |
50.00 | % | | | 104 | | | |||||||||||||||||
Total jointly-controlled entities |
104 | | | |||||||||||||||||||||
Total Chemicals |
306 | 79 | 75 | |||||||||||||||||||||
Sanofi-Aventis (c) |
| 7.39 | % | 11.38 | % | 209 | 486 | 515 | ||||||||||||||||
Total associates |
209 | 486 | 515 | |||||||||||||||||||||
Total jointly-controlled entities |
| | | |||||||||||||||||||||
Total Corporate |
209 | 486 | 515 | |||||||||||||||||||||
Total investments |
1,953 | 1,642 | 1,721 | |||||||||||||||||||||
(a) | Investment accounted for by the equity method as from 2008. | |
(b) | Investment accounted for by the equity method as from 2010. | |
(c) | End of the accounting for by the equity method of Sanofi-Aventis as of July 1st, 2010 (see Note 3 to the Consolidated Financial Statements). | |
(d) | Change in the consolidation method as of January 1st, 2010. |
Page 38
2010 | 2009 | 2008 | ||||||||||||||||||||||
Jointly- | Jointly- | Jointly- | ||||||||||||||||||||||
As of December 31, | controlled | controlled | controlled | |||||||||||||||||||||
(M) | Associates | entities | Associates | entities | Associates | entities | ||||||||||||||||||
Assets |
19,192 | 2,770 | 22,681 | | 23,173 | | ||||||||||||||||||
Shareholders equity |
7,985 | 1,148 | 11,257 | | 12,663 | | ||||||||||||||||||
Liabilities |
11,207 | 1,622 | 11,424 | | 10,510 | | ||||||||||||||||||
2010 | 2009 | 2008 | ||||||||||||||||||||||
Jointly- | Jointly- | Jointly- | ||||||||||||||||||||||
For the year ended December 31, | controlled | controlled | controlled | |||||||||||||||||||||
(M) | Associates | entities | Associates | entities | Associates | entities | ||||||||||||||||||
Revenues from sales |
16,529 | 2,575 | 14,434 | | 19,982 | | ||||||||||||||||||
Pre-tax income |
2,389 | 166 | 2,168 | | 2,412 | | ||||||||||||||||||
Income tax |
(568 | ) | (34 | ) | (526 | ) | | (691 | ) | | ||||||||||||||
Net income |
1,821 | 132 | 1,642 | 1,721 | ||||||||||||||||||||
As of December 31, 2010 | Carrying | |||||||||||
(M) | amount | Unrealized gain (loss) | Balance sheet value | |||||||||
Sanofi-Aventis (a) |
3,510 | (56 | ) | 3,454 | ||||||||
Areva (b) |
69 | 63 | 132 | |||||||||
Arkema |
| | | |||||||||
Chicago Mercantile Exchange Group (c) |
1 | 9 | 10 | |||||||||
Olympia Energy Fund energy investment fund (d) |
37 | (3 | ) | 34 | ||||||||
Other publicly traded equity securities |
2 | (1 | ) | 1 | ||||||||
Total publicly traded equity securities (e) |
3,619 | 12 | 3,631 | |||||||||
BBPP |
60 | | 60 | |||||||||
BTC Limited |
141 | | 141 | |||||||||
Other equity securities |
758 | | 758 | |||||||||
Total other equity securities (e) |
959 | | 959 | |||||||||
Other investments |
4,578 | 12 | 4,590 | |||||||||
Page 39
As of December 31, 2009 | Carrying | |||||||||||
(M) | amount | Unrealized gain (loss) | Balance sheet value | |||||||||
Areva (b) |
69 | 58 | 127 | |||||||||
Arkema |
15 | 47 | 62 | |||||||||
Chicago Mercantile Exchange Group (c) |
1 | 9 | 10 | |||||||||
Olympia Energy Fund energy investment fund (d) |
35 | (2 | ) | 33 | ||||||||
Other publicly traded equity securities |
| | | |||||||||
Total publicly traded equity securities (e) |
120 | 112 | 232 | |||||||||
BBPP |
72 | | 72 | |||||||||
BTC Limited |
144 | | 144 | |||||||||
Other equity securities |
714 | | 714 | |||||||||
Total other equity securities (e) |
930 | | 930 | |||||||||
Other investments |
1,050 | 112 | 1,162 | |||||||||
As of December 31, 2008 | Carrying | |||||||||||
(M) | amount | Unrealized gain (loss) | Balance sheet value | |||||||||
Areva (b) |
69 | 59 | 128 | |||||||||
Arkema |
16 | 15 | 31 | |||||||||
Chicago Mercantile Exchange Group (c) |
1 | 5 | 6 | |||||||||
Olympia Energy Fund energy investment fund (d) |
36 | (5 | ) | 31 | ||||||||
Other publicly traded equity securities |
| | | |||||||||
Total publicly traded equity securities (e) |
122 | 74 | 196 | |||||||||
BBPP |
75 | | 75 | |||||||||
BTC Limited |
161 | | 161 | |||||||||
Other equity securities |
733 | | 733 | |||||||||
Total other equity securities (e) |
969 | | 969 | |||||||||
Other investments |
1,091 | 74 | 1,165 | |||||||||
(a) | End of the accounting for by the equity method of Sanofi-Aventis as of July 1st, 2010 (see Note 3 to the Consolidated Financial Statements). | |
(b) | Unrealized gain based on the investment certificate. | |
(c) | The Nymex Holdings Inc. securities have been traded during the acquisition process running from June 11 to August 22, 2008 through which Chicago Mercantile Exchange Group acquired all the Nymex Holdings Inc. securities. | |
(d) | Securities acquired in 2008. | |
(e) | Including cumulative impairments of 597 million in 2010, 599 million in 2009 and 608 million in 2008. |
Page 40
As of December 31, 2010 | ||||||||||||
(M) | Gross value | Valuation allowance | Net value | |||||||||
Deferred income tax assets |
1,378 | | 1,378 | |||||||||
Loans and advances(a) |
2,060 | (464 | ) | 1,596 | ||||||||
Other |
681 | | 681 | |||||||||
Total |
4,119 | (464 | ) | 3,655 | ||||||||
As of December 31, 2009 | ||||||||||||
(M) | Gross value | Valuation allowance | Net value | |||||||||
Deferred income tax assets |
1,164 | | 1,164 | |||||||||
Loans and advances(a) |
1,871 | (587 | ) | 1,284 | ||||||||
Other |
633 | | 633 | |||||||||
Total |
3,668 | (587 | ) | 3,081 | ||||||||
As of December 31, 2008 | ||||||||||||
(M) | Gross value | Valuation allowance | Net value | |||||||||
Deferred income tax assets |
1,010 | | 1,010 | |||||||||
Loans and advances(a) |
1,932 | (529 | ) | 1,403 | ||||||||
Other |
631 | | 631 | |||||||||
Total |
3,573 | (529 | ) | 3,044 | ||||||||
(a) | Excluding loans to equity affiliates. |
Currency | ||||||||||||||||||||
Valuation | translation | Valuation | ||||||||||||||||||
For the year ended December 31, | allowance as of | adjustment and | allowance as of | |||||||||||||||||
(M) | January 1, | Increases | Decreases | other variations | December 31, | |||||||||||||||
2010 |
(587 | ) | (33 | ) | 220 | (64 | ) | (464 | ) | |||||||||||
2009 |
(529 | ) | (19 | ) | 29 | (68 | ) | (587 | ) | |||||||||||
2008 |
(527 | ) | (33 | ) | 52 | (21 | ) | (529 | ) | |||||||||||
Page 41
As of December 31, 2010 | ||||||||||||
(M) | Gross value | Valuation allowance | Net value | |||||||||
Crude oil and natural gas |
4,990 | | 4,990 | |||||||||
Refined products |
7,794 | (28 | ) | 7,766 | ||||||||
Chemicals products |
1,350 | (99 | ) | 1,251 | ||||||||
Other inventories |
1,911 | (318 | ) | 1,593 | ||||||||
Total |
16,045 | (445 | ) | 15,600 | ||||||||
As of December 31, 2009 | ||||||||||||
(M) | Gross value | Valuation allowance | Net value | |||||||||
Crude oil and natural gas |
4,581 | | 4,581 | |||||||||
Refined products |
6,647 | (18 | ) | 6,629 | ||||||||
Chemicals products |
1,234 | (113 | ) | 1,121 | ||||||||
Other inventories |
1,822 | (286 | ) | 1,536 | ||||||||
Total |
14,284 | (417 | ) | 13,867 | ||||||||
As of December 31, 2008 | ||||||||||||
(M) | Gross value | Valuation allowance | Net value | |||||||||
Crude oil and natural gas |
2,772 | (326 | ) | 2,446 | ||||||||
Refined products |
4,954 | (416 | ) | 4,538 | ||||||||
Chemicals products |
1,419 | (105 | ) | 1,314 | ||||||||
Other inventories |
1,591 | (268 | ) | 1,323 | ||||||||
Total |
10,736 | (1,115 | ) | 9,621 | ||||||||
Currency | ||||||||||||||||
translation | ||||||||||||||||
For the year ended December 31, | Valuation allowance | adjustment and | Valuation allowance | |||||||||||||
(M) | as of January 1, | Increase (net) | other variations | as of December 31, | ||||||||||||
2010 |
(417 | ) | (39 | ) | 11 | (445 | ) | |||||||||
2009 |
(1,115 | ) | 700 | (2 | ) | (417 | ) | |||||||||
2008 |
(325 | ) | (740 | ) | (50 | ) | (1,115 | ) | ||||||||
Page 42
As of December 31, 2010 | Gross | Valuation | Net | |||||||||
(M) | value | allowance | value | |||||||||
Accounts receivable |
18,635 | (476 | ) | 18,159 | ||||||||
Recoverable taxes |
2,227 | | 2,227 | |||||||||
Other operating receivables |
4,543 | (136 | ) | 4,407 | ||||||||
Deferred income tax |
151 | | 151 | |||||||||
Prepaid expenses |
657 | | 657 | |||||||||
Other current assets |
41 | | 41 | |||||||||
Other current assets |
7,619 | (136 | ) | 7,483 | ||||||||
As of December 31, 2009 | Gross | Valuation | Net | |||||||||
(M) | value | allowance | value | |||||||||
Accounts receivable |
16,187 | (468 | ) | 15,719 | ||||||||
Recoverable taxes |
2,156 | | 2,156 | |||||||||
Other operating receivables |
5,214 | (69 | ) | 5,145 | ||||||||
Deferred income tax |
214 | | 214 | |||||||||
Prepaid expenses |
638 | | 638 | |||||||||
Other current assets |
45 | | 45 | |||||||||
Other current assets |
8,267 | (69 | ) | 8,198 | ||||||||
As of December 31, 2008 | Gross | Valuation | Net | |||||||||
(M) | value | allowance | value | |||||||||
Accounts receivable |
15,747 | (460 | ) | 15,287 | ||||||||
Recoverable taxes |
2,510 | | 2,510 | |||||||||
Other operating receivables |
6,227 | (19 | ) | 6,208 | ||||||||
Deferred income tax |
206 | | 206 | |||||||||
Prepaid expenses |
650 | | 650 | |||||||||
Other current assets |
68 | | 68 | |||||||||
Other current assets |
9,661 | (19 | ) | 9,642 | ||||||||
Valuation | Currency translation | Valuation | ||||||||||||||
allowance as of | adjustments and | allowance as of | ||||||||||||||
(M) | January 1, | Increase (net) | other variations | December 31, | ||||||||||||
Accounts receivable |
||||||||||||||||
2010 |
(468 | ) | (31 | ) | 23 | (476 | ) | |||||||||
2009 |
(460 | ) | (17 | ) | 9 | (468 | ) | |||||||||
2008 |
(482 | ) | 9 | 13 | (460 | ) | ||||||||||
Other current assets |
||||||||||||||||
2010 |
(69 | ) | (66 | ) | (1 | ) | (136 | ) | ||||||||
2009 |
(19 | ) | (14 | ) | (36 | ) | (69 | ) | ||||||||
2008 |
(27 | ) | 7 | 1 | (19 | ) |
Page 43
Variation of the share capital |
||||||
As of January 1, 2008
|
2,395,532,097 | |||||
Shares issued in connection with:
|
Capital increase reserved for employees | 4,870,386 | ||||
Exercise of TOTAL share subscription options | 1,178,167 | |||||
Exchange guarantee offered to the beneficiaries of Elf Aquitaine share subscription options | 227,424 | |||||
Cancellation of shares(a)
|
(30,000,000 | ) | ||||
As of January 1, 2009
|
2,371,808,074 | |||||
Shares issued in connection with:
|
Exercise of TOTAL share subscription options | 934,780 | ||||
Exchange guarantee offered to the beneficiaries of Elf Aquitaine share subscription options | 480,030 | |||||
Cancellation of shares(b)
|
(24,800,000 | ) | ||||
As of January 1, 2010
|
2,348,422,884 | |||||
Shares issued in connection with:
|
Exercise of TOTAL share subscription options | 1,218,047 | ||||
As of December 31, 2010 (c)
|
2,349,640,931 |
(a) | Decided by the Board of Directors on July 31, 2008. | |
(b) | Decided by the Board of Directors on July 30, 2009. | |
(c) | Including 112,487,679 treasury shares deducted from consolidated shareholders equity. |
Page 44
2010 | 2009 | 2008 | ||||||||||
Number of shares as of January 1, | 2,348,422,884 | 2,371,808,074 | 2,395,532,097 | |||||||||
Number of shares issued during the year (pro rated) |
||||||||||||
Exercise of TOTAL share subscription options |
412,114 | 221,393 | 742,588 | |||||||||
Exercise of TOTAL share purchase options |
984,800 | 93,827 | 2,426,827 | |||||||||
Exchange guarantee offered to the beneficiaries of Elf
Aquitaine share subscription options |
| 393,623 | 86,162 | |||||||||
TOTAL restricted shares |
416,420 | 1,164,389 | 1,112,393 | |||||||||
Global free TOTAL share plan (a) |
15 | | | |||||||||
Capital increase reserved for employees |
| | 3,246,924 | |||||||||
TOTAL shares held by TOTAL S.A. or by its subsidiaries
and deducted from shareholders equity |
(115,407,190 | ) | (143,082,095 | ) | (168,290,440 | ) | ||||||
Weighted-average number of shares |
2,234,829,043 | 2,230,599,211 | 2,234,856,551 | |||||||||
Dilutive effect |
||||||||||||
TOTAL share subscription and purchase options |
1,758,006 | 1,711,961 | 6,784,200 | |||||||||
TOTAL restricted shares |
6,031,963 | 4,920,599 | 4,172,944 | |||||||||
Global free TOTAL share plan (a) |
1,504,071 | | | |||||||||
Exchange guarantee offered to the beneficiaries of Elf
Aquitaine share subscription options |
| 60,428 | 460,935 | |||||||||
Capital increase reserved for employees |
371,493 | | 383,912 | |||||||||
Weighted-average number of diluted shares |
2,244,494,576 | 2,237,292,199 | 2,246,658,542 |
(a) | The Board of Directors approved on May 21, 2010 the implementation and conditions of a global free share plan intended for the Group employees. |
| 6,012,460 shares allocated to TOTAL restricted shares plans for Group employees; | ||
| 6,143,951 shares intended to be allocated to new TOTAL share purchase option plans or to new restricted shares plans. |
Page 45
| 6,017,499 shares allocated to covering TOTAL share purchase option plans for Group employees and executive officers; | ||
| 5,799,400 shares allocated to TOTAL restricted shares plans for Group employees; and | ||
| 3,259,023 shares intended to be allocated to new TOTAL share purchase option plans or to new restricted shares plans. |
| 12,627,522 shares allocated to covering TOTAL share purchase option plans for Group employees; | ||
| 5,323,305 shares allocated to TOTAL restricted shares plans for Group employees; and | ||
| 24,800,000 shares purchased for cancellation between January and October 2008 pursuant to the authorization granted by the shareholders meetings held on May 11, 2007 and May 16, 2008. The Board of Directors on July 30, 2009 decided to cancel these 24,800,000 shares acquired at an average price of 49.28 per share. |
| 2,023,672 shares held by a consolidated subsidiary, Total Nucléaire, 100% indirectly controlled by TOTAL S.A.; and | ||
| 98,307,596 shares held by subsidiaries of Elf Aquitaine (Financière Valorgest, Sogapar and Fingestval). |
Page 46
For the year ended December 31, | ||||||||||||||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||||||||||||||
Currency translation adjustment |
2,231 | (244 | ) | (722 | ) | |||||||||||||||||||
- Unrealized gain/(loss) of the period |
2,234 | (243 | ) | (722 | ) | |||||||||||||||||||
- Less gain/(loss) included in net income |
3 | 1 | | |||||||||||||||||||||
Available for sale financial assets |
(100 | ) | 38 | (254 | ) | |||||||||||||||||||
- Unrealized gain/(loss) of the period |
(50 | ) | 38 | (254 | ) | |||||||||||||||||||
- Less gain/(loss) included in net income |
50 | | | |||||||||||||||||||||
Cash flow hedge |
(80 | ) | 128 | | ||||||||||||||||||||
- Unrealized gain/(loss) of the period |
(195 | ) | 349 | | ||||||||||||||||||||
- Less gain/(loss) included in net income |
(115 | ) | 221 | | ||||||||||||||||||||
Share of other comprehensive income of equity affiliates, net amount |
302 | 234 | 173 | |||||||||||||||||||||
Other |
(7 | ) | (5 | ) | 1 | |||||||||||||||||||
- Unrealized gain/(loss) of the period |
(7 | ) | (5 | ) | 1 | |||||||||||||||||||
- Less gain/(loss) included in net income |
| | | |||||||||||||||||||||
Tax effect |
28 | (38 | ) | 30 | ||||||||||||||||||||
Total other comprehensive income, net amount |
2,374 | 113 | (772 | ) | ||||||||||||||||||||
2010 | 2009 | 2008 | ||||||||||||||||||||||||||||||||||
For the year ended December 31, | Pre-tax | Tax | Net | Pre-tax | Tax | Net | Pre-tax | Tax | Net | |||||||||||||||||||||||||||
(M) | amount | effect | amount | amount | effect | amount | amount | effect | amount | |||||||||||||||||||||||||||
Currency translation adjustment |
2,231 | | 2,231 | (244 | ) | | (244 | ) | (722 | ) | | (722 | ) | |||||||||||||||||||||||
Available for sale financial assets |
(100 | ) | 2 | (98 | ) | 38 | 4 | 42 | (254 | ) | 30 | (224 | ) | |||||||||||||||||||||||
Cash flow hedge |
(80 | ) | 26 | (54 | ) | 128 | (42 | ) | 86 | | | | ||||||||||||||||||||||||
Share of other comprehensive income of equity affiliates, net amount |
302 | | 302 | 234 | | 234 | 173 | | 173 | |||||||||||||||||||||||||||
Other |
(7 | ) | | (7 | ) | (5 | ) | | (5 | ) | 1 | | 1 | |||||||||||||||||||||||
Total other comprehensive income |
2,346 | 28 | 2,374 | 151 | (38 | ) | 113 | (802 | ) | 30 | (772 | ) | ||||||||||||||||||||||||
As of December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Pension benefits liabilities |
1,268 | 1,236 | 1,187 | |||||||||
Other benefits liabilities |
605 | 592 | 608 | |||||||||
Restructuring reserves (early retirement plans) |
298 | 212 | 216 | |||||||||
Total |
2,171 | 2,040 | 2,011 | |||||||||
| The benefits are usually based on the final salary and seniority; | ||
| They are usually funded (pension fund or insurer); and | ||
| They are closed to new employees who benefit from defined contribution pension plans. |
Page 47
As of December 31, | Pension benefits | Other benefits | ||||||||||||||||||||||
(M) | 2010 | 2009 | 2008 | 2010 | 2009 | 2008 | ||||||||||||||||||
Change in benefit obligation |
||||||||||||||||||||||||
Benefit obligation at beginning of year |
8,169 | 7,405 | 8,129 | 547 | 544 | 583 | ||||||||||||||||||
Service cost |
159 | 134 | 143 | 11 | 10 | 14 | ||||||||||||||||||
Interest cost |
441 | 428 | 416 | 29 | 30 | 24 | ||||||||||||||||||
Curtailments |
(4 | ) | (5 | ) | (3 | ) | (3 | ) | (1 | ) | | |||||||||||||
Settlements |
(60 | ) | (3 | ) | (5 | ) | | | (4 | ) | ||||||||||||||
Special termination benefits |
| | | 1 | | | ||||||||||||||||||
Plan participants contributions |
11 | 10 | 12 | | | | ||||||||||||||||||
Benefits paid |
(471 | ) | (484 | ) | (463 | ) | (33 | ) | (33 | ) | (37 | ) | ||||||||||||
Plan amendments |
28 | 118 | 12 | 1 | (2 | ) | (12 | ) | ||||||||||||||||
Actuarial losses (gains) |
330 | 446 | (248 | ) | 57 | | (27 | ) | ||||||||||||||||
Foreign currency translation and other |
137 | 120 | (588 | ) | 13 | (1 | ) | 3 | ||||||||||||||||
Benefit obligation at year-end |
8,740 | 8,169 | 7,405 | 623 | 547 | 544 | ||||||||||||||||||
Change in fair value of plan assets |
||||||||||||||||||||||||
Fair value of plan assets at beginning of year |
(6,286 | ) | (5,764 | ) | (6,604 | ) | | | | |||||||||||||||
Expected return on plan assets |
(396 | ) | (343 | ) | (402 | ) | | | | |||||||||||||||
Actuarial losses (gains) |
(163 | ) | (317 | ) | 1,099 | | | | ||||||||||||||||
Settlements |
56 | 2 | 2 | | | | ||||||||||||||||||
Plan participants contributions |
(11 | ) | (10 | ) | (12 | ) | | | | |||||||||||||||
Employer contributions (a) |
(269 | ) | (126 | ) | (855 | ) | | | | |||||||||||||||
Benefits paid |
394 | 396 | 375 | | | | ||||||||||||||||||
Foreign currency translation and other |
(134 | ) | (124 | ) | 633 | | | | ||||||||||||||||
Fair value of plan assets at year-end |
(6,809 | ) | (6,286 | ) | (5,764 | ) | | | | |||||||||||||||
Unfunded status |
1,931 | 1,883 | 1,641 | 623 | 547 | 544 | ||||||||||||||||||
Unrecognized prior service cost |
(105 | ) | (153 | ) | (48 | ) | 10 | 15 | 21 | |||||||||||||||
Unrecognized actuarial (losses) gains |
(1,170 | ) | (1,045 | ) | (953 | ) | (28 | ) | 30 | 43 | ||||||||||||||
Asset ceiling |
9 | 9 | 5 | | | | ||||||||||||||||||
Net recognized amount |
665 | 694 | 645 | 605 | 592 | 608 | ||||||||||||||||||
Pension benefits and other benefits liabilities |
1,268 | 1,236 | 1,187 | 605 | 592 | 608 | ||||||||||||||||||
Other non-current assets |
(603 | ) | (542 | ) | (542 | ) | | | | |||||||||||||||
(a) | In 2010, the Group covered certain employee pension benefit plans through insurance companies for an amount of 90 million (757 million in 2008). |
Page 48
For the year ended December 31, | ||||||||||||||||
(M) | 2010 | 2009 | 2008 | 2007 | ||||||||||||
Experience actuarial (gains) losses related to the defined benefit obligation |
(54 | ) | (108 | ) | 12 | 80 | ||||||||||
Experience actuarial (gains) losses related to the fair value of plan assets |
(163 | ) | (317 | ) | 1,099 | 140 | ||||||||||
As of December 31, | ||||||||||||||||||||
(M) | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||
Pension benefits |
||||||||||||||||||||
Benefit obligation |
8,740 | 8,169 | 7,405 | 8,129 | 8,742 | |||||||||||||||
Fair value of plan assets |
(6,809 | ) | (6,286 | ) | (5,764 | ) | (6,604 | ) | (6,401 | ) | ||||||||||
Unfunded status |
1,931 | 1,883 | 1,641 | 1,525 | 2,341 | |||||||||||||||
Other benefits |
||||||||||||||||||||
Benefits obligation |
623 | 547 | 544 | 583 | 648 | |||||||||||||||
Fair value of plan assets |
| | | | | |||||||||||||||
Unfunded status |
623 | 547 | 544 | 583 | 648 | |||||||||||||||
Estimated future payments | ||||||||
(M) | Pension benefits | Other benefits | ||||||
2011 |
487 | 38 | ||||||
2012 |
478 | 38 | ||||||
2013 |
477 | 38 | ||||||
2014 |
477 | 39 | ||||||
2015 |
497 | 40 | ||||||
2016-2020 |
2,628 | 203 | ||||||
Asset allocation | Pension benefits | |||||||||||
As of December 31, | 2010 | 2009 | 2008 | |||||||||
Equity securities |
34 | % | 31 | % | 25 | % | ||||||
Debt securities |
60 | % | 62 | % | 56 | % | ||||||
Monetary |
3 | % | 3 | % | 16 | % | ||||||
Real estate |
3 | % | 4 | % | 3 | % | ||||||
Page 49
Assumptions used to determine benefits obligations | Pension benefits | Other benefits | ||||||||||||||||||||||||||
As of December 31, | 2010 | 2009 | 2008 | 2010 | 2009 | 2008 | ||||||||||||||||||||||
Discount rate (weighted average for all regions) |
5.01 | % | 5.41 | % | 5.93 | % | 5.00 | % | 5.60 | % | 6.00 | % | ||||||||||||||||
Of which Euro zone |
4.58 | % | 5.12 | % | 5.72 | % | 4.55 | % | 5.18 | % | 5.74 | % | ||||||||||||||||
Of which United States |
5.49 | % | 6.00 | % | 6.23 | % | 5.42 | % | 5.99 | % | 6.21 | % | ||||||||||||||||
Of which United Kingdom |
5.50 | % | 5.50 | % | 6.00 | % | | | 6.00 | % | ||||||||||||||||||
Average expected rate of salary increase |
4.55 | % | 4.50 | % | 4.56 | % | | | | |||||||||||||||||||
Expected rate of healthcare inflation |
||||||||||||||||||||||||||||
- initial rate |
| | | 4.82 | % | 4.91 | % | 4.88 | % | |||||||||||||||||||
- ultimate rate |
| | | 3.75 | % | 3.79 | % | 3.64 | % | |||||||||||||||||||
Assumptions used to determine the net periodic benefit cost (income) | Pension benefits | Other benefits | ||||||||||||||||||||||||||
For the year ended December 31, | 2010 | 2009 | 2008 | 2010 | 2009 | 2008 | ||||||||||||||||||||||
Discount rate (weighted average for all regions) |
5.41 | % | 5.93 | % | 5.50 | % | 5.60 | % | 6.00 | % | 5.50 | % | ||||||||||||||||
Of which Euro zone |
5.12 | % | 5.72 | % | 5.15 | % | 5.18 | % | 5.74 | % | 5.14 | % | ||||||||||||||||
Of which United States |
6.00 | % | 6.23 | % | 6.00 | % | 5.99 | % | 6.21 | % | 5.98 | % | ||||||||||||||||
Of which United Kingdom |
5.50 | % | 6.00 | % | 5.75 | % | | 6.00 | % | 5.75 | % | |||||||||||||||||
Average expected rate of salary increase |
4.50 | % | 4.56 | % | 4.29 | % | | | | |||||||||||||||||||
Expected return on plan assets |
6.39 | % | 6.14 | % | 6.60 | % | | | | |||||||||||||||||||
Expected rate of healthcare inflation |
||||||||||||||||||||||||||||
- initial rate |
| | | 4.91 | % | 4.88 | % | 5.16 | % | |||||||||||||||||||
- ultimate rate |
| | | 3.79 | % | 3.64 | % | 3.64 | % | |||||||||||||||||||
(M) | 0.5% increase | 0.5% decrease | ||||||
Benefit obligation as of December 31, 2010 |
(520 | ) | 574 | |||||
2011 net periodic benefit cost (income) |
(19 | ) | 52 | |||||
For the year ended December 31, | Pension benefits | Other benefits | ||||||||||||||||||||||
(M) | 2010 | 2009 | 2008 | 2010 | 2009 | 2008 | ||||||||||||||||||
Service cost |
159 | 134 | 143 | 11 | 10 | 14 | ||||||||||||||||||
Interest cost |
441 | 428 | 416 | 29 | 30 | 24 | ||||||||||||||||||
Expected return on plan assets |
(396 | ) | (343 | ) | (402 | ) | | | | |||||||||||||||
Amortization of prior service cost |
74 | 13 | 34 | (5 | ) | (7 | ) | (10 | ) | |||||||||||||||
Amortization of actuarial losses (gains) |
66 | 50 | 22 | (4 | ) | (6 | ) | (2 | ) | |||||||||||||||
Asset ceiling |
(3 | ) | 4 | 1 | | | | |||||||||||||||||
Curtailments |
(3 | ) | (4 | ) | (3 | ) | (3 | ) | (1 | ) | | |||||||||||||
Settlements |
7 | (1 | ) | (2 | ) | | | (3 | ) | |||||||||||||||
Special termination benefits |
| | | 1 | | | ||||||||||||||||||
Net periodic benefit cost (income) |
345 | 281 | 209 | 29 | 26 | 23 | ||||||||||||||||||
Page 50
(M) | 1% point increase | 1% point decrease | ||||||
Benefit obligation as of December 31, 2010 |
63 | (52 | ) | |||||
2010 net periodic benefit cost (income) |
5 | (4 | ) | |||||
As of December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Litigations and accrued penalty claims |
485 | 423 | 546 | |||||||||
Provisions for environmental contingencies |
644 | 623 | 558 | |||||||||
Asset retirement obligations |
5,917 | 5,469 | 4,500 | |||||||||
Other non-current provisions |
1,116 | 1,331 | 1,804 | |||||||||
Other non-current liabilities |
936 | 1,535 | 450 | |||||||||
Total |
9,098 | 9,381 | 7,858 | |||||||||
| The contingency reserve related to the Toulouse-AZF plant explosion (civil liability) for 31 million as of December 31, 2010; | ||
| Provisions related to restructuring activities in the Downstream and Chemicals segments for 261 million as of December 31, 2010; and | ||
| The contingency reserve related to the Buncefield depot explosion (civil liability) for 194 million as of December 31, 2010. |
| The contingency reserve related to the Toulouse-AZF plant explosion (civil liability) for 40 million as of December 31, 2009; | ||
| Provisions related to restructuring activities in the Downstream and Chemicals segments for 130 million as of December 31, 2009; and | ||
| The contingency reserve related to the Buncefield depot explosion (civil liability) for 295 million as of December 31, 2009. |
Page 51
Currency | ||||||||||||||||||||||||
As of | translation | As of | ||||||||||||||||||||||
(M) | January 1, | Allowances | Reversals | adjustment | Other | December 31, | ||||||||||||||||||
2010 |
9,381 | 1,052 | (971 | ) | 497 | (861 | ) | 9,098 | ||||||||||||||||
2009 |
7,858 | 1,254 | (1,413 | ) | 202 | 1,480 | 9,381 | |||||||||||||||||
2008 |
6,843 | 1,424 | (864 | ) | (460 | ) | 915 | 7,858 | ||||||||||||||||
| Asset retirement obligations for 338 million (accretion); | ||
| Environmental contingencies for 88 million in the Downstream and Chemicals segments; | ||
| The contingency reserve related to the Buncefield depot explosion (civil liability) for 79 million; and | ||
| Provisions related to restructuring of activities for 226 million. |
| Asset retirement obligations for 283 million (accretion); | ||
| Environmental contingencies for 147 million in the Downstream and Chemicals segments; | ||
| The contingency reserve related to the Buncefield depot explosion (civil liability) for 223 million; and | ||
| Provisions related to restructuring of activities for 121 million. |
| Asset retirement obligations for 229 million (accretion); | ||
| The contingency reserve related to the Toulouse-AZF plant explosion (civil liability) for 140 million; | ||
| Environmental contingencies for 89 million; | ||
| An allowance of 48 million for litigation reserves in connection with antitrust investigations, as described in Note 32 to the Consolidated Financial Statements Other risks and contingent liabilities; and | ||
| Provisions related to restructuring of activities for 27 million. |
| Provisions for asset retirement obligations for 214 million; | ||
| 26 million for litigation reserves in connection with antitrust investigations; | ||
| Environmental contingencies written back for 66 million; | ||
| The contingency reserve related to the Toulouse-AZF plant explosion (civil liability), written back for 9 million; | ||
| The contingency reserve related to the Buncefield depot explosion (civil liability), written back for 190 million; and | ||
| Provisions for restructuring and social plans written back for 60 million. |
Page 52
| Provisions for asset retirement obligations for 191 million; | ||
| 52 million for litigation reserves in connection with antitrust investigations; | ||
| Environmental contingencies written back for 86 million; | ||
| The contingency reserve related to the Toulouse-AZF plant explosion (civil liability), written back for 216 million; | ||
| The contingency reserve related to the Buncefield depot explosion (civil liability), written back for 375 million; and | ||
| Provisions for restructuring and social plans written back for 28 million. |
| Provisions for asset retirement obligations for 280 million; | ||
| 163 million for litigation reserves in connection with antitrust investigations; | ||
| Environmental contingencies written back for 96 million; | ||
| The contingency reserve related to the Toulouse-AZF plant explosion (civil liability), written back for 18 million; and | ||
| Provisions for restructuring and social plans written back for 10 million. |
Spending on | Currency | |||||||||||||||||||||||||||||||
As of | Revision in | New | existing | translation | As of | |||||||||||||||||||||||||||
(M) | January 1, | Accretion | estimates | obligations | obligations | adjustment | Other | December 31, | ||||||||||||||||||||||||
2010 |
5,469 | 338 | 79 | 175 | (214 | ) | 316 | (246 | ) | 5,917 | ||||||||||||||||||||||
2009 |
4,500 | 283 | 447 | 179 | (191 | ) | 232 | 19 | 5,469 | |||||||||||||||||||||||
2008 |
4,206 | 229 | 563 | 188 | (280 | ) | (414 | ) | 8 | 4,500 | ||||||||||||||||||||||
As of December 31, 2010 | ||||||||||||
(M) | ||||||||||||
(Assets) / Liabilities | Secured | Unsecured | Total | |||||||||
Non-current financial debt |
287 | 20,496 | 20,783 | |||||||||
of which hedging instruments of non-current financial debt (liabilities) |
| 178 | 178 | |||||||||
Hedging instruments of non-current financial debt (assets) (a) |
| (1,870 | ) | (1,870 | ) | |||||||
Non-current financial debt net of hedging instruments |
287 | 18,626 | 18,913 | |||||||||
Bonds after fair value hedge |
| 15,491 | 15,491 | |||||||||
Fixed rate bonds and bonds after cash flow hedge |
| 2,836 | 2,836 | |||||||||
Bank and other, floating rate |
47 | 189 | 236 | |||||||||
Bank and other, fixed rate |
65 | 110 | 175 | |||||||||
Financial lease obligations |
175 | | 175 | |||||||||
Non-current financial debt net of hedging instruments |
287 | 18,626 | 18,913 | |||||||||
(a) | See the description of these hedging instruments in Notes 1 paragraph M (iii) Long-term financing, 28 and 29 to the Consolidated Financial Statements. |
Page 53
As of December 31, 2009 | ||||||||||||
(M) | ||||||||||||
(Assets) / Liabilities | Secured | Unsecured | Total | |||||||||
Non-current financial debt |
312 | 19,125 | 19,437 | |||||||||
of which hedging instruments of non-current financial debt (liabilities) |
| 241 | 241 | |||||||||
Hedging instruments of non-current financial debt (assets) (a) |
| (1,025 | ) | (1,025 | ) | |||||||
Non-current financial debt net of hedging instruments |
312 | 18,100 | 18,412 | |||||||||
Bonds after fair value hedge |
| 15,884 | 15,884 | |||||||||
Fixed rate bonds and bonds after cash flow hedge |
| 1,700 | 1,700 | |||||||||
Bank and other, floating rate |
60 | 379 | 439 | |||||||||
Bank and other, fixed rate |
50 | 79 | 129 | |||||||||
Financial lease obligations |
202 | 58 | 260 | |||||||||
Non-current financial debt net of hedging instruments |
312 | 18,100 | 18,412 | |||||||||
(a) | See the description of these hedging instruments in Notes 1 paragraph M(iii) Long-term financing, 28 and 29 to the Consolidated Financial Statements. |
As of December 31, 2008 | ||||||||||||
(M) | ||||||||||||
(Assets) / Liabilities | Secured | Unsecured | Total | |||||||||
Non-current financial debt |
895 | 15,296 | 16,191 | |||||||||
of which hedging instruments of non-current financial debt (liabilities) |
| 440 | 440 | |||||||||
Hedging instruments of non-current financial debt (assets) (a) |
| (892 | ) | (892 | ) | |||||||
Non-current financial debt net of hedging instruments |
895 | 14,404 | 15,299 | |||||||||
Bonds after fair value hedge |
| 13,380 | 13,380 | |||||||||
Fixed rate bonds and bonds after cash flow hedge |
| 287 | 287 | |||||||||
Bank and other, floating rate |
553 | 665 | 1,218 | |||||||||
Bank and other, fixed rate |
140 | 6 | 146 | |||||||||
Financial lease obligations |
202 | 66 | 268 | |||||||||
Non-current financial debt net of hedging instruments |
895 | 14,404 | 15,299 | |||||||||
(a) | See the description of these hedging instruments in Notes 1 paragraph M(iii) Long-term financing, 28 and 29 to the Consolidated Financial Statements. |
Page 54
Fair value after | Fair value after | Fair value after | ||||||||||||||||||||||||||
hedging as of | hedging as of | hedging as of | ||||||||||||||||||||||||||
Bonds after fair value hedge | Year of | December 31, | December 31, | December 31, | Initial rate before hedging | |||||||||||||||||||||||
(M) | issue | 2010 | 2009 | 2008 | Currency | Maturity | instruments | |||||||||||||||||||||
Parent company |
||||||||||||||||||||||||||||
Bond |
1997 | | | 124 | FRF | 2009 | 6.200 | % | ||||||||||||||||||||
Bond |
1998 | | | 119 | FRF | 2009 | 5.125 | % | ||||||||||||||||||||
Bond |
1998 | 125 | 116 | 121 | FRF | 2013 | 5.000 | % | ||||||||||||||||||||
Bond |
2000 | | 61 | 63 | EUR | 2010 | 5.650 | % | ||||||||||||||||||||
Current portion (less than one year) |
| (61 | ) | (243 | ) | |||||||||||||||||||||||
Total parent company |
125 | 116 | 184 | |||||||||||||||||||||||||
Elf Aquitaine SA |
||||||||||||||||||||||||||||
Bond |
1999 | | | 1 003 | EUR | 2009 | 4.500 | % | ||||||||||||||||||||
Current portion (less than one year) |
| | (1 003 | ) | ||||||||||||||||||||||||
Total Elf Aquitaine SA |
| | - | |||||||||||||||||||||||||
TOTAL CAPITAL (a) |
||||||||||||||||||||||||||||
Bond |
2002 | 15 | 14 | 14 | USD | 2012 | 5.890 | % | ||||||||||||||||||||
Bond |
2003 | | | 52 | AUD | 2009 | 6.250 | % | ||||||||||||||||||||
Bond |
2003 | | | 154 | CHF | 2009 | 2.385 | % | ||||||||||||||||||||
Bond |
2003 | | 160 | 166 | CHF | 2010 | 2.385 | % | ||||||||||||||||||||
Bond |
2003 | 22 | 21 | 22 | USD | 2013 | 4.500 | % | ||||||||||||||||||||
Bond |
2003-2004 | | | 395 | USD | 2009 | 3.500 | % | ||||||||||||||||||||
Bond |
2004 | | | 57 | AUD | 2009 | 6.000 | % | ||||||||||||||||||||
Bond |
2004 | | | 28 | AUD | 2009 | 6.000 | % | ||||||||||||||||||||
Bond |
2004 | | 53 | 55 | CAD | 2010 | 4.000 | % | ||||||||||||||||||||
Bond |
2004 | | 113 | 117 | CHF | 2010 | 2.385 | % | ||||||||||||||||||||
Bond |
2004 | | 438 | 454 | EUR | 2010 | 3.750 | % | ||||||||||||||||||||
Bond |
2004 | | 322 | 334 | GBP | 2010 | 4.875 | % | ||||||||||||||||||||
Bond |
2004 | | 128 | 132 | GBP | 2010 | 4.875 | % | ||||||||||||||||||||
Bond |
2004 | | 185 | 191 | GBP | 2010 | 4.875 | % | ||||||||||||||||||||
Bond |
2004 | 57 | 53 | 55 | AUD | 2011 | 5.750 | % | ||||||||||||||||||||
Bond |
2004 | 116 | 107 | 111 | CAD | 2011 | 4.875 | % | ||||||||||||||||||||
Bond |
2004 | 235 | 203 | 216 | USD | 2011 | 4.125 | % | ||||||||||||||||||||
Bond |
2004 | 75 | 69 | 72 | USD | 2011 | 4.125 | % | ||||||||||||||||||||
Bond |
2004 | 125 | 116 | 120 | CHF | 2012 | 2.375 | % | ||||||||||||||||||||
Bond |
2004 | 51 | 47 | 49 | NZD | 2014 | 6.750 | % | ||||||||||||||||||||
Bond |
2005 | | | 36 | USD | 2009 | 3.500 | % | ||||||||||||||||||||
Bond |
2005 | 57 | 53 | 55 | AUD | 2011 | 5.750 | % | ||||||||||||||||||||
Bond |
2005 | 60 | 56 | 58 | CAD | 2011 | 4.000 | % | ||||||||||||||||||||
Bond |
2005 | 120 | 112 | 116 | CHF | 2011 | 1.625 | % | ||||||||||||||||||||
Bond |
2005 | 226 | 226 | 226 | CHF | 2011 | 1.625 | % | ||||||||||||||||||||
Bond |
2005 | 139 | 144 | 144 | USD | 2011 | 4.125 | % | ||||||||||||||||||||
Bond |
2005 | 63 | 63 | 63 | AUD | 2012 | 5.750 | % | ||||||||||||||||||||
Bond |
2005 | 194 | 180 | 187 | CHF | 2012 | 2.135 | % | ||||||||||||||||||||
Bond |
2005 | 65 | 65 | 65 | CHF | 2012 | 2.135 | % | ||||||||||||||||||||
Bond |
2005 | 97 | 97 | 98 | CHF | 2012 | 2.375 | % | ||||||||||||||||||||
Bond |
2005 | 391 | 363 | 376 | EUR | 2012 | 3.250 | % | ||||||||||||||||||||
Bond |
2005 | 57 | 57 | 57 | NZD | 2012 | 6.500 | % | ||||||||||||||||||||
Bond |
2006 | | 75 | 75 | GBP | 2010 | 4.875 | % | ||||||||||||||||||||
Bond |
2006 | | 50 | 50 | EUR | 2010 | 3.750 | % | ||||||||||||||||||||
Bond |
2006 | | 50 | 50 | EUR | 2010 | 3.750 | % | ||||||||||||||||||||
Bond |
2006 | | 100 | 102 | EUR | 2010 | 3.750 | % | ||||||||||||||||||||
Bond |
2006 | 42 | 42 | 42 | EUR | 2011 | EURIBOR 3 months +0.040% | |||||||||||||||||||||
Bond |
2006 | 300 | 300 | 300 | EUR | 2011 | 3.875 | % | ||||||||||||||||||||
Bond |
2006 | 150 | 150 | 150 | EUR | 2011 | 3.875 | % | ||||||||||||||||||||
Bond |
2006 | 300 | 300 | 300 | EUR | 2011 | 3.875 | % | ||||||||||||||||||||
Bond |
2006 | 120 | 120 | 120 | USD | 2011 | 5.000 | % | ||||||||||||||||||||
Bond |
2006 | 300 | 300 | 300 | EUR | 2011 | 3.875 | % | ||||||||||||||||||||
Bond |
2006 | 472 | 472 | 473 | USD | 2011 | 5.000 | % | ||||||||||||||||||||
Bond |
2006 | 62 | 62 | 62 | AUD | 2012 | 5.625 | % | ||||||||||||||||||||
Bond |
2006 | 72 | 72 | 72 | CAD | 2012 | 4.125 | % | ||||||||||||||||||||
Bond |
2006 | 100 | 100 | 100 | EUR | 2012 | 3.250 | % | ||||||||||||||||||||
Bond |
2006 | 74 | 74 | 74 | GBP | 2012 | 4.625 | % | ||||||||||||||||||||
Bond |
2006 | 100 | 100 | 100 | EUR | 2012 | 3.250 | % | ||||||||||||||||||||
Bond |
2006 | 125 | 125 | 125 | CHF | 2013 | 2.510 | % | ||||||||||||||||||||
Bond |
2006 | 127 | 127 | 127 | CHF | 2014 | 2.635 | % | ||||||||||||||||||||
Bond |
2006 | 130 | 130 | 130 | CHF | 2016 | 2.385 | % | ||||||||||||||||||||
Bond |
2006 | 65 | 65 | 65 | CHF | 2016 | 2.385 | % | ||||||||||||||||||||
Bond |
2006 | 64 | 64 | 64 | CHF | 2016 | 2.385 | % | ||||||||||||||||||||
Bond |
2006 | 63 | 63 | 64 | CHF | 2016 | 2.385 | % | ||||||||||||||||||||
Bond |
2006 | 129 | 129 | 129 | CHF | 2018 | 3.135 | % | ||||||||||||||||||||
Bond |
2007 | | 60 | 60 | CHF | 2010 | 2.385 | % | ||||||||||||||||||||
Bond |
2007 | | 74 | 74 | GBP | 2010 | 4.875 | % | ||||||||||||||||||||
Bond |
2007 | 77 | 77 | 77 | USD | 2011 | 5.000 | % | ||||||||||||||||||||
Bond |
2007 | 370 | 370 | 370 | USD | 2012 | 5.000 | % | ||||||||||||||||||||
Bond |
2007 | 222 | 222 | 222 | USD | 2012 | 5.000 | % | ||||||||||||||||||||
Bond |
2007 | 61 | 61 | 61 | AUD | 2012 | 6.500 | % | ||||||||||||||||||||
Bond |
2007 | 72 | 72 | 72 | CAD | 2012 | 4.125 | % | ||||||||||||||||||||
Bond |
2007 | 71 | 71 | 71 | GBP | 2012 | 4.625 | % | ||||||||||||||||||||
Bond |
2007 | 300 | 300 | 300 | EUR | 2013 | 4.125 | % | ||||||||||||||||||||
Bond |
2007 | 73 | 73 | 74 | GBP | 2013 | 5.500 | % | ||||||||||||||||||||
Bond |
2007 | 306 | 306 | 306 | GBP | 2013 | 5.500 | % | ||||||||||||||||||||
Bond |
2007 | 72 | 72 | 73 | GBP | 2013 | 5.500 | % | ||||||||||||||||||||
Bond |
2007 | 248 | 248 | 248 | CHF | 2014 | 2.635 | % |
Page 55
Fair value after | Fair value after | Fair value after | ||||||||||||||||||||||||||
hedging as of | hedging as of | hedging as of | ||||||||||||||||||||||||||
Bonds after fair value hedge | Year of | December 31, | December 31, | December 31, | Initial rate before hedging | |||||||||||||||||||||||
(M) | issue | 2010 | 2009 | 2008 | Currency | Maturity | instruments | |||||||||||||||||||||
TOTAL CAPITAL (a) |
||||||||||||||||||||||||||||
Bond |
2007 | 31 | 31 | 31 | JPY | 2014 | 1.505 | % | ||||||||||||||||||||
Bond |
2007 | 61 | 61 | 61 | CHF | 2014 | 2.635 | % | ||||||||||||||||||||
Bond |
2007 | 49 | 49 | 49 | JPY | 2014 | 1.723 | % | ||||||||||||||||||||
Bond |
2007 | 121 | 121 | 121 | CHF | 2015 | 3.125 | % | ||||||||||||||||||||
Bond |
2007 | 300 | 300 | 300 | EUR | 2017 | 4.700 | % | ||||||||||||||||||||
Bond |
2007 | 76 | 76 | 76 | CHF | 2018 | 3.135 | % | ||||||||||||||||||||
Bond |
2007 | 60 | 60 | 60 | CHF | 2018 | 3.135 | % | ||||||||||||||||||||
Bond |
2008 | | 63 | 63 | GBP | 2010 | 4.875 | % | ||||||||||||||||||||
Bond |
2008 | | 66 | 66 | GBP | 2010 | 4.875 | % | ||||||||||||||||||||
Bond |
2008 | 92 | 92 | 92 | AUD | 2011 | 7.500 | % | ||||||||||||||||||||
Bond |
2008 | 100 | 100 | 100 | EUR | 2011 | 3.875 | % | ||||||||||||||||||||
Bond |
2008 | 150 | 150 | 151 | EUR | 2011 | 3.875 | % | ||||||||||||||||||||
Bond |
2008 | 50 | 50 | 50 | EUR | 2011 | 3.875 | % | ||||||||||||||||||||
Bond |
2008 | 50 | 50 | 50 | EUR | 2011 | 3.875 | % | ||||||||||||||||||||
Bond |
2008 | 60 | 60 | 60 | JPY | 2011 | EURIBOR 6 months + 0.018% | |||||||||||||||||||||
Bond |
2008 | 102 | 102 | 102 | USD | 2011 | 3.750 | % | ||||||||||||||||||||
Bond |
2008 | 62 | 62 | 62 | CHF | 2012 | 2.135 | % | ||||||||||||||||||||
Bond |
2008 | 124 | 124 | 124 | CHF | 2012 | 3.635 | % | ||||||||||||||||||||
Bond |
2008 | 46 | 46 | 46 | CHF | 2012 | 2.385 | % | ||||||||||||||||||||
Bond |
2008 | 92 | 92 | 92 | CHF | 2012 | 2.385 | % | ||||||||||||||||||||
Bond |
2008 | 64 | 64 | 64 | CHF | 2012 | 2.385 | % | ||||||||||||||||||||
Bond |
2008 | 50 | 50 | 50 | EUR | 2012 | 3.250 | % | ||||||||||||||||||||
Bond |
2008 | 63 | 63 | 63 | GBP | 2012 | 4.625 | % | ||||||||||||||||||||
Bond |
2008 | 63 | 63 | 63 | GBP | 2012 | 4.625 | % | ||||||||||||||||||||
Bond |
2008 | 63 | 63 | 64 | GBP | 2012 | 4.625 | % | ||||||||||||||||||||
Bond |
2008 | 62 | 62 | 62 | NOK | 2012 | 6.000 | % | ||||||||||||||||||||
Bond |
2008 | 69 | 69 | 69 | USD | 2012 | 5.000 | % | ||||||||||||||||||||
Bond |
2008 | 60 | 60 | 60 | AUD | 2013 | 7.500 | % | ||||||||||||||||||||
Bond |
2008 | 61 | 61 | 61 | AUD | 2013 | 7.500 | % | ||||||||||||||||||||
Bond |
2008 | 127 | 127 | 128 | CHF | 2013 | 3.135 | % | ||||||||||||||||||||
Bond |
2008 | 62 | 62 | 63 | CHF | 2013 | 3.135 | % | ||||||||||||||||||||
Bond |
2008 | 200 | 200 | 200 | EUR | 2013 | 4.125 | % | ||||||||||||||||||||
Bond |
2008 | 100 | 100 | 100 | EUR | 2013 | 4.125 | % | ||||||||||||||||||||
Bond |
2008 | 1,000 | 1,000 | 1,002 | EUR | 2013 | 4.750 | % | ||||||||||||||||||||
Bond |
2008 | 63 | 63 | 63 | GBP | 2013 | 5.500 | % | ||||||||||||||||||||
Bond |
2008 | 149 | 149 | 149 | JPY | 2013 | EURIBOR 6 months + 0.008% | |||||||||||||||||||||
Bond |
2008 | 191 | 191 | 194 | USD | 2013 | 4.000 | % | ||||||||||||||||||||
Bond |
2008 | 61 | 61 | 61 | CHF | 2015 | 3.135 | % | ||||||||||||||||||||
Bond |
2008 | 62 | 62 | 62 | CHF | 2015 | 3.135 | % | ||||||||||||||||||||
Bond |
2008 | 61 | 61 | 62 | CHF | 2015 | 3.135 | % | ||||||||||||||||||||
Bond |
2008 | 62 | 62 | 62 | CHF | 2018 | 3.135 | % | ||||||||||||||||||||
Bond |
2009 | 56 | 56 | | AUD | 2013 | 5.500 | % | ||||||||||||||||||||
Bond |
2009 | 54 | 54 | | AUD | 2013 | 5.500 | % | ||||||||||||||||||||
Bond |
2009 | 236 | 236 | | CHF | 2013 | 2.500 | % | ||||||||||||||||||||
Bond |
2009 | 77 | 77 | | USD | 2013 | 4.000 | % | ||||||||||||||||||||
Bond |
2009 | 131 | 131 | | CHF | 2014 | 2.625 | % | ||||||||||||||||||||
Bond |
2009 | 997 | 998 | | EUR | 2014 | 3.500 | % | ||||||||||||||||||||
Bond |
2009 | 150 | 150 | | EUR | 2014 | 3.500 | % | ||||||||||||||||||||
Bond |
2009 | 40 | 40 | | HKD | 2014 | 3.240 | % | ||||||||||||||||||||
Bond |
2009 | 103 | 96 | | AUD | 2015 | 6.000 | % | ||||||||||||||||||||
Bond |
2009 | 550 | 550 | | EUR | 2015 | 3.625 | % | ||||||||||||||||||||
Bond |
2009 | 684 | 684 | | USD | 2015 | 3.125 | % | ||||||||||||||||||||
Bond |
2009 | 224 | 208 | | USD | 2015 | 3.125 | % | ||||||||||||||||||||
Bond |
2009 | 99 | 99 | | CHF | 2016 | 2.385 | % | ||||||||||||||||||||
Bond |
2009 | 115 | 115 | | GBP | 2017 | 4.250 | % | ||||||||||||||||||||
Bond |
2009 | 225 | 225 | | GBP | 2017 | 4.250 | % | ||||||||||||||||||||
Bond |
2009 | 448 | 448 | | EUR | 2019 | 4.875 | % | ||||||||||||||||||||
Bond |
2009 | 69 | 69 | | HKD | 2019 | 4.180 | % | ||||||||||||||||||||
Bond |
2009 | 374 | 347 | | USD | 2021 | 4.250 | % | ||||||||||||||||||||
Bond |
2010 | 102 | AUD | 2014 | 5.750 | % | ||||||||||||||||||||||
Bond |
2010 | 108 | CAD | 2014 | 2.500 | % | ||||||||||||||||||||||
Bond |
2010 | 53 | NZD | 2014 | 4.750 | % | ||||||||||||||||||||||
Bond |
2010 | 187 | USD | 2015 | 2.875 | % | ||||||||||||||||||||||
Bond |
2010 | 935 | USD | 2015 | 3.000 | % | ||||||||||||||||||||||
Bond |
2010 | 748 | USD | 2016 | 2.300 | % | ||||||||||||||||||||||
Bond |
2010 | 68 | AUD | 2015 | 6.000 | % | ||||||||||||||||||||||
Bond |
2010 | 69 | AUD | 2015 | 6.000 | % | ||||||||||||||||||||||
Bond |
2010 | 64 | AUD | 2015 | 6.000 | % | ||||||||||||||||||||||
Bond |
2010 | 476 | EUR | 2022 | 3.125 | % | ||||||||||||||||||||||
Current portion (less than one year) |
(3,450 | ) | (1,937 | ) | (722 | ) | ||||||||||||||||||||||
Total TOTAL CAPITAL |
15,143 | 15,615 | 13,093 | |||||||||||||||||||||||||
Other consolidated subsidiaries |
223 | 153 | 103 | |||||||||||||||||||||||||
Total bonds after fair value hedge |
15,491 | 15,884 | 13,380 | |||||||||||||||||||||||||
Page 56
Amount after | Amount after | Amount after | ||||||||||||||||||||||||||
hedging as of | hedging as of | hedging as of | Initial rate before | |||||||||||||||||||||||||
Fixed rate bonds and bonds after cash flow hedge | Year of | December 31, | December 31, | December 31, | hedging | |||||||||||||||||||||||
(M) | issue | 2010 | 2009 | 2008 | Currency | Maturity | instruments | |||||||||||||||||||||
TOTAL CAPITAL (a) |
||||||||||||||||||||||||||||
Bond |
2005 | 293 | 292 | 287 | GBP | 2012 | 4.625 | % | ||||||||||||||||||||
Bond |
2009 | 691 | 602 | | EUR | 2019 | 4.875 | % | ||||||||||||||||||||
Bond |
2009 | 917 | 806 | | EUR | 2024 | 5.125 | % | ||||||||||||||||||||
Bond |
2010 | 935 | USD | 2020 | 4.450 | % | ||||||||||||||||||||||
Total fixed rate bonds and bonds after cash flow
hedge |
2,836 | 1,700 | 287 | |||||||||||||||||||||||||
(a) | TOTAL CAPITAL is a wholly-owned indirect subsidiary of TOTAL S.A. (with the exception of one share held by each member of its Board of Directors). It acts as a financing vehicle for the Group. Its debt securities are fully and unconditionally guaranteed by TOTAL S.A. as to payment of principal, premium, if any, interest and any other amounts due. |
of which hedging | ||||||||||||||||||||
instruments of | Hedging instruments of | |||||||||||||||||||
non-current | non-current | Non-current financial | ||||||||||||||||||
As of December 31, 2010 | Non-current | financial debt | financial debt | debt net of hedging | ||||||||||||||||
(M) | financial debt | (liabilities) | (assets) | instruments | % | |||||||||||||||
2012 |
3,756 | 34 | ( 401 | ) | 3,355 | 18 | % | |||||||||||||
2013 |
4,017 | 76 | ( 473 | ) | 3,544 | 19 | % | |||||||||||||
2014 |
2,508 | 1 | ( 290 | ) | 2,218 | 12 | % | |||||||||||||
2015 |
3,706 | 2 | ( 302 | ) | 3,404 | 18 | % | |||||||||||||
2016 and beyond |
6,796 | 65 | ( 404 | ) | 6,392 | 33 | % | |||||||||||||
Total |
20,783 | 178 | (1 870 | ) | 18,913 | 100 | % | |||||||||||||
of which hedging | ||||||||||||||||||||
instruments of | Hedging instruments | |||||||||||||||||||
non-current | of non-current | Non-current financial | ||||||||||||||||||
As of December 31, 2009 | Non-current | financial debt | financial debt | debt net of hedging | ||||||||||||||||
(M) | financial debt | (liabilities) | (assets) | instruments | % | |||||||||||||||
2011 |
3,857 | 42 | ( 199 | ) | 3,658 | 20 | % | |||||||||||||
2012 |
3,468 | 48 | ( 191 | ) | 3,277 | 18 | % | |||||||||||||
2013 |
3,781 | 95 | ( 236 | ) | 3,545 | 19 | % | |||||||||||||
2014 |
2,199 | 6 | ( 90 | ) | 2,109 | 11 | % | |||||||||||||
2015 and beyond |
6,132 | 50 | ( 309 | ) | 5,823 | 32 | % | |||||||||||||
Total |
19,437 | 241 | (1 025 | ) | 18,412 | 100 | % | |||||||||||||
of which hedging | ||||||||||||||||||||
instruments of | Hedging instruments | |||||||||||||||||||
non-current | of non-current | Non-current financial | ||||||||||||||||||
As of December 31, 2008 | Non-current | financial debt | financial debt | debt net of hedging | ||||||||||||||||
(M) | financial debt | (liabilities) | (assets) | instruments | % | |||||||||||||||
2010 |
3,160 | 170 | ( 168 | ) | 2,992 | 20 | % | |||||||||||||
2011 |
3,803 | 24 | ( 145 | ) | 3,658 | 24 | % | |||||||||||||
2012 |
3,503 | 115 | ( 179 | ) | 3,324 | 22 | % | |||||||||||||
2013 |
3,430 | 127 | ( 198 | ) | 3,232 | 21 | % | |||||||||||||
2014 and beyond |
2,295 | 4 | ( 202 | ) | 2,093 | 13 | % | |||||||||||||
Total |
16,191 | 440 | ( 892 | ) | 15,299 | 100 | % | |||||||||||||
Page 57
As of December 31, | ||||||||||||||||||||||||
(M) | 2010 | % | 2009 | % | 2008 | % | ||||||||||||||||||
U.S. Dollar |
7,248 | 39 | % | 3,962 | 21 | % | 3,990 | 26 | % | |||||||||||||||
Euro |
11,417 | 60 | % | 14,110 | 77 | % | 10,685 | 70 | % | |||||||||||||||
Other currencies |
248 | 1 | % | 340 | 2 | % | 624 | 4 | % | |||||||||||||||
Total |
18,913 | 100 | % | 18,412 | 100 | % | 15,299 | 100 | % | |||||||||||||||
As of December 31, | ||||||||||||||||||||||||
(M) | 2010 | % | 2009 | % | 2008 | % | ||||||||||||||||||
Fixed rate |
3,177 | 17 | % | 2,064 | 11 | % | 633 | 4 | % | |||||||||||||||
Floating rate |
15,736 | 83 | % | 16,348 | 89 | % | 14,666 | 96 | % | |||||||||||||||
Total |
18,913 | 100 | % | 18,412 | 100 | % | 15,299 | 100 | % | |||||||||||||||
As of December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
(Assets) / Liabilities |
||||||||||||
Current financial debt (a) |
5,867 | 4,761 | 5,586 | |||||||||
Current portion of non-current financial debt |
3,786 | 2,233 | 2,136 | |||||||||
Current borrowings (note 28) |
9,653 | 6,994 | 7,722 | |||||||||
Current portion of hedging instruments of debt (liabilities) |
12 | 97 | 12 | |||||||||
Other current financial instruments (liabilities) |
147 | 26 | 146 | |||||||||
Other current financial liabilities (note 28) |
159 | 123 | 158 | |||||||||
Current deposits beyond three months |
(869 | ) | (55 | ) | (1 | ) | ||||||
Current portion of hedging instruments of debt (assets) |
(292 | ) | (197 | ) | (100 | ) | ||||||
Other current financial instruments (assets) |
(44 | ) | (59 | ) | (86 | ) | ||||||
Current financial assets (note 28) |
(1,205 | ) | (311 | ) | (187 | ) | ||||||
Current borrowings and related financial assets and liabilities, net |
8,607 | 6,806 | 7,693 | |||||||||
(a) | As of December 31, 2010, the current financial debt includes a commercial paper program in Total Capital Canada Ltd. Total Capital Canada Ltd. is a wholly-owned direct subsidiary of TOTAL S.A. It acts as a financing vehicle for the activities of the Group in Canada. Its debt securities are fully and unconditionally guaranteed by TOTAL S.A. as to payment of principal, premium, if any, interest and any other amounts due. |
Page 58
As of December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
(Assets) / Liabilities |
||||||||||||
Current borrowings |
9,653 | 6,994 | 7,722 | |||||||||
Other current financial liabilities |
159 | 123 | 158 | |||||||||
Current financial assets |
(1,205 | ) | (311 | ) | (187 | ) | ||||||
Non-current financial debt |
20,783 | 19,437 | 16,191 | |||||||||
Hedging instruments on non-current financial debt |
(1,870 | ) | (1,025 | ) | (892 | ) | ||||||
Cash and cash equivalents |
(14,489 | ) | (11,662 | ) | (12,321 | ) | ||||||
Net financial debt |
13,031 | 13,556 | 10,671 | |||||||||
Shareholders equity Group share |
60,414 | 52,552 | 48,992 | |||||||||
Estimated dividend payable |
(2,553 | ) | (2,546 | ) | (2,540 | ) | ||||||
Minority interest |
857 | 987 | 958 | |||||||||
Total shareholders equity |
58,718 | 50,993 | 47,410 | |||||||||
Net-debt-to-equity ratio |
22.2 | % | 26.6 | % | 22.5 | % | ||||||
As of December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Accruals and deferred income |
184 | 223 | 151 | |||||||||
Payable to States (including taxes and duties) |
7,235 | 6,024 | 6,256 | |||||||||
Payroll |
996 | 955 | 928 | |||||||||
Other operating liabilities |
3,574 | 4,706 | 4,297 | |||||||||
Total |
11,989 | 11,908 | 11,632 | |||||||||
Page 59
For the year ended December 31, 2010 | ||||||||
(M) | Operating leases | Finance leases | ||||||
2011 |
582 | 39 | ||||||
2012 |
422 | 39 | ||||||
2013 |
335 | 39 | ||||||
2014 |
274 | 35 | ||||||
2015 |
230 | 35 | ||||||
2016 and beyond |
1,105 | 54 | ||||||
Total minimum payments |
2,948 | 241 | ||||||
Less financial expenses |
| (43 | ) | |||||
Nominal value of contracts |
| 198 | ||||||
Less current portion of finance lease contracts |
| (23 | ) | |||||
Outstanding liability of finance lease contracts |
| 175 | ||||||
For the year ended December 31, 2009 | ||||||||
(M) | Operating leases | Finance leases | ||||||
2010 |
523 | 42 | ||||||
2011 |
377 | 43 | ||||||
2012 |
299 | 42 | ||||||
2013 |
243 | 41 | ||||||
2014 |
203 | 39 | ||||||
2015 and beyond |
894 | 128 | ||||||
Total minimum payments |
2,539 | 335 | ||||||
Less financial expenses |
| (53 | ) | |||||
Nominal value of contracts |
| 282 | ||||||
Less current portion of finance lease contracts |
| (22 | ) | |||||
Outstanding liability of finance lease contracts |
| 260 | ||||||
For the year ended December 31, 2008 | ||||||||
(M) | Operating leases | Finance leases | ||||||
2009 |
429 | 47 | ||||||
2010 |
306 | 42 | ||||||
2011 |
243 | 42 | ||||||
2012 |
208 | 42 | ||||||
2013 |
166 | 40 | ||||||
2014 and beyond |
675 | 148 | ||||||
Total minimum payments |
2,027 | 361 | ||||||
Less financial expenses |
| (70 | ) | |||||
Nominal value of contracts |
| 291 | ||||||
Less current portion of finance lease contracts |
| (23 | ) | |||||
Outstanding liability of finance lease contracts |
| 268 | ||||||
Page 60
Maturity and installments | ||||||||||||||||
As of December 31, 2010 | Less than 1 | Between 1 | More than 5 | |||||||||||||
(M) | Total | year | and 5 years | years | ||||||||||||
Non-current debt obligations net of hedging instruments (Note 20) |
18,738 | | 12,392 | 6,346 | ||||||||||||
Current portion of non-current debt obligations net of hedging instruments
(Note 20) |
3,483 | 3,483 | | | ||||||||||||
Finance lease obligations (Note 22) |
198 | 23 | 129 | 46 | ||||||||||||
Asset retirement obligations (Note 19) |
5,917 | 177 | 872 | 4,868 | ||||||||||||
Contractual obligations recorded in the balance sheet |
28,336 | 3,683 | 13,393 | 11,260 | ||||||||||||
Operating lease obligations (Note 22) |
2,948 | 582 | 1,261 | 1,105 | ||||||||||||
Purchase obligations |
61,293 | 6,347 | 14,427 | 40,519 | ||||||||||||
Contractual obligations not recorded in the balance sheet |
64,241 | 6,929 | 15,688 | 41,624 | ||||||||||||
Total of contractual obligations |
92,577 | 10,612 | 29,081 | 52,884 | ||||||||||||
Guarantees given for excise taxes |
1,753 | 1,594 | 71 | 88 | ||||||||||||
Guarantees given against borrowings |
5,005 | 1,333 | 493 | 3,179 | ||||||||||||
Indemnities related to sales of businesses |
37 | | 31 | 6 | ||||||||||||
Guarantees of current liabilities |
171 | 147 | 19 | 5 | ||||||||||||
Guarantees to customers / suppliers |
3,020 | 1,621 | 96 | 1,303 | ||||||||||||
Letters of credit |
1,250 | 1,247 | | 3 | ||||||||||||
Other operating commitments |
2,057 | 467 | 220 | 1,370 | ||||||||||||
Total of other commitments given |
13,293 | 6,409 | 930 | 5,954 | ||||||||||||
Mortgages and liens received |
429 | 2 | 114 | 313 | ||||||||||||
Other commitments received |
6,387 | 3,878 | 679 | 1,830 | ||||||||||||
Total of commitments received |
6,816 | 3,880 | 793 | 2,143 | ||||||||||||
Maturity and installments | ||||||||||||||||
As of December 31, 2009 | Less than 1 | Between 1 | More than 5 | |||||||||||||
(M) | Total | year | and 5 years | years | ||||||||||||
Non-current debt obligations net of hedging instruments (Note 20) |
18,152 | | 12,443 | 5,709 | ||||||||||||
Current portion of non-current debt obligations net of hedging instruments
(Note 20) |
2,111 | 2,111 | | | ||||||||||||
Finance lease obligations (Note 22) |
282 | 22 | 146 | 114 | ||||||||||||
Asset retirement obligations (Note 19) |
5,469 | 235 | 972 | 4,262 | ||||||||||||
Contractual obligations recorded in the balance sheet |
26,014 | 2,368 | 13,561 | 10,085 | ||||||||||||
Operating lease obligations (Note 22) |
2,539 | 523 | 1,122 | 894 | ||||||||||||
Purchase obligations |
49,808 | 4,542 | 9,919 | 35,347 | ||||||||||||
Contractual obligations not recorded in the balance sheet |
52,347 | 5,065 | 11,041 | 36,241 | ||||||||||||
Total of contractual obligations |
78,361 | 7,433 | 24,602 | 46,326 | ||||||||||||
Guarantees given for excise taxes |
1,765 | 1,617 | 69 | 79 | ||||||||||||
Guarantees given against borrowings |
2,882 | 1,383 | 709 | 790 | ||||||||||||
Indemnities related to sales of businesses |
36 | | 1 | 35 | ||||||||||||
Guarantees of current liabilities |
203 | 160 | 38 | 5 | ||||||||||||
Guarantees to customers / suppliers |
2,770 | 1,917 | 70 | 783 | ||||||||||||
Letters of credit |
1,499 | 1,485 | 2 | 12 | ||||||||||||
Other operating commitments |
765 | 582 | 103 | 80 | ||||||||||||
Total of other commitments given |
9,920 | 7,144 | 992 | 1,784 | ||||||||||||
Mortgages and liens received |
330 | 5 | 106 | 219 | ||||||||||||
Other commitments received |
5,637 | 3,187 | 481 | 1,969 | ||||||||||||
Total of commitments received |
5,967 | 3,192 | 587 | 2,188 | ||||||||||||
Page 61
Maturity and installments | ||||||||||||||||
As of December 31, 2008 | Less than | Between 1 | More than | |||||||||||||
(M) | Total | 1 year | and 5 years | 5 years | ||||||||||||
Non-current debt obligations net of hedging instruments (Note 20) |
15,031 | | 13,064 | 1,967 | ||||||||||||
Current portion of non-current debt obligations net of hedging instruments
(Note 20) |
2,025 | 2,025 | | | ||||||||||||
Finance lease obligations (Note 22) |
291 | 23 | 142 | 126 | ||||||||||||
Asset retirement obligations (Note 19) |
4,500 | 154 | 653 | 3,693 | ||||||||||||
Contractual obligations recorded in the balance sheet |
21,847 | 2,202 | 13,859 | 5,786 | ||||||||||||
Operating lease obligations (Note 22) |
2,027 | 429 | 923 | 675 | ||||||||||||
Purchase obligations |
60,226 | 4,420 | 13,127 | 42,679 | ||||||||||||
Contractual obligations not recorded in the balance sheet |
62,253 | 4,849 | 14,050 | 43,354 | ||||||||||||
Total of contractual obligations |
84,100 | 7,051 | 27,909 | 49,140 | ||||||||||||
Guarantees given for excise taxes |
1,720 | 1,590 | 58 | 72 | ||||||||||||
Guarantees given against borrowings |
2,870 | 1,119 | 519 | 1,232 | ||||||||||||
Indemnities related to sales of businesses |
39 | 3 | 1 | 35 | ||||||||||||
Guarantees of current liabilities |
315 | 119 | 164 | 32 | ||||||||||||
Guarantees to customers / suppliers |
2,866 | 68 | 148 | 2,650 | ||||||||||||
Letters of credit |
1,080 | 1,024 | 17 | 39 | ||||||||||||
Other operating commitments |
648 | 246 | 132 | 270 | ||||||||||||
Total of other commitments given |
9,538 | 4,169 | 1,039 | 4,330 | ||||||||||||
Mortgages and liens received |
321 | 72 | 110 | 139 | ||||||||||||
Other commitments received |
4,218 | 2,440 | 234 | 1,544 | ||||||||||||
Total of commitments received |
4,539 | 2,512 | 344 | 1,683 | ||||||||||||
Page 62
Page 63
As of December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Balance sheet |
||||||||||||
Receivables |
||||||||||||
Debtors and other debtors |
432 | 293 | 244 | |||||||||
Loans (excl. loans to equity affiliates) |
315 | 438 | 354 | |||||||||
Payables |
||||||||||||
Creditors and other creditors |
497 | 386 | 136 | |||||||||
Debts |
28 | 42 | 50 | |||||||||
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Statement of income |
||||||||||||
Sales |
3,194 | 2,183 | 3,082 | |||||||||
Purchases |
5,576 | 2,958 | 4,061 | |||||||||
Financial expense |
69 | 1 | | |||||||||
Financial income |
74 | 68 | 114 | |||||||||
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Number of people |
26 | 27 | 30 | |||||||||
Direct or indirect compensation |
20.8 | 19.4 | 20.4 | |||||||||
Pension expenses(a) |
12.2 | 10.6 | 11.9 | |||||||||
Other long-term benefits |
| | | |||||||||
Termination benefits |
| | | |||||||||
Share-based payments expense (IFRS 2)(b) |
10.0 | 11.2 | 16.6 | |||||||||
(a) | The benefits provided for executive officers and certain members of the Board of Directors, employees and former employees of the Group, include severance to be paid on retirement, supplementary pension schemes and insurance plans, which represent 113.8 million provisioned as of December 31, 2010 (against 96.6 million as of December 31, 2009 and 98.0 million as of December 31, 2008). | |
(b) | Share-based payments expense computed for the executive officers and the members of the Board of Directors who are employees of the Group as described in Note 25 paragraph E to the Consolidated Financial Statements and based on the principles of IFRS 2 Share-based payments described in Note 1 paragraph E to the Consolidated Financial Statements. |
Page 64
Weighted | ||||||||||||||||||||||||||||||||||||||||
average | ||||||||||||||||||||||||||||||||||||||||
exercise | ||||||||||||||||||||||||||||||||||||||||
2003 Plan | 2004 Plan | 2005 Plan | 2006 Plan | 2007 Plan | 2008 Plan | 2009 Plan | 2010 Plan | Total | price | |||||||||||||||||||||||||||||||
Date of the shareholders
meeting |
05/17/2001 | 05/14/2004 | 05/14/2004 | 05/14/2004 | 05/11/2007 | 05/11/2007 | 05/11/2007 | 05/21/2010 | ||||||||||||||||||||||||||||||||
Grant Date (a) |
07/16/2003 | 07/20/2004 | 07/19/2005 | 07/18/2006 | 07/17/2007 | 10/09/2008 | 09/15/2009 | 09/14/2010 | ||||||||||||||||||||||||||||||||
Exercise price until May 23,
2006 included (b) |
33.30 | 39.85 | 49.73 | | | | | | ||||||||||||||||||||||||||||||||
Exercise price since May 24,
2006 (b) |
32.84 | 39.30 | 49.04 | 50.60 | 60.10 | 42.90 | 39.90 | 38.20 | ||||||||||||||||||||||||||||||||
Expiry date |
07/16/2011 | 07/20/2012 | 07/19/2013 | 07/18/2014 | 07/17/2015 | 10/09/2016 | 09/15/2017 | 09/14/2018 | ||||||||||||||||||||||||||||||||
Number of options (c) |
||||||||||||||||||||||||||||||||||||||||
Outstanding as of January 1,
2008 |
8,368,378 | 13,197,236 | 6,243,438 | 5,711,060 | 5,920,105 | 39,440,217 | 44.23 | |||||||||||||||||||||||||||||||||
Awarded |
| | | | | 4,449,810 | 4,449,810 | 42.90 | ||||||||||||||||||||||||||||||||
Canceled |
(25,184 | ) | (118,140 | ) | (34,032 | ) | (53,304 | ) | (34,660 | ) | (6,000 | ) | (271,320 | ) | 44.88 | |||||||||||||||||||||||||
Exercised |
(841,846 | ) | (311,919 | ) | (17,702 | ) | (6,700 | ) | | | (1,178,167 | ) | 34.89 | |||||||||||||||||||||||||||
Outstanding as of January 1,
2009 |
7,501,348 | 12,767,177 | 6,191,704 | 5,651,056 | 5,885,445 | 4,443,810 | 42,440,540 | 44.35 | ||||||||||||||||||||||||||||||||
Awarded |
| | | | | | 4,387,620 | 4,387,620 | 39.90 | |||||||||||||||||||||||||||||||
Canceled |
(8,020 | ) | (18,387 | ) | (6,264 | ) | (5,370 | ) | (13,780 | ) | (2,180 | ) | (10,610 | ) | (64,611 | ) | 45.04 | |||||||||||||||||||||||
Exercised |
(681,699 | ) | (253,081 | ) | | | | | | (934,780 | ) | 34.59 | ||||||||||||||||||||||||||||
Outstanding as of January 1,
2010 |
6,811,629 | 12,495,709 | 6,185,440 | 5,645,686 | 5,871,665 | 4,441,630 | 4,377,010 | 45,828,769 | 44.12 | |||||||||||||||||||||||||||||||
Awarded |
| | | | | | | 4,788,420 | 4,788,420 | 38.20 | ||||||||||||||||||||||||||||||
Canceled (d) |
(1,420 | ) | (15,660 | ) | (6,584 | ) | (4,800 | ) | (5,220 | ) | (92,472 | ) | (4,040 | ) | (1,120 | ) | (131,316 | ) | 43.50 | |||||||||||||||||||||
Exercised |
(1,075,765 | ) | (141,202 | ) | | | | | (1,080 | ) | | (1,218,047 | ) | 33.60 | ||||||||||||||||||||||||||
Outstanding as of
December 31, 2010 |
5,734,444 | 12,338,847 | 6,178,856 | 5,640,886 | 5,866,445 | 4,349,158 | 4,371,890 | 4,787,300 | 49,267,826 | 43.80 |
(a) | The grant date is the date of the Board meeting awarding the share subscription options, except for the grant of October 9, 2008, decided by the Board on September 9, 2008. | |
(b) | Exercise price in euro. The exercise prices of TOTAL subscription shares of the plans in force at that date were multiplied by 0.25 to take into account the four-for-one stock split on May 18, 2006. Moreover, following the spin-off of Arkema, the exercise prices of TOTAL subscription shares of these plans were multiplied by an adjustment factor equal to 0.986147 effective as of May 24, 2006. | |
(c) | The number of options awarded, outstanding, canceled or exercised before May 23, 2006 included, was multiplied by four to take into account the four-for-one stock split approved by the shareholders meeting on May 12, 2006. | |
(d) | Out of 92,472 options awarded under the 2008 Plan that were canceled, 88,532 options were canceled due to the performance condition. The acquisition rate applicable to the subscription options that were subject to the performance condition of the 2008 Plan was 60%. |
| For each grantee of up to 3,000 options, other than the Chairman and Chief Executive Officer, the options will be finally granted to their beneficiary. | |
| For each grantee of more than 3,000 options and less or equal to 50,000 options (other than the Chairman and Chief Executive Officer): |
| The first 3,000 options and two-thirds above the first 3,000 options will be finally granted to their beneficiary; | ||
| The outstanding options, that is one-third of the options above the first 3,000 options, will be finally granted provided that the performance condition described below is fulfilled. |
| For each grantee of more than 50,000 options, other than the Chairman and Chief Executive Officer: |
| The first 3,000 options, two-thirds of the options above the first 3,000 options and below the first 50,000 options, and one-third of the options above the first 50,000 options, will be finally granted to their beneficiary; | ||
| The outstanding options, that is one-third of the options above the first 3,000 options and below the first 50,000 options and two-thirds of the options above the first 50,000 options, will be finally granted provided that the performance condition is fulfilled. |
Page 65
| is equal to zero if the average ROE is less than or equal to 7%; | ||
| varies on straight-line basis between 0% and 100% if the average ROE is more than 7% and less than 18%; and | ||
| is equal to 100% if the average ROE is more than or equal to 18%. |
| For 50% of the share subscription options granted, the performance condition states that the number of options finally granted is based on the average ROE of the Group. The average ROE is calculated by the Group based on TOTALs consolidated balance sheet and statement of income for fiscal years 2010 and 2011. The acquisition rate is equal to zero if the average ROE is less than or equal to 7%; varies on a straight-line basis between 0% and 100% if the average ROE is more than 7% and less than 18%; and is equal to 100% if the average ROE is more than or equal to 18%. | ||
| For 50% of the share subscription options granted, the performance condition states that the number of options finally granted is based on the average of the Return On Average Capital Employed (ROACE) of the Group. The average ROACE is calculated by the Group based on TOTALs consolidated balance sheet and statement of income for fiscal years 2010 and 2011. The acquisition rate is equal to zero if the average ROACE is less than or equal to 6%; varies on a straight-line basis between 0% and 100% if the average ROACE is more than 6% and less than 15%; and is equal to 100% if the average ROACE is more than or equal to 15%. |
| is equal to zero if the average ROE is less than or equal to 7%; | ||
| varies on straight-line basis between 0% and 100% if the average ROE is more than 7% and less than 18%; and | ||
| is equal to 100% if the average ROE is more than or equal to 18%. |
| For 50% of the share subscription options granted, the performance condition states that the number of options finally granted is based on the average ROE of the Group as published by TOTAL. The average ROE is calculated based on the Groups consolidated balance sheet and statement of income for fiscal years 2009 and 2010. The acquisition rate is equal to zero if the average ROE is less than or equal to 7%; varies on a straight-line basis between 0% and 100% if the average ROE is more than 7% and less than 18%; and is equal to 100% if the average ROE is more than or equal to 18%. | ||
| For 50% of the share subscription options granted, the performance condition states that the number of options finally granted is based on the average ROACE of the Group as published by TOTAL. The average ROACE is calculated based on the Groups consolidated balance sheet and statement of income for fiscal years 2009 and 2010. The acquisition rate is equal to zero if the average ROACE is less than or equal to 6%; varies on a straight-line basis between 0% and 100% if the average ROACE is more than 6% and less than 15%; and is equal to 100% if the average ROACE is more than or equal to 15%. |
Page 66
| is equal to zero if the ROE is less than or equal to 10%; | ||
| varies on a straight-line basis between 0% and 80% if the ROE is more than 10% and less than 18%; | ||
| varies on a straight-line basis between 80% and 100% if the ROE is more than or equal to 18% and less than 30%; and | ||
| is equal to 100% if the ROE is more than or equal to 30%. |
Weighted | ||||||||||||||||||||
average | ||||||||||||||||||||
2000 Plan(a) | 2001 Plan(b) | 2002 Plan(c) | Total | exercise price | ||||||||||||||||
Date of the shareholders meeting |
05/21/1997 | 05/17/2001 | 05/17/2001 | |||||||||||||||||
Grant date (d) |
07/11/2000 | 07/10/2001 | 07/09/2002 | |||||||||||||||||
Exercise price until May 23, 2006 included (e) |
40.68 | 42.05 | 39.58 | |||||||||||||||||
Exercise price since May 24, 2006 (e) |
40.11 | 41.47 | 39.03 | |||||||||||||||||
Expiry date |
07/11/2008 | 07/10/2009 | 07/09/2010 | |||||||||||||||||
Number of options (f) |
||||||||||||||||||||
Outstanding as of January 1, 2008 |
3,142,188 | 5,150,258 | 7,063,183 | 15,355,629 | 40.07 | |||||||||||||||
Awarded |
| | | | | |||||||||||||||
Canceled |
(480,475 | ) | (3,652 | ) | (13,392 | ) | (497,519 | ) | 40.09 | |||||||||||
Exercised |
(2,661,713 | ) | (455,180 | ) | (598,934 | ) | (3,715,827 | ) | 40.10 | |||||||||||
Outstanding as of January 1, 2009 |
| 4,691,426 | 6,450,857 | 11,142,283 | 40.06 | |||||||||||||||
Awarded |
| | | | ||||||||||||||||
Canceled |
(4,650,446 | ) | (7,920 | ) | (4,658,366 | ) | 41.47 | |||||||||||||
Exercised |
(40,980 | ) | (507,676 | ) | (548,656 | ) | 39.21 | |||||||||||||
Outstanding as of January 1, 2010 |
| 5,935,261 | 5,935,261 | 39.03 | ||||||||||||||||
Awarded |
| | | |||||||||||||||||
Canceled (g) |
(4,671,989 | ) | (4,671,989 | ) | 39.03 | |||||||||||||||
Exercised |
(1,263,272 | ) | (1,263,272 | ) | 39.03 | |||||||||||||||
Outstanding as of December 31, 2010 |
| | |
(a) | Options were exercisable, subject to a continued employment condition, after a 4-year vesting period from the date of the Board meeting awarding the options and expired eight years after this date. The underlying shares may not be transferred during the 5-year period from the date of the grant. This plan expired on July 11, 2008. | |
(b) | Options were exercisable, subject to a continued employment condition, after a 3.5-year vesting period from the date of the Board meeting awarding the options and expired eight years after this date. The underlying shares may not be transferred during the 4-year period from the date of the grant. This plan expired on July 10, 2009. | |
(c) | Options were exercisable, subject to a continued employment condition, after a 2-year vesting period from the date of the Board meeting awarding the options and expired eight years after this date. The underlying shares may not be transferred during the 4-year period from the date of the grant. This plan expired on July 9, 2010. | |
(d) | The grant date is the date of the Board meeting awarding the options. | |
(e) | Exercise price in euro. The exercise prices of TOTAL share purchase options of the plans at that date were multiplied by 0.25 to take into account the four-for-one stock split on May 18, 2006. Moreover, following the spin-off of Arkema, the exercise prices of TOTAL share purchase options of these plans were multiplied by an adjustment factor equal to 0.986147 effective as of May 24, 2006. | |
(f) | The number of options awarded, outstanding, canceled or exercised before May 23, 2006 included, was multiplied by four to take into account the four-for-one stock split approved by the shareholders meeting on May 12, 2006. | |
(g) | Out of the 4,671,989 options canceled in 2010, 4,671,145 options that were not exercised expired due to the expiry of the 2002 purchase option Plan on July 9, 2010. |
Page 67
2005 Plan | 2006 Plan | 2007 Plan | 2008 Plan | 2009 Plan | 2010 Plan | Total | ||||||||||||||||||||||
Date of the shareholders meeting |
05/17/2005 | 05/17/2005 | 05/17/2005 | 05/16/2008 | 05/16/2008 | 05/16/2008 | ||||||||||||||||||||||
Grant date(a) |
07/19/2005 | 07/18/2006 | 07/17/2007 | 10/09/2008 | 09/15/2009 | 09/14/2010 | ||||||||||||||||||||||
Final grant date (end of the vesting period) |
07/20/2007 | 07/19/2008 | 07/18/2009 | 10/10/2010 | 09/16/2011 | 09/15/2012 | ||||||||||||||||||||||
Transfer possible from |
07/20/2009 | 07/19/2010 | 07/18/2011 | 10/10/2012 | 09/16/2013 | 09/15/2014 | ||||||||||||||||||||||
Number of restricted shares |
||||||||||||||||||||||||||||
Outstanding as of January 1, 2008 |
| 2,263,956 | 2,363,057 | 4,627,013 | ||||||||||||||||||||||||
Awarded |
| | | 2,791,968 | 2,791,968 | |||||||||||||||||||||||
Canceled |
2,840 | (43,822 | ) | (29,504 | ) | (19,220 | ) | (89,706 | ) | |||||||||||||||||||
Finally granted(b)(c) |
(2,840 | ) | (2,220,134 | ) | (336 | ) | | (2,223,310 | ) | |||||||||||||||||||
Outstanding as of January 1, 2009 |
| | 2,333,217 | 2,772,748 | 5,105,965 | |||||||||||||||||||||||
Awarded |
| | | | 2,972,018 | 2,972,018 | ||||||||||||||||||||||
Canceled |
1,928 | 2,922 | (12,418 | ) | (9,672 | ) | (5,982 | ) | (23,222 | ) | ||||||||||||||||||
Finally granted(b)(c) |
(1,928 | ) | (2,922 | ) | (2,320,799 | ) | (600 | ) | | (2,326,249 | ) | |||||||||||||||||
Outstanding as of January 1, 2010 |
| | | 2,762,476 | 2,966,036 | 5,728,512 | ||||||||||||||||||||||
Awarded |
| | | | | 3,010,011 | 3,010,011 | |||||||||||||||||||||
Canceled(d) |
1,024 | 3,034 | 552 | (1,113,462 | ) | (9,796 | ) | (8,738 | ) | (1,127,386 | ) | |||||||||||||||||
Finally granted(b)(c) |
(1,024 | ) | (3,034 | ) | (552 | ) | (1,649,014 | ) | (1,904 | ) | (636 | ) | (1,656,164 | ) | ||||||||||||||
Outstanding as of December 31, 2010 |
| | | | 2,954,336 | 3,000,637 | 5,954,973 |
(a) | The grant date is the date of the Board of Directors meeting that awarded the shares, except for the shares awarded by the Board of Directors at their meeting of September 9, 2008, and granted on October 9, 2008. | |
(b) | Restricted shares finally granted following the death of their beneficiaries (2007 Plan for fiscal year 2008, 2008 Plan for fiscal year 2009, 2009 Plan for fiscal year 2010). | |
(c) | Including restricted shares finally granted for which the entitlement right had been canceled erroneously. | |
(d) | Out of the 1,113,462 canceled rights to the grant share under the 2008 Plan, 1,094,914 entitlement rights were canceled due to the performance condition. The acquisition rate for the 2008 Plan was 60%. |
| is equal to zero if the average ROE is less than or equal to 7%; |
Page 68
| varies on a straight-line basis between 0% and 100% if the average ROE is greater than 7% and less than 18%; and | ||
| is equal to 100% if the average ROE is greater than or equal to 18%. |
| is equal to zero if the average ROE is less than or equal to 7%; | ||
| varies on a straight-line basis between 0% and 100% if the average ROE is greater than 7% and less than 18%; and | ||
| is equal to 100% if the average ROE is greater than or equal to 18%. |
| is equal to zero if the ROE is less than or equal to 10%; | ||
| varies on a straight-line basis between 0% and 80% if the ROE is greater than 10% and less than 18%; | ||
| varies on a straight-line basis between 80% and 100% if the ROE is greater than or equal to 18% and less than 30%; and | ||
| is equal to 100% if the ROE is greater than or equal to 30%. |
2010 Plan | 2010 Plan | |||||||||||
(2+2) | (4+0) | Total | ||||||||||
Date of the shareholders meeting |
05/16/2008 | 05/16/2008 | ||||||||||
Grant date(a) |
06/30/2010 | 06/30/2010 | ||||||||||
Final grant date (end of the vesting period) |
07/01/2012 | 07/01/2014 | ||||||||||
Transfer possible from |
07/01/2014 | 07/01/2014 | ||||||||||
Number of free shares |
||||||||||||
Outstanding as of January 1, 2008 |
||||||||||||
Awarded |
||||||||||||
Canceled |
||||||||||||
Finally granted |
||||||||||||
Outstanding as of January 1, 2009 |
||||||||||||
Awarded |
||||||||||||
Canceled |
||||||||||||
Finally granted |
||||||||||||
Outstanding as of January 1, 2010 |
||||||||||||
Awarded |
1,508,850 | 1,070,650 | 2,579,500 | |||||||||
Canceled |
(125 | ) | (75 | ) | (200 | ) | ||||||
Finally granted (b) |
(75 | ) | | (75 | ) | |||||||
Outstanding as of December 31, 2010 |
1,508,650 | 1,070,575 | 2,579,225 |
(a) | The June 30, 2010, grant was decided by the Board of Directors on May 21, 2010. | |
(b) | Final grant following the death or disability of the beneficiary of the shares. |
Page 69
| 31 million for TOTAL share subscription plans; and | ||
| 109 million for TOTAL restricted shares plans. |
| 38 million for TOTAL share subscription plans; and | ||
| 68 million for TOTAL restricted shares plans. |
| 61 million for TOTAL share subscription plans; | ||
| 105 million for TOTAL restricted shares plans; and | ||
| (12) million for the adjustment to the expense booked in 2007 related to TOTAL capital increase reserved for employees (see Note 17 to the Consolidated Financial Statements). |
For the year ended December 31, | 2010 | 2009 | 2008 | |||||||||
Risk free interest rate (%) (a)
|
2.1 | 2.9 | 4.3 | |||||||||
Expected dividends (%) (b)
|
5.9 | 4.8 | 8.4 | |||||||||
Expected volatility (%) (c)
|
25.0 | 31.0 | 32.7 | |||||||||
Vesting period (years)
|
2 | 2 | 2 | |||||||||
Exercise period (years)
|
8 | 8 | 8 | |||||||||
Fair value of the granted options ( per option)
|
5.8 | 8.4 | 5.0 | |||||||||
(a) | Zero coupon Euro swap rate at 6 years. | |
(b) | The expected dividends are based on the price of TOTAL share derivatives traded on the markets. | |
(c) | The expected volatility is based on the implied volatility of TOTAL share options and of share indices options traded on the markets. |
Page 70
For the year ended December 31, | 2010 | 2009 | 2008 | |||||||||
Personnel expenses (M) |
||||||||||||
Wages and salaries (including social charges) |
6,246 | 6,177 | 6,014 | |||||||||
Group employees |
||||||||||||
France |
||||||||||||
Management |
10,852 | 10,906 | 10,688 | |||||||||
Other |
24,317 | 25,501 | 26,413 | |||||||||
International |
||||||||||||
Management |
15,146 | 15,243 | 14,709 | |||||||||
Other |
42,540 | 44,737 | 45,149 | |||||||||
Total |
92,855 | 96,387 | 96,959 | |||||||||
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Interests paid |
(470 | ) | (678 | ) | (958 | ) | ||||||
Interests received |
132 | 148 | 505 | |||||||||
Income tax paid |
(6,990 | ) | (6,202 | ) | (10,631 | ) | ||||||
Dividends received |
1,722 | 1,456 | 1,590 | |||||||||
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Inventories |
(1,896 | ) | (4,217 | ) | 4,020 | |||||||
Accounts receivable |
(2,712 | ) | (344 | ) | 3,222 | |||||||
Other current assets |
911 | 1,505 | (982 | ) | ||||||||
Accounts payable |
2,482 | 571 | (3,056 | ) | ||||||||
Other creditors and accrued liabilities |
719 | (831 | ) | (633 | ) | |||||||
Net amount |
(496 | ) | (3,316 | ) | 2,571 | |||||||
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Issuance of non-current debt |
3,995 | 6,309 | 5,513 | |||||||||
Repayment of non-current debt |
(206 | ) | (787 | ) | (2,504 | ) | ||||||
Net amount |
3,789 | 5,522 | 3,009 | |||||||||
Page 71
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Cash |
4,679 | 2,448 | 1,836 | |||||||||
Cash equivalents |
9,810 | 9,214 | 10,485 | |||||||||
Total |
14,489 | 11,662 | 12,321 | |||||||||
Other financial | Fair | |||||||||||||||||||||||||||||||||||||||
Financial instruments related to financing and trading activities | instruments | Total | value | |||||||||||||||||||||||||||||||||||||
Amortized | Fair | |||||||||||||||||||||||||||||||||||||||
cost | value | |||||||||||||||||||||||||||||||||||||||
As of December 31, 2010 | ||||||||||||||||||||||||||||||||||||||||
(M) | Available | Held for | Financial debt | Hedging of | Net investment | |||||||||||||||||||||||||||||||||||
Assets / (Liabilities) | for sale (a) | trading | (b) | financial debt | Cash flow hedge | hedge and other | ||||||||||||||||||||||||||||||||||
Equity affiliates: loans |
2,383 | 2,383 | 2,383 | |||||||||||||||||||||||||||||||||||||
Other investments |
4,590 | 4,590 | 4,590 | |||||||||||||||||||||||||||||||||||||
Hedging instruments of
non-current financial debt |
1,814 | 56 | 1,870 | 1,870 | ||||||||||||||||||||||||||||||||||||
Other non-current assets |
1,596 | 1,596 | 1,596 | |||||||||||||||||||||||||||||||||||||
Accounts receivable, net |
18,159 | 18,159 | 18,159 | |||||||||||||||||||||||||||||||||||||
Other operating receivables |
499 | 3,908 | 4,407 | 4,407 | ||||||||||||||||||||||||||||||||||||
Current financial assets |
869 | 38 | 292 | 6 | 1,205 | 1,205 | ||||||||||||||||||||||||||||||||||
Cash and
cash equivalents |
14,489 | 14,489 | 14,489 | |||||||||||||||||||||||||||||||||||||
Total financial assets |
4,848 | 4,590 | 537 | | 2,106 | 56 | 6 | 36,556 | 48,699 | 48,699 | ||||||||||||||||||||||||||||||
Total non-financial |
95,019 | |||||||||||||||||||||||||||||||||||||||
assets |
||||||||||||||||||||||||||||||||||||||||
Total assets |
143,718 | |||||||||||||||||||||||||||||||||||||||
Non-current financial |
(3,186 | ) | (17,419 | ) | (178 | ) | (20,783 | ) | (21,172 | ) | ||||||||||||||||||||||||||||||
debt |
||||||||||||||||||||||||||||||||||||||||
Accounts payable |
(18,450 | ) | (18,450 | ) | (18,450 | ) | ||||||||||||||||||||||||||||||||||
Other operating |
(559 | ) | (3,015 | ) | (3,574 | ) | (3,574 | ) | ||||||||||||||||||||||||||||||||
liabilities |
||||||||||||||||||||||||||||||||||||||||
Current borrowings |
(5,916 | ) | (3,737 | ) | (9,653 | ) | (9,653 | ) | ||||||||||||||||||||||||||||||||
Other current financial
liabilities |
(147 | ) | (12 | ) | | (159 | ) | (159 | ) | |||||||||||||||||||||||||||||||
Total financial |
(9,102 | ) | (706 | ) | (21,156 | ) | (190 | ) | | | (21,465 | ) | (52,619 | ) | (53,008 | ) | ||||||||||||||||||||||||
liabilities |
||||||||||||||||||||||||||||||||||||||||
Total non-financial
liabilities |
(91,099 | ) | ||||||||||||||||||||||||||||||||||||||
Total liabilities |
(143,718 | ) | ||||||||||||||||||||||||||||||||||||||
(a) | Financial assets available for sale are measured at their fair value except for unlisted securities (see Note 1 paragraph M(ii) and Note 13 to the Consolidated Financial Statements). | |
(b) | The financial debt is adjusted to the hedged risks value (currency and interest rate) as part of hedge accounting (see Note 1 paragraph M(iii) to the Consolidated Financial Statements). |
Page 72
Other financial | Fair | |||||||||||||||||||||||||||||||||||||||
Financial instruments related to financing and trading activities | instruments | Total | value | |||||||||||||||||||||||||||||||||||||
Amortized | Fair | |||||||||||||||||||||||||||||||||||||||
cost | value | |||||||||||||||||||||||||||||||||||||||
As of December 31, 2009 | Available | |||||||||||||||||||||||||||||||||||||||
(M) | for sale | Held for | Financial debt | Hedging of | Net investment | |||||||||||||||||||||||||||||||||||
Assets / (Liabilities) | (a) | trading | (b) | financial debt | Cash flow hedge | hedge and other | ||||||||||||||||||||||||||||||||||
Equity affiliates: loans |
2,367 | 2,367 | 2,367 | |||||||||||||||||||||||||||||||||||||
Other investments |
1,162 | 1,162 | 1,162 | |||||||||||||||||||||||||||||||||||||
Hedging instruments of
non-current financial debt |
889 | 136 | 1,025 | 1,025 | ||||||||||||||||||||||||||||||||||||
Other non-current assets |
1,284 | 1,284 | 1,284 | |||||||||||||||||||||||||||||||||||||
Accounts receivable, net |
15,719 | 15,719 | 15,719 | |||||||||||||||||||||||||||||||||||||
Other operating receivables |
1,029 | 4,116 | 5,145 | 5,145 | ||||||||||||||||||||||||||||||||||||
Current financial assets |
55 | 53 | 197 | 6 | 311 | 311 | ||||||||||||||||||||||||||||||||||
Cash and
cash equivalents |
11,662 | 11,662 | 11,662 | |||||||||||||||||||||||||||||||||||||
Total financial assets |
3,706 | 1,162 | 1,082 | | 1,086 | 136 | 6 | 31,497 | 38,675 | 38,675 | ||||||||||||||||||||||||||||||
Total
non-financial assets |
89,078 | |||||||||||||||||||||||||||||||||||||||
Total assets |
127,753 | |||||||||||||||||||||||||||||||||||||||
Non-current
financial debt |
(2,089 | ) | (17,107 | ) | (241 | ) | (19,437 | ) | (19,905 | ) | ||||||||||||||||||||||||||||||
Accounts payable |
(15,383 | ) | (15,383 | ) | (15,383 | ) | ||||||||||||||||||||||||||||||||||
Other
operating liabilities |
(923 | ) | (3,783 | ) | (4,706 | ) | (4,706 | ) | ||||||||||||||||||||||||||||||||
Current borrowings |
(4,849 | ) | (2,145 | ) | (6,994 | ) | (6,994 | ) | ||||||||||||||||||||||||||||||||
Other current financial
liabilities |
(25 | ) | (97 | ) | (1 | ) | (123 | ) | (123 | ) | ||||||||||||||||||||||||||||||
Total
financial liabilities |
(6,938 | ) | (948 | ) | (19,252 | ) | (338 | ) | | (1 | ) | (19,166 | ) | (46,643 | ) | (47,111 | ) | |||||||||||||||||||||||
Total non-financial
liabilities |
(81,110 | ) | ||||||||||||||||||||||||||||||||||||||
Total liabilities |
(127,753 | ) | ||||||||||||||||||||||||||||||||||||||
(a) | Financial assets available for sale are measured at their fair value except for unlisted securities (see Note 1 paragraph M(ii) and Note 13 to the Consolidated Financial Statements). | |
(b) | The financial debt is adjusted to the hedged risks value (currency and interest rate) as part of hedge accounting (see Note 1 paragraph M(iii) to the Consolidated Financial Statements). |
Other financial | Fair | |||||||||||||||||||||||||||||||||||||||
Financial instruments related to financing and trading activities | instruments | Total | value | |||||||||||||||||||||||||||||||||||||
Amortized | Fair | |||||||||||||||||||||||||||||||||||||||
cost | value | |||||||||||||||||||||||||||||||||||||||
As of December 31, 2008 | Available | |||||||||||||||||||||||||||||||||||||||
(M) | for sale | Held for | Financial debt | Hedging of | Net investment | |||||||||||||||||||||||||||||||||||
Assets / (Liabilities) | (a) | trading | (b) | financial debt | Cash flow hedge | hedge and other | ||||||||||||||||||||||||||||||||||
Equity affiliates: loans |
2,005 | 2,005 | 2,005 | |||||||||||||||||||||||||||||||||||||
Other investments |
1,165 | 1,165 | 1,165 | |||||||||||||||||||||||||||||||||||||
Hedging instruments of
non-current financial debt |
892 | 892 | 892 | |||||||||||||||||||||||||||||||||||||
Other non-current assets |
1,403 | 1,403 | 1,403 | |||||||||||||||||||||||||||||||||||||
Accounts receivable, net |
| 15,287 | 15,287 | 15,287 | ||||||||||||||||||||||||||||||||||||
Other operating receivables |
1,664 | 4,544 | 6,208 | 6,208 | ||||||||||||||||||||||||||||||||||||
Current financial assets |
1 | 86 | 100 | | 187 | 187 | ||||||||||||||||||||||||||||||||||
Cash and cash |
12,321 | 12,321 | 12,321 | |||||||||||||||||||||||||||||||||||||
equivalents |
||||||||||||||||||||||||||||||||||||||||
Total financial assets |
3,409 | 1,165 | 1,750 | | 992 | | | 32,152 | 39,468 | 39,468 | ||||||||||||||||||||||||||||||
Total
non-financial assets |
78,842 | |||||||||||||||||||||||||||||||||||||||
Total assets |
118,310 | |||||||||||||||||||||||||||||||||||||||
Non-current
financial debt |
(701 | ) | (15,050 | ) | (440 | ) | (16,191 | ) | (16,191 | ) | ||||||||||||||||||||||||||||||
Accounts payable |
| (14,815 | ) | (14,815 | ) | (14,815 | ) | |||||||||||||||||||||||||||||||||
Other
operating liabilities |
(1,033 | ) | (3,264 | ) | (4,297 | ) | (4,297 | ) | ||||||||||||||||||||||||||||||||
Current borrowings |
(5,721 | ) | (2,001 | ) | (7,722 | ) | (7,722 | ) | ||||||||||||||||||||||||||||||||
Other current financial
liabilities |
(146 | ) | (12 | ) | (158 | ) | (158 | ) | ||||||||||||||||||||||||||||||||
Total
financial liabilities |
(6,422 | ) | (1,179 | ) | (17,051 | ) | (452 | ) | | | (18,079 | ) | (43,183 | ) | (43,183 | ) | ||||||||||||||||||||||||
Total non-financial
liabilities |
(75,127 | ) | ||||||||||||||||||||||||||||||||||||||
Total liabilities |
(118,310 | ) | ||||||||||||||||||||||||||||||||||||||
(a) | Financial assets available for sale are measured at their fair value except for unlisted securities (see Note 1 paragraph M(ii) and Note 13 to the Consolidated Financial Statements). | |
(b) | The financial debt is adjusted to the hedged risks value (currency and interest rate) as part of hedge accounting (see Note 1 paragraph M(iii) to the Consolidated Financial Statements). |
Page 73
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Assets available for sale (investments): |
||||||||||||
- dividend
income on non-consolidated subsidiaries |
255 | 210 | 238 | |||||||||
- gains (losses) on disposal of assets |
60 | 6 | 15 | |||||||||
- other |
(17 | ) | (18 | ) | (15 | ) | ||||||
Loans and receivables |
90 | 41 | 100 | |||||||||
Impact on net operating income |
388 | 239 | 338 | |||||||||
| Dividends and gains or losses on disposal of other investments classified as Other investments; | ||
| Financial gains and depreciation on loans related to equity affiliates, non-consolidated companies and on receivables reported in Loans and receivables. |
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Loans and receivables |
133 | 158 | 547 | |||||||||
Financing liabilities and associated hedging instruments |
(469 | ) | (563 | ) | (996 | ) | ||||||
Fair value hedge (ineffective portion) |
4 | 33 | (4 | ) | ||||||||
Assets and liabilities held for trading |
(2 | ) | (26 | ) | (74 | ) | ||||||
Impact on the cost of net debt |
(334 | ) | (398 | ) | (527 | ) | ||||||
| Financial income on cash, cash equivalents, and current financial assets (notably current deposits beyond three months) classified as Loans and receivables; | ||
| Financial expense of long term subsidiaries financing, associated hedging instruments (excluding ineffective portion of the hedge detailed below) and financial expense of short term financing classified as Financing liabilities and associated hedging instruments; | ||
| Ineffective portion of bond hedging; and | ||
| Financial income, financial expense and fair value of derivative instruments used for cash management purposes classified as Assets and liabilities held for trading. |
Page 74
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Revaluation at market value of bonds |
(1,164 | ) | (183 | ) | (66 | ) | ||||||
Swap hedging of bonds |
1,168 | 216 | 62 | |||||||||
Ineffective portion of the fair value hedge |
4 | 33 | (4 | ) | ||||||||
For the year ended December 31, | As of | As of | ||||||||||||||
(M) | January 1, | Variations | Disposals | December 31, | ||||||||||||
2010 |
25 | (268 | ) | | (243 | ) | ||||||||||
2009 |
124 | (99 | ) | | 25 | |||||||||||
2008 |
29 | 95 | | 124 | ||||||||||||
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Profit (Loss) recorded in equity during the period |
(80 | ) | 128 | | ||||||||
Recycled amount from equity to the income statement during the period |
(115 | ) | 221 | | ||||||||
Page 75
Notional value(a) | ||||||||||||||||||||||||||||||||
As of December 31, 2010 | ||||||||||||||||||||||||||||||||
(M) | Fair | 2016 | ||||||||||||||||||||||||||||||
Assets / (Liabilities) | value | Total | 2011 | 2012 | 2013 | 2014 | 2015 | and after | ||||||||||||||||||||||||
Fair value hedge |
||||||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (liabilities) |
(178 | ) | 2,244 | |||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (assets) |
1,814 | 13,939 | ||||||||||||||||||||||||||||||
Total swaps hedging fixed-rates bonds (assets and liabilities) |
1,636 | 16,183 | 2,967 | 3,461 | 2,421 | 3,328 | 4,006 | |||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (current portion) (liabilities) |
(12 | ) | 592 | |||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (current portion) (assets) |
292 | 2,815 | ||||||||||||||||||||||||||||||
Total swaps hedging fixed-rates bonds (current portion) (assets and liabilities) |
280 | 3,407 | 3,407 | |||||||||||||||||||||||||||||
Cash flow hedge |
||||||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (liabilities) |
| | ||||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (assets) |
56 | 1,957 | ||||||||||||||||||||||||||||||
Total swaps hedging fixed-rates bonds (assets and liabilities) |
56 | 1,957 | 295 | 1,662 | ||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (current portion) (liabilities) |
||||||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (current portion) (assets) |
||||||||||||||||||||||||||||||||
Total swaps hedging fixed-rates bonds (current portion) (assets and liabilities) |
| | | |||||||||||||||||||||||||||||
Net investment hedge |
||||||||||||||||||||||||||||||||
Currency swaps and forward exchange contracts (assets) |
6 | 381 | ||||||||||||||||||||||||||||||
Currency swaps and forward exchange contracts (liabilities) |
| | ||||||||||||||||||||||||||||||
Total swaps hedging net investments |
6 | 381 | 381 | |||||||||||||||||||||||||||||
Held for trading |
||||||||||||||||||||||||||||||||
Other interest rate swaps (assets) |
1 | 6,463 | ||||||||||||||||||||||||||||||
Other interest rate swaps (liabilities) |
(3 | ) | 11,395 | |||||||||||||||||||||||||||||
Total other interest rate swaps (assets and liabilities) |
(2 | ) | 17,858 | 17,667 | 189 | | | 2 | | |||||||||||||||||||||||
Currency swaps and forward exchange contracts (assets) |
37 | 1,532 | ||||||||||||||||||||||||||||||
Currency swaps and forward exchange contracts (liabilities) |
(144 | ) | 6,757 | |||||||||||||||||||||||||||||
Total currency swaps and forward exchange contracts (assets and liabilities) |
(107 | ) | 8,289 | 8,102 | | 25 | 49 | 31 | 82 |
(a) | These amounts set the levels of notional commitment and are not indicative of a contingent gain or loss. |
Page 76
Notional value(a) | ||||||||||||||||||||||||||||||||
As of December 31, 2009 | ||||||||||||||||||||||||||||||||
(M) | Fair | 2015 | ||||||||||||||||||||||||||||||
Assets / (Liabilities) | value | Total | 2010 | 2011 | 2012 | 2013 | 2014 | and after | ||||||||||||||||||||||||
Fair value hedge |
||||||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (liabilities) |
(241 | ) | 4,615 | |||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (assets) |
889 | 11,076 | ||||||||||||||||||||||||||||||
Total swaps hedging fixed-rates bonds (assets and liabilities) |
648 | 15,691 | | 3,345 | 2,914 | 3,450 | 1,884 | 4,098 | ||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (current portion) (liabilities) |
(97 | ) | 912 | |||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (current portion) (assets) |
197 | 1,084 | ||||||||||||||||||||||||||||||
Total swaps hedging fixed-rates bonds (current portion) (assets and liabilities) |
100 | 1,996 | 1,996 | |||||||||||||||||||||||||||||
Cash flow hedge |
||||||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (liabilities) |
||||||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (assets) |
136 | 1,837 | 295 | 1,542 | ||||||||||||||||||||||||||||
Total swaps hedging fixed-rates bonds (assets and liabilities) |
136 | 1,837 | 295 | 1,542 | ||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (current portion) (liabilities) |
||||||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (current portion) (assets) |
||||||||||||||||||||||||||||||||
Total swaps hedging fixed-rates bonds (current portion) (assets and liabilities) |
||||||||||||||||||||||||||||||||
Net investment hedge |
||||||||||||||||||||||||||||||||
Currency swaps and forward exchange contracts (assets) |
6 | 701 | ||||||||||||||||||||||||||||||
Currency swaps and forward exchange contracts (liabilities) |
(1 | ) | 224 | |||||||||||||||||||||||||||||
Total swaps hedging net investments |
5 | 925 | 925 | |||||||||||||||||||||||||||||
Held for trading |
||||||||||||||||||||||||||||||||
Other interest rate swaps (assets) |
1,459 | |||||||||||||||||||||||||||||||
Other interest rate swaps (liabilities) |
(1 | ) | 10,865 | |||||||||||||||||||||||||||||
Total other interest rate swaps (assets and liabilities) |
(1 | ) | 12,324 | 12,208 | 114 | 2 | ||||||||||||||||||||||||||
Currency swaps and forward exchange contracts (assets) |
53 | 4,017 | ||||||||||||||||||||||||||||||
Currency swaps and forward exchange contracts (liabilities) |
(24 | ) | 3,456 | |||||||||||||||||||||||||||||
Total currency swaps and forward exchange contracts (assets and liabilities) |
29 | 7,473 | 7,224 | 52 | 50 | 47 | 100 |
(a) | These amounts set the levels of notional commitment and are not indicative of a contingent gain or loss. |
Page 77
As of December 31, 2008 | Notional value(a) | |||||||||||||||||||||||||||||||
(M) | Fair | 2014 | ||||||||||||||||||||||||||||||
Assets / (Liabilities) | value | Total | 2009 | 2010 | 2011 | 2012 | 2013 | and after | ||||||||||||||||||||||||
Fair value hedge |
||||||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (liabilities) |
(440 | ) | 9,309 | |||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (assets) |
892 | 4,195 | ||||||||||||||||||||||||||||||
Total swaps hedging fixed-rates bonds (assets and liabilities) |
452 | 13,504 | | 2,048 | 3,373 | 3,233 | 3,032 | 1,818 | ||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (current portion) (liabilities) |
(12 | ) | 92 | |||||||||||||||||||||||||||||
Swaps hedging fixed-rates bonds (current portion) (assets) |
100 | 1,871 | ||||||||||||||||||||||||||||||
Total swaps hedging fixed-rates bonds (current portion) (assets and liabilities) |
88 | 1,963 | 1,963 | |||||||||||||||||||||||||||||
Net investment hedge |
||||||||||||||||||||||||||||||||
Currency swaps and forward exchange contracts (liabilities) |
| 1,347 | 1,347 | |||||||||||||||||||||||||||||
Held for trading |
||||||||||||||||||||||||||||||||
Other interest rate swaps (assets) |
| 2,853 | ||||||||||||||||||||||||||||||
Other interest rate swaps (liabilities) |
(4 | ) | 5,712 | |||||||||||||||||||||||||||||
Total other interest rate swaps (assets and liabilities) |
(4 | ) | 8,565 | 8,559 | 4 | 2 | ||||||||||||||||||||||||||
Currency swaps and forward exchange contracts (assets) |
86 | 5,458 | ||||||||||||||||||||||||||||||
Currency swaps and forward exchange contracts (liabilities) |
(142 | ) | 2,167 | |||||||||||||||||||||||||||||
Total currency swaps and forward exchange contracts (assets and liabilities) |
(56 | ) | 7,625 | 6,595 | 483 | 114 | 67 | 76 | 290 |
(a) | These amounts set the levels of notional commitment and are not indicative of a contingent gain or loss. |
Quoted prices in | ||||||||||||||||
active markets | Prices based on | |||||||||||||||
for identical | Prices based on | non observable | ||||||||||||||
As of December 31, 2010 | assets | observable data | data | |||||||||||||
(M) | (level 1) | (level 2) | (level 3) | Total | ||||||||||||
Fair value hedge instruments |
| 1,916 | | 1,916 | ||||||||||||
Cash flow hedge instruments |
| 56 | | 56 | ||||||||||||
Net investment hedge instruments |
| 6 | | 6 | ||||||||||||
Assets and liablities held for trading |
| (109 | ) | | (109 | ) | ||||||||||
Assets available for sale |
3,631 | | | 3,631 | ||||||||||||
Total |
3,631 | 1,869 | | 5,500 | ||||||||||||
Quoted prices in | ||||||||||||||||
active markets | Prices based on | |||||||||||||||
for identical | Prices based on | non observable | ||||||||||||||
As of December 31, 2009 | assets | observable data | data | |||||||||||||
(M) | (level 1) | (level 2) | (level 3) | Total | ||||||||||||
Fair value hedge instruments |
| 748 | | 748 | ||||||||||||
Cash flow hedge instruments |
| 136 | | 136 | ||||||||||||
Net investment hedge instruments |
| 5 | | 5 | ||||||||||||
Assets and liablities held for trading |
| 28 | | 28 | ||||||||||||
Assets available for sale |
232 | | | 232 | ||||||||||||
Total |
232 | 917 | | 1,149 | ||||||||||||
Page 78
As of December 31, 2010 | ||||||||
(M) | ||||||||
Assets / (Liabilities) | Carrying amount | Fair value(b) | ||||||
Crude oil, petroleum products and freight rates activities |
||||||||
Petroleum products and crude oil swaps |
(2 | ) | (2 | ) | ||||
Freight rate swaps |
| | ||||||
Forwards (a) |
5 | 5 | ||||||
Options |
51 | 51 | ||||||
Futures |
(12 | ) | (12 | ) | ||||
Options on futures |
(4 | ) | (4 | ) | ||||
Total crude oil, petroleum products and freight rates |
38 | 38 | ||||||
Gas & Power activities |
||||||||
Swaps |
(1 | ) | (1 | ) | ||||
Forwards (a) |
(102 | ) | (102 | ) | ||||
Options |
5 | 5 | ||||||
Futures |
| | ||||||
Total Gas & Power |
(98 | ) | (98 | ) | ||||
Total |
(60 | ) | (60 | ) | ||||
Total of fair value non recognized in the balance sheet |
|
(a) | Forwards: contracts resulting in physical delivery are accounted for as derivative commodity contracts and included in the amounts shown. | |
(b) | When the fair value of derivatives listed on an organized exchange market (futures, options on futures and swaps) is offset with the margin call received or paid on the face of the balance sheet, this fair value is set to zero. |
As of December 31, 2009 | ||||||||
(M) | ||||||||
Assets / (Liabilities) | Carrying amount | Fair value(b) | ||||||
Crude oil, petroleum products and freight rates activities |
||||||||
Petroleum products and crude oil swaps |
(29 | ) | (29 | ) | ||||
Freight rate swaps |
| | ||||||
Forwards (a) |
(9 | ) | (9 | ) | ||||
Options |
21 | 21 | ||||||
Futures |
(17 | ) | (17 | ) | ||||
Options on futures |
6 | 6 | ||||||
Total crude oil, petroleum products and freight rates |
(28 | ) | (28 | ) | ||||
Gas & Power activities |
||||||||
Swaps |
52 | 52 | ||||||
Forwards (a) |
78 | 78 | ||||||
Options |
4 | 4 | ||||||
Futures |
| | ||||||
Total Gas & Power |
134 | 134 | ||||||
Total |
106 | 106 | ||||||
Total of fair value non recognized in the balance sheet |
|
(a) | Forwards: contracts resulting in physical delivery are accounted for as derivative commodity contracts and included in the amounts shown. | |
(b) | When the fair value of derivatives listed on an organized exchange market (futures, options on futures and swaps) is offset with the margin call received or paid on the face of the balance sheet, this fair value is set to zero. |
Page 79
As of December 31, 2008 | ||||||||
(M) | ||||||||
Assets / (Liabilities) | Carrying amount | Fair value(b) | ||||||
Crude oil, petroleum products and freight rates activities |
||||||||
Petroleum products and crude oil swaps |
141 | 141 | ||||||
Freight rate swaps |
8 | 8 | ||||||
Forwards (a) |
(120 | ) | (120 | ) | ||||
Options |
| | ||||||
Futures |
17 | 17 | ||||||
Options on futures |
(7 | ) | (7 | ) | ||||
Total crude oil, petroleum products and freight rates |
39 | 39 | ||||||
Gas & Power activities |
||||||||
Swaps |
(48 | ) | (48 | ) | ||||
Forwards (a) |
659 | 659 | ||||||
Options |
| | ||||||
Futures |
(19 | ) | (19 | ) | ||||
Total Gas & Power |
592 | 592 | ||||||
Total |
631 | 631 | ||||||
Total of fair value non recognized in the balance sheet |
|
(a) | Forwards: contracts resulting in physical delivery are accounted for as derivative commodity contracts and included in the amounts shown. | |
(b) | When the fair value of derivatives listed on an organized exchange market (futures, options on futures and swaps) is offset with the margin call received or paid on the face of the balance sheet, this fair value is set to zero. |
For the year ended December 31, | Fair value | Impact on | Settled | Fair value | ||||||||||||||||
(M) | as of January 1, | income | contracts | Other | as of December 31, | |||||||||||||||
Crude oil, petroleum products and freight rates activities |
||||||||||||||||||||
2010 |
(28 | ) | 1,556 | (1,488 | ) | (2 | ) | 38 | ||||||||||||
2009 |
39 | 1,713 | (1,779 | ) | (1 | ) | (28 | ) | ||||||||||||
2008 |
18 | 1,734 | (1,715 | ) | 2 | 39 | ||||||||||||||
Gas & Power activities |
||||||||||||||||||||
2010 |
134 | 410 | (648 | ) | 6 | (98 | ) | |||||||||||||
2009 |
592 | 327 | (824 | ) | 39 | 134 | ||||||||||||||
2008 |
232 | 787 | (310 | ) | (117 | ) | 592 |
Quoted prices | ||||||||||||||||
in active markets | Prices based on | Prices based on non | ||||||||||||||
As of December 31, 2010 | for identical | observable data | observable | |||||||||||||
(M) | assets (level 1) | (level 2) | data (level 3) | Total | ||||||||||||
Crude oil, petroleum products and freight rates activities |
(10 | ) | 48 | | 38 | |||||||||||
Gas & Power activities |
50 | (148 | ) | | (98 | ) | ||||||||||
Total |
40 | (100 | ) | | (60 | ) |
Quoted prices | ||||||||||||||||
in active markets | Prices based on | Prices based on non | ||||||||||||||
As of December 31, 2009 | for identical | observable data | observable | |||||||||||||
(M) | assets (level 1) | (level 2) | data (level 3) | Total | ||||||||||||
Crude oil, petroleum products and freight rates activities |
(45 | ) | 17 | | (28 | ) | ||||||||||
Gas & Power activities |
140 | (6 | ) | | 134 | |||||||||||
Total |
95 | 11 | | 106 |
Page 80
As of December 31, | ||||||||||||||||
(M) | High | Low | Average | Year end | ||||||||||||
2010 |
23.1 | 3.4 | 8.9 | 3.8 | ||||||||||||
2009 |
18.8 | 5.8 | 10.2 | 7.6 | ||||||||||||
2008 |
13.5 | 2.8 | 6.9 | 11.8 | ||||||||||||
As of December 31, | ||||||||||||||||
(M) | High | Low | Average | Year end | ||||||||||||
2010 |
13.9 | 2.7 | 6.8 | 10.0 | ||||||||||||
2009 |
9.8 | 1.9 | 5.0 | 4.8 | ||||||||||||
2008 |
16.3 | 1.3 | 5.0 | 1.4 | ||||||||||||
Page 81
Page 82
Change in fair value due to a change in | ||||||||||||||||
interest rate by | ||||||||||||||||
Assets / (Liabilities) | Carrying | Estimated | + 10 basis | - 10 basis | ||||||||||||
(M) | amount | fair value | points | points | ||||||||||||
As of December 31, 2010 |
||||||||||||||||
Bonds (non-current portion, before swaps) |
(20,019 | ) | (20,408 | ) | 86 | (84 | ) | |||||||||
Swaps hedging fixed-rates bonds (liabilities) |
(178 | ) | (178 | ) | ||||||||||||
Swaps hedging fixed-rates bonds (assets) |
1,870 | 1,870 | ||||||||||||||
Total swaps hedging fixed-rates bonds (assets and liabilities) |
1,692 | 1,692 | (59 | ) | 59 | |||||||||||
Current portion of non-current debt after swap (excluding capital
lease obligations) |
3,483 | 3,483 | 4 | (4 | ) | |||||||||||
Other interest rates swaps |
(2 | ) | (2 | ) | 3 | (3 | ) | |||||||||
Currency swaps and forward exchange contracts |
(101 | ) | (101 | ) | | | ||||||||||
As of December 31, 2009 |
||||||||||||||||
Bonds (non-current portion, before swaps) |
(18,368 | ) | (18,836 | ) | 75 | (75 | ) | |||||||||
Swaps hedging fixed-rates bonds (liabilities) |
(241 | ) | (241 | ) | ||||||||||||
Swaps hedging fixed-rates bonds (assets) |
1,025 | 1,025 | ||||||||||||||
Total swaps hedging fixed-rates bonds (assets and liabilities) |
784 | 784 | (57 | ) | 57 | |||||||||||
Current portion of non-current debt after swap (excluding capital
lease obligations) |
(2,111 | ) | (2,111 | ) | 3 | (3 | ) | |||||||||
Other interest rates swaps |
(1 | ) | (1 | ) | 1 | (1 | ) | |||||||||
Currency swaps and forward exchange contracts |
34 | 34 | | | ||||||||||||
As of December 31, 2008 |
||||||||||||||||
Bonds (non-current portion, before swaps) |
(14,119 | ) | (14,119 | ) | 47 | (43 | ) | |||||||||
Swaps hedging fixed-rates bonds (liabilities) |
(440 | ) | (440 | ) | ||||||||||||
Swaps hedging fixed-rates bonds (assets) |
892 | 892 | ||||||||||||||
Total swaps hedging fixed-rates bonds (assets and liabilities) |
452 | 452 | (44 | ) | 44 | |||||||||||
Current portion of non-current debt after swap (excluding capital
lease obligations) |
(2,025 | ) | (2,025 | ) | 3 | (3 | ) | |||||||||
Other interest rates swaps |
(4 | ) | (4 | ) | 1 | (1 | ) | |||||||||
Currency swaps and forward exchange contracts |
(56 | ) | (56 | ) | | |
Page 83
For the year ended December 31, | ||||||||||||
(M) | 2010 | 2009 | 2008 | |||||||||
Cost of net debt |
(334 | ) | (398 | ) | (527 | ) | ||||||
Interest rate translation of : |
||||||||||||
+ 10 basis points |
(11 | ) | (11 | ) | (11 | ) | ||||||
- 10 basis points |
11 | 11 | 11 | |||||||||
+ 100 basis points |
(107 | ) | (108 | ) | (113 | ) | ||||||
- 100 basis points |
107 | 108 | 113 | |||||||||
Euro / Dollar | Euro / Pound sterling | |||||||
exchange rates | exchange rates | |||||||
As of December 31, 2010 |
1.34 | 0.86 | ||||||
As of December 31, 2009 |
1.44 | 0.89 | ||||||
As of December 31, 2008 |
1.39 | 0.95 | ||||||
As of December 31, 2010 | Pound | Other currencies and | ||||||||||||||||||
(M) | Total | Euro | Dollar | sterling | equity affiliates(a) | |||||||||||||||
Shareholders equity at historical exchange rate |
62,909 | 32,894 | 22,242 | 4,997 | 2,776 | |||||||||||||||
Currency translation adjustment before net investment hedge |
(2,501 | ) | | (1,237 | ) | (1,274 | ) | 10 | ||||||||||||
Net investment hedge open instruments |
6 | | 6 | | | |||||||||||||||
Shareholders equity at exchange rate as of December 31, 2010 |
60,414 | 32,894 | 21,011 | 3,723 | 2,786 | |||||||||||||||
As of December 31, 2009 | Pound | Other currencies | ||||||||||||||||||
(M) | Total | Euro | Dollar | sterling | and equity affiliates | |||||||||||||||
Shareholders equity at historical exchange rate |
57,621 | 27,717 | 18,671 | 5,201 | 6,032 | |||||||||||||||
Currency translation adjustment before net investment hedge |
(5,074 | ) | | (3,027 | ) | (1,465 | ) | (582 | ) | |||||||||||
Net investment hedge open instruments |
5 | | 6 | (1 | ) | | ||||||||||||||
Shareholders equity at exchange rate as of December 31, 2009 |
52,552 | 27,717 | 15,650 | 3,735 | 5,450 | |||||||||||||||
As of December 31, 2008 | Pound | Other currencies | ||||||||||||||||||
(M) | Total | Euro | Dollar | sterling | and equity affiliates | |||||||||||||||
Shareholders equity at historical exchange rate |
53,868 | 25,084 | 15,429 | 5,587 | 7,768 | |||||||||||||||
Currency translation adjustment before net investment hedge |
(4,876 | ) | | (2,191 | ) | (1,769 | ) | (916 | ) | |||||||||||
Net investment hedge open instruments |
| | | | | |||||||||||||||
Shareholders equity at exchange rate as of December 31, 2008 |
48,992 | 25,084 | 13,238 | 3,818 | 6,852 | |||||||||||||||
(a) | The decrease in the heading Other currencies and equity affiliates is mainly explained by the change in the consolidation method of Sanofi-Aventis (see Note 3 to the Consolidated Financial Statements). The contribution to the shareholders equity of this investment is now reclassified into the heading for the Eurozone. |
Page 84
As of December 31, 2010 | ||||||||||||||||||||||||||||
(M) | Less than | More than | ||||||||||||||||||||||||||
Assets/(Liabilities) | one year | 1-2 years | 2-3 years | 3-4 years | 4-5 years | 5 years | Total | |||||||||||||||||||||
Non-current financial debt (notional value excluding interests) |
(3,355 | ) | (3,544 | ) | (2,218 | ) | (3,404 | ) | (6,392 | ) | (18,913 | ) | ||||||||||||||||
Current borrowings |
(9,653 | ) | (9,653 | ) | ||||||||||||||||||||||||
Other current financial liabilities |
(159 | ) | (159 | ) | ||||||||||||||||||||||||
Current financial assets |
1,205 | 1,205 | ||||||||||||||||||||||||||
Cash and cash equivalents |
14,489 | 14,489 | ||||||||||||||||||||||||||
Net amount before financial expense |
5,882 | (3,355 | ) | (3,544 | ) | (2,218 | ) | (3,404 | ) | (6,392 | ) | (13,031 | ) | |||||||||||||||
Financial expense on non-current financial debt |
(843 | ) | (729 | ) | (605 | ) | (450 | ) | (358 | ) | (1,195 | ) | (4,180 | ) | ||||||||||||||
Interest differential on swaps |
461 | 334 | 153 | 33 | 2 | (78 | ) | 905 | ||||||||||||||||||||
Net amount |
5,500 | (3,750 | ) | (3,996 | ) | (2,635 | ) | (3,760 | ) | (7,665 | ) | (16,306 | ) | |||||||||||||||
As of December 31, 2009 | ||||||||||||||||||||||||||||
(M) | Less than | More than | ||||||||||||||||||||||||||
Assets/(Liabilities) | one year | 1-2 years | 2-3 years | 3-4 years | 4-5 years | 5 years | Total | |||||||||||||||||||||
Non-current financial debt (notional value excluding interests) |
(3,658 | ) | (3,277 | ) | (3,545 | ) | (2,109 | ) | (5,823 | ) | (18,412 | ) | ||||||||||||||||
Current borrowings |
(6,994 | ) | (6,994 | ) | ||||||||||||||||||||||||
Other current financial liabilities |
(123 | ) | (123 | ) | ||||||||||||||||||||||||
Current financial assets |
311 | 311 | ||||||||||||||||||||||||||
Cash and cash equivalents |
11,662 | 11,662 | ||||||||||||||||||||||||||
Net amount before financial expense |
4,856 | (3,658 | ) | (3,277 | ) | (3,545 | ) | (2,109 | ) | (5,823 | ) | (13,556 | ) | |||||||||||||||
Financial expense on non-current financial debt |
(768 | ) | (697 | ) | (561 | ) | (448 | ) | (301 | ) | (1,112 | ) | (3,887 | ) | ||||||||||||||
Interest differential on swaps |
447 | 233 | 100 | 25 | (16 | ) | (55 | ) | 734 | |||||||||||||||||||
Net amount |
4,535 | (4,122 | ) | (3,738 | ) | (3,968 | ) | (2,426 | ) | (6,990 | ) | (16,709 | ) | |||||||||||||||
As of December 31, 2008 | ||||||||||||||||||||||||||||
(M) | Less than | More than | ||||||||||||||||||||||||||
Assets/(Liabilities) | one year | 1-2 years | 2-3 years | 3-4 years | 4-5 years | 5 years | Total | |||||||||||||||||||||
Non-current financial debt (notional value excluding interests) |
(2,992 | ) | (3,658 | ) | (3,324 | ) | (3,232 | ) | (2,093 | ) | (15,299 | ) | ||||||||||||||||
Current borrowings |
(7,722 | ) | (7,722 | ) | ||||||||||||||||||||||||
Other current financial liabilities |
(158 | ) | (158 | ) | ||||||||||||||||||||||||
Current financial assets |
187 | 187 | ||||||||||||||||||||||||||
Cash and cash equivalents |
12,321 | 12,321 | ||||||||||||||||||||||||||
Net amount before financial expense |
4,628 | (2,992 | ) | (3,658 | ) | (3,324 | ) | (3,232 | ) | (2,093 | ) | (10,671 | ) | |||||||||||||||
Financial expense on non-current financial debt |
(554 | ) | (512 | ) | (431 | ) | (299 | ) | (189 | ) | (174 | ) | (2,159 | ) | ||||||||||||||
Interest differential on swaps |
118 | 211 | 100 | 62 | 37 | (7 | ) | 521 | ||||||||||||||||||||
Net amount |
4,192 | (3,293 | ) | (3,989 | ) | (3,561 | ) | (3,384 | ) | (2,274 | ) | (12,309 | ) | |||||||||||||||
Page 85
As of December 31 | ||||||||||||
(M) | ||||||||||||
Assets/(Liabilities) | 2010 | 2009 | 2008 | |||||||||
Accounts payable |
(18,450 | ) | (15,383 | ) | (14,815 | ) | ||||||
Other operating liabilities |
(3,574 | ) | (4,706 | ) | (4,297 | ) | ||||||
including financial instruments related to commodity contracts |
(559 | ) | (923 | ) | (1,033 | ) | ||||||
Accounts receivable, net |
18,159 | 15,719 | 15,287 | |||||||||
Other operating receivables |
4,407 | 5,145 | 6,208 | |||||||||
including financial instruments related to commodity contracts |
499 | 1,029 | 1,664 | |||||||||
Total |
542 | 775 | 2,383 | |||||||||
As of December 31, | ||||||||||||
(M) | ||||||||||||
Assets/(Liabilities) | 2010 | 2009 | 2008 | |||||||||
Loans to equity affiliates (Note 12) |
2,383 | 2,367 | 2,005 | |||||||||
Loans and advances (Note 14) |
1,596 | 1,284 | 1,403 | |||||||||
Hedging instruments of non-current financial debt (Note 20) |
1,870 | 1,025 | 892 | |||||||||
Accounts receivable (Note 16) |
18,159 | 15,719 | 15,287 | |||||||||
Other operating receivables (Note 16) |
4,407 | 5,145 | 6,208 | |||||||||
Current financial assets (Note 20) |
1,205 | 311 | 187 | |||||||||
Cash and cash equivalents (Note 27) |
14,489 | 11,662 | 12,321 | |||||||||
Total |
44,109 | 37,513 | 38,303 | |||||||||
Page 86
Page 87
| implementation of credit limits with different authorization procedures for possible credit overruns; | ||
| use of insurance policies or specific guarantees (letters of credit); | ||
| regular monitoring and assessment of overdue accounts (aging balance), including collection procedures; and | ||
| provisioning of bad debts on a customer-by-customer basis, according to payment delays and local payment practices (provisions may also be calculated based on statistics). |
Page 88
| As part of the spin-off of Arkema1 in 2006, TOTAL S.A. or certain other Group companies agreed to grant Arkema guarantees for potential monetary consequences related to antitrust proceedings arising from events prior to the spin-off. | |
These guarantees cover, for a period of ten years, 90% of amounts paid by Arkema related to (i) fines imposed by European authorities or European member-states for competition law violations, (ii) fines imposed by U.S. courts or antitrust authorities for federal antitrust violations or violations of the competition laws of U.S. states, (iii) damages awarded in civil proceedings related to the government proceedings mentioned above, and (iv) certain costs related to these proceedings. The guarantee related to anti-competition violations in Europe applies to amounts above a 176.5 million threshold. On the other hand, the agreements provide that Arkema will indemnify TOTAL S.A. or any Group company for 10% of any amount that TOTAL S.A. or any Group company are required to pay under any of the proceedings covered by these guarantees. | ||
If one or more individuals or legal entities, acting alone or together, directly or indirectly holds more than one-third of the voting rights of Arkema, or if Arkema transfers more than 50% of its assets (as calculated under the enterprise valuation method, as of the date of the transfer) to a third party or parties acting together, irrespective of the type or number of transfers, these guarantees will become void. | ||
| In the United States, investigations into certain commercial practices of some subsidiaries of the Arkema group have been closed since 2007; no charges have been brought against Arkema. Civil liability lawsuits, for which TOTAL S.A. has been named as the parent company, are about to be closed and are not expected to have a significant impact on the Groups financial position. | |
| In Europe, since May 2006, the European Commission has fined companies of the Group in its configuration prior to the spin-off an overall amount of 385.47 million, of which Elf Aquitaine and/or TOTAL S.A. and their subsidiaries were held jointly liable for 280.17 million, Elf Aquitaine being personally fined 23.6 million for deterrence. These fines are entirely settled as of today. | |
As a result2, since the spin-off, the Group has paid the overall amount of 188.07 million, corresponding to 90% of the fines overall amount once the threshold provided for by the guarantee is deducted. | ||
The European Commission imposed these fines following investigations between 2000 and 2004 into commercial practices involving eight products sold by Arkema. Five of these investigations resulted in prosecutions from the European Commission for which Elf Aquitaine has been named as the parent company, and two of these investigations named TOTAL S.A. as the ultimate parent company of the Group. | ||
TOTAL S.A. and Elf Aquitaine are contesting their liability based solely on their status as parent companies and appealed for cancellation and reformation of the rulings that are still pending before the relevant EU court of appeals or supreme court of appeals. | ||
Besides, a civil proceeding against Arkema and five groups of companies was initiated before a German regional court by a third party for an alleged damage pursuant to one of the above described legal proceedings. TOTAL S.A. was summoned to serve notice of the dispute before this court. At this point, the probability to have a favorable verdict and the financial impacts of this procedure are uncertain due to the number of legal difficulties it gave rise to, the lack of documented claim and the complex evaluation of the alleged damage. | ||
Arkema began implementing compliance procedures in 2001 that are designed to prevent its employees from violating antitrust provisions. However, it is not possible to exclude the possibility that the relevant authorities could commence additional proceedings involving Arkema regarding events prior to the spin-off, as well as Elf Aquitaine and/or TOTAL S.A. based on their status as parent company. |
1 | Arkema is used in this section to designate those companies of the Arkema group whose ultimate parent company is Arkema S.A. Arkema became an independent company after being spun-off from TOTAL S.A. in May 2006. | |
2 | This amount does not take into account a case that led to Arkema, prior to Arkemas spin-off from TOTAL, and Elf Aquitaine being fined jointly 45 million and Arkema being fined 13.5 million. This case is referred to in past Registration Documents. |
Page 89
| Pursuant to a statement of objections received by Total Nederland N.V. and TOTAL S.A. (based on its status as parent company) from the European Commission, Total Nederland N.V. was fined in 2006 20.25 million, which has been paid, and for which TOTAL S.A. was held jointly liable for 13.5 million. TOTAL S.A. appealed this decision before the relevant court and this appeal is still pending. | |
In addition, pursuant to a statement of objections received by Total Raffinage Marketing (formerly Total France) and TOTAL S.A. from the European Commission regarding another product line of the Refining & Marketing division, Total Raffinage Marketing was fined 128.2 million in 2008, which has been paid, and for which TOTAL S.A. was held jointly liable based on its status as parent company. TOTAL S.A. also appealed this decision before the relevant court and this appeal is still pending. | ||
| Finally, TotalGaz and Total Raffinage Marketing received a statement of objections from the French Antitrust Authority (Autorité de la concurrence française) regarding alleged antitrust practices concerning another product line of the Refining & Marketing division. The case was dismissed by decision of the French antitrust authorities on December 17, 2010. |
Page 90
Page 91
34) | Changes in progress in the Group structure |
| Upstream |
| TOTAL finalized in November 2010 an agreement in principle with Perenco, an independent exploration and production French company, to sell its 75.8% equity in its upstream Cameroonian affiliate Total E&P Cameroun. This agreement is subject to the Cameroonian Authorities approval. | ||
As of December 31, 2010, assets and liabilities of the affiliate Total E&P Cameroun have been classified respectively as Assets classified as held for sale on the face of the Consolidated Balance Sheet for 183 million and as Liabilities directly associated with the assets classified as held for sale on the face of the Consolidated Balance Sheet for 137 million. The concerned assets and liabilities mainly include tangible assets for 109 million and provisions and other non-current liabilities for 74 million. | |||
| In addition to the agreement signed during September 2010 (see Note 3 to the Consolidated Financial Statements), TOTAL signed in December 2010 an agreement to acquire an additional 7.5% interest in Australias GLNG project from Santos for an amount of $281 million. This will increase Totals overall stake in the project to 27.5%. | ||
At the same time, South Koreas Kogas has signed an agreement to join the project with a 15% stake. Once both transactions, which are subject to the approval of Australias Foreign Investment Review Board, have been finalized, interests in the project will be: Santos (30%, operator), Petronas (27.5%), TOTAL (27.5%) and Kogas (15%). | |||
| Total E&P Canada Ltd., a TOTAL subsidiary, and Suncor Energy Inc. (Suncor) have signed in December 2010 several agreements to form a strategic oil sands alliance encompassing the Suncor-operated Fort Hills mining project, the TOTAL-operated Joslyn mining project and the Suncor-operated Voyageur upgrader project. All three assets are located in the Athabasca region of the province of Alberta, in Canada. Under the alliance, the companies will pool their combined interests in these projects, with the respective operator holding 51% and the other partner 49%. | ||
The agreements comprise four significant and related transactions: |
| TOTAL is acquiring 19.2% of Suncors interest in the Fort Hills project. Taking into account the acquisition of UTS, finalized in September 2010, TOTAL will have an overall 39.2% interest in Fort Hills. Suncor, as operator, will hold 40.8%; | ||
| Suncor is acquiring 36.75% of TOTALs interest in the Joslyn project. TOTAL, as operator, will retain a 38.25% interest in the project; | ||
| TOTAL is also acquiring a 49% stake in the Suncor-operated Voyageur upgrader project; | ||
| As a result of the terms of these transactions and the related net balancing of the portfolio, in particular to contribute to the past costs of the Voyageur project, TOTAL will pay Suncor CAD 1,751 million, with a value date of January 1st, 2011. |
The implementation of the agreements is subject to securing the necessary regulatory approvals from the Government of Canada and certain other approvals. | |||
As a result of the agreements, TOTAL will no longer proceed with the planned construction of an upgrader in Edmonton. | |||
As of December 31, 2010, the share of assets and liabilities of the Joslyn mining project covered by the agreements has been classified respectively as Assets classified as held for sale on the face of the Consolidated Balance Sheet for 622 million and as Liabilities directly associated with the assets classified as held for sale on the face of the Consolidated Balance Sheet for 8 million. The concerned assets include mineral interests for 390 million and tangible assets for 232 million. |
Page 92
| Chemicals |
| TOTAL has announced in December 2010 a plan to sell its photocure and coatings resins businesses to Arkema for a 550 million enterprise value. The divestment is subject to the applicable legally required consultation and notification processes for employee representatives at TOTAL and Arkema and to the approval of the anti-trust authorities in the countries concerned. It could take place in the first half of 2011. | ||
As of December 31, 2010, assets and liabilities of the photocure and coatings resins businesses have been classified respectively as Assets classified as held for sale on the face of the Consolidated Balance Sheet for 465 million and as Liabilities directly associated with the assets classified as held for sale on the face of the Consolidated Balance Sheet for 52 million. The concerned assets mainly include a goodwill for 63 million, tangible assets for 196 million and inventories for 138 million. |
35. | Consolidation scope |
Page 93
,GYDYY&M"4.T1JIO5UN6:KM??P(,+
M'TZ\N/&N8"T[7#80+12[&C"SAJ+68=R@]DZ:L+$ )T;
MD`O1J9P:H)P>((?7:0HB]8TV>1&V:0,W>:&"H)R'H`$/FF^/,(F#H`L<\`&!
MI&;
MOYDW':" P$:U?N9[IP"=97.
MR?/VSC+9`X4^%_B<0$&XTXDG$0A!P-$%1QPKG;Q`0"E-#+6A*)U@` '>XKP%MP$FZU)5.'+6Y96FW6@-#`_>T(T2C
M[D_/N]*`JW>T]:V@1`L$D(^052/NG/&W'.1KA3J!K$;N%T>('`J!&HO&%97?
M16_EBVX5DU(4H(T$@`"64HQB(1*;E'*LP(+R\+?2H#3M72TE-!Q[MO6`#B=!
M-(@E@W@-OA#P"NP HNTF'ST
M2,9YG;LIG(-'G+,W"*F("1&>4`F6F0BX11(%HPF3\!^W(XH4H0`?H1(:-0@F`3)(
M\1%"HQZL0`BT,!*1P`!F43DL(U.#L!`ONA6%:#.IL`+-`0&TP"D90Q",P%(%
M<3,!8`@J`H\JHCX*X5L9\HT&02HWV(.NN(.J1E229I(M$`)C1585NE_`AP$]
ME7SG%:@/P%]:-4SYE?^H"!"H!;:BZ!55%4"I%I!?)YE3-A=RMEB$0C627>HF
M,1IX,[H+`0$4EG`5@O`7`Y$5@H,5!9-0?1,2!4,X3F$1Y3@5)-%;NPH3).%N
MQ+H2&B4)N%6J.Z$*XKB)F"`*3^9D$2%E/CI4\B6H$]I3/<54K<2@F=93)MFN*$FB9*5IKG1H$Z!6"VJI1*BH436O
MJ99JKH1>216P-G=I'JJL9'*J?I>JNC`?QV$5L.)'4HI0O.%NS9$;$YD1VH:(
MF?`I$W6`(Y$A^U$=[R$@B/`*BY0)J\$KS:&RW54=(6,?DZBP['!0?O1MK<#_
M&]_V':ZC&Z$B'0"5LI;`>2"2(B8!-/P(@W6Z,O_S32]U'-MFW5MTG?-V/)L
MU`/=V)C`TW\MUTB=EX\MU)&MV45=O9/LS`6]T)*=U7'9V28YSH9=SA"=TYN]
MTW'MTY:-#I@MVFEMS6R=V9-]SIB)PAF]V^68T()MVND@K<*=W*&]UXE=VHL-
MVGRMU6C-U5#=VEL\U94=V]\WV[JJW8X=U*O=U5C]U6']RZC=TMR-KTQMS%O]
MSJP]WGG]VKZMG>G\W+3MW<>MV@2IULH-W_+-W(,\T7Y=V/$;V!@RV!K-V]:-
MV[;I&'2:U&1]VM'=#F#$I-/MWN*-UZY-V>C@`ZSVX.@=X=#=W%KAX7#JLL'=
MR3V]X-B-#AH0!#Q*V@)N_]SW?=[L,!C@O=^ZS>)2GETS:B-VZG3@7R>WT-\37/#5C/VS%2S3G0NF2
4S:=D08[E0*8B5^;Q%BIF[_T9*J&2#8]=+,(=+$`U+DNM*+_=>(9>O
MR61+M?14(8?"MC1AP^14KX3"R"1,5WM,MX1,$CV$\)PEZ'QQZOS2?O>:Z+!V
M+H7_2+\`O#2M"TJX"S^-*A[P-D1=U$9]U$B=U$J]U$S=U$[]U$QM0^@0T_LV
MTSU]U5BM7,CS0ES=U5[]U6`=UF(]UF1=UF9-UB80`7>RR)1(G)CV5#[%5-D,
M`K(=\#E$3+\8")5855B$(,M84FD$"LI$"2_$0.6!?
M]D`($8$4V(=]]]=F,+$;`U8"4R9B!IB"*K=ZP(""KD!@J\!F*CB#+$>#-GB#
MK\<+`X4?!05!!U4H7U)/2E(>"Z4H^#%,^L$?F8*#3#B#2#52EZ3_)C7E5!O@
M`2,T(1*R'Q42'O@A"A^22O9S)B;2A&1H@$AU3+8$!4SE5.1@A3TB(K8$5$F%
M3/8#)5+"@F68AY#55C)2A7`U'NDQ5VI8)W5B`ZAS)D<2/8C21_)S)G@B)LRC
MAY+8>I+E19Q2*99E*">E))M21)VE*9#21)ERB9?H*4,UB:BX@MM04::P1ZC@
MBJD8B[,V3U/B*)P2A9ZRA"=U1[+0*:'%49-2*;(XC*Y&BR!21#?2`>7#(TG5
M6B^T67:D*498'Q(E0+F#'D&4(+!(C-R886?('VD8)0KB1\S0232R(%'%(2-B
M.V<5/M